document_id	entity_type	entity_text	entity_span
25591652_en	DISO	seizure	32-39
25591652_en	DISO	epileptic seizure	22-39
25591652_en	CHEM	antiepileptic drugs	68-87
25591652_en	CHEM	AED	89-92
25591652_en	DISO	seizure	202-209
25591652_en	CHEM	topiramate	352-362
25591652_en	CHEM	TPM	364-367
25591652_en	CHEM	valproates	389-399
25591652_en	CHEM	VPA	401-404
25591652_en	CHEM	carbamazepine	413-426
25591652_en	CHEM	CBZ	428-431
25591652_en	CHEM	lamotrigine	440-451
25591652_en	CHEM	LTG	453-456
25591652_en	CHEM	levetiracetam	468-481
25591652_en	CHEM	LEV	483-486
25591652_en	DISO	epilepsies	533-543
25591652_en	DISO	idiopathic generalized epilepsies	510-543
25591652_en	DISO	IGE	545-548
25591652_en	CHEM	CBZ	576-579
25591652_en	CHEM	VPA	593-596
25591652_en	CHEM	TPM	605-608
25591652_en	CHEM	LTG	617-620
25591652_en	CHEM	LEV	632-635
25591652_en	CHEM	CBZ	645-648
25591652_en	DISO	epilepsy	703-711
25591652_en	DISO	juvenile absence epilepsy	686-711
25591652_en	DISO	JAE	713-716
25591652_en	DISO	epilepsy	778-786
25591652_en	DISO	childhood absence epilepsy	760-786
25591652_en	DISO	CAE	788-791
25591652_en	DISO	myoclonic jerks	827-842
25591652_en	DISO	epilepsy	865-873
25591652_en	DISO	myoclonic	855-864
25591652_en	DISO	myoclonic epilepsy	855-873
25591652_en	DISO	juvenile myoclonic epilepsy	846-873
25591652_en	DISO	JME	875-878
25591652_en	ANATOMY	eyelid	916-922
25591652_en	DISO	myoclonus	923-932
25591652_en	DISO	eyelid myoclonus	916-932
25591652_en	DISO	Jeavons syndrome	934-950
25591652_en	FINDING	Seizure aggravations	976-996
25591652_en	CHEM	AEDs	1012-1016
25591652_en	DISO	epilepsy	1106-1114
25591652_en	FINDING	Seizure aggravation	1137-1156
25591652_en	CHEM	AEDs	1187-1191
25591652_en	DISO	epilepsy	1244-1252
25591652_en	DISO	resistant epilepsy	1234-1252
25591652_en	FINDING	poor outcome	1257-1269
25591652_en	CHEM	CBZ	1311-1314
25591652_en	DISO	IGE	1344-1347
25591652_en	CHEM	TPM	1363-1366
25591652_en	CHEM	VPA	1376-1379
25591652_en	CHEM	LTG	1385-1388
25591652_en	CHEM	LEV	1394-1397
25591652_en	CHEM	clonazepam	1411-1421
25591652_en	FINDING	seizure aggravation	1448-1467
25591652_en	CHEM	CBZ	1488-1491
25591652_en	DISO	IGE	1495-1498
25591652_en	CHEM	LTG	1525-1528
25591652_en	CHEM	TPM	1530-1533
25591652_en	CHEM	CBZ	1538-1541
25591652_en	DISO	epileptic syndromes	1565-1584
25591652_en	DISO	IGE	1590-1593
25591652_en	CHEM	AEDs	1654-1658
25591652_en	DISO	Seizures	1683-1691
25591652_en	CHEM	TPM	1753-1756
25591652_en	DISO	Seizure	1775-1782
25591652_en	CHEM	AEDs	1810-1814
25591652_en	CHEM	AEDs	1849-1853
25591652_en	FINDING	seizure aggravation	1903-1922
25591652_en	CHEM	LTG	1953-1956
25591652_en	CHEM	CBZ	1965-1968
25591652_en	CHEM	TPM	1980-1983
25591652_en	CHEM	AEDs	2033-2037
25591652_en	DISO	seizures	2071-2079
25591652_en	FINDING	Aggravated seizures	265-284
25591652_en	FINDING	poor outcome	1874-1886
25591652_en	DISO	resistant epilepsy	1096-1114
25591652_en	DISO	non IGE	1586-1593
25591652_en	FINDING	seizure aggravation	202-221
25591652_en	FINDING	epileptic seizure aggravation	22-51
25591652_en	DISO	seizures	276-284
25591652_en	DISO	Seizure	1137-1144
25591652_en	DISO	seizure	1448-1455
25591652_en	FINDING	Seizures aggravation	1683-1703
25591652_en	FINDING	Seizure aggravation	1775-1794
25591652_en	DISO	seizure	1903-1910
25591652_en	LABPROC	titration	2038-2047
25591652_en	FINDING	poor prognosis	1119-1133
25591652_en	DISO	Seizure	976-983
25591652_en	FINDING	risk of aggravation	2007-2026
25591652_en	FINDING	reduce the risk of aggravation	1996-2026
25591652_en	FINDING	aggravation	559-570
25591652_en	FINDING	aggravated absences	649-668
25591652_en	FINDING	"True" aggravation	1272-1290
25591652_en	DISO	absences	814-822
25591652_en	DISO	absences	660-668
25591652_en	DISO	absences	902-910
25591652_en	PHYS	adult	97-102
25591652_en	DISO	epileptic	22-31
25591652_en	PHYS	childhood	760-769
25591652_en	FINDING	aggravation	1064-1075
25591652_en	FINDING	pattern of aggravation	1053-1075
25591652_en	FINDING	aggravation	1669-1680
25591652_en	FINDING	aggravation	2015-2026
25726786_en	DISO	cognitive impairment	6-26
25726786_en	DISO	Mild cognitive impairment	1-26
25726786_en	ANATOMY	coronary	44-52
25726786_en	ANATOMY	artery	53-59
25726786_en	ANATOMY	coronary artery	44-59
25726786_en	DISO	coronary artery disease	44-67
25726786_en	LABPROC	EEG	94-97
25726786_en	DISO	cognitive impairment	181-201
25726786_en	DISO	mild cognitive impairment	176-201
25726786_en	DISO	MCI	203-206
25726786_en	LABPROC	electroencephalogram	242-262
25726786_en	LABPROC	EEG	264-267
25726786_en	ANATOMY	coronary	301-309
25726786_en	ANATOMY	artery	310-316
25726786_en	ANATOMY	coronary artery	301-316
25726786_en	DISO	coronary artery disease	301-324
25726786_en	DISO	CAD	326-329
25726786_en	DISO	MCI	371-374
25726786_en	PHYS	male	424-428
25726786_en	DISO	CAD	443-446
25726786_en	DISO	MCI	499-502
25726786_en	ANATOMY	coronary	765-773
25726786_en	DISO	lesions	774-781
25726786_en	FINDING	more severe coronary lesions	753-781
25726786_en	ANATOMY	cardiac	792-799
25726786_en	ANATOMY	parietooccipital	862-878
25726786_en	DISO	CAD	913-916
25726786_en	DISO	MCI	931-934
25726786_en	DISO	MCI	964-967
25726786_en	DISO	MCI	995-998
25726786_en	DISO	CAD	1130-1133
25726786_en	ANATOMY	coronary	1165-1173
25726786_en	ANATOMY	artery	1174-1180
25726786_en	DISO	lesions	1181-1188
25726786_en	ANATOMY	coronary artery	1165-1180
25726786_en	DISO	coronary artery lesions	1165-1188
25726786_en	ANATOMY	cardiac	1197-1204
25726786_en	ANATOMY	cerebral	1240-1248
25726786_en	DISO	ischemia	1249-1257
25726786_en	DISO	cerebral ischemia	1240-1257
25726786_en	ANATOMY	neuronal	1262-1270
25726786_en	DISO	dysfunction	1271-1282
25726786_en	DISO	neuronal dysfunction	1262-1282
25726786_en	LABPROC	EEG	1304-1307
25726786_en	LABPROC	EEG	1345-1348
25726786_en	DISO	cognitive disorders	1404-1423
25726786_en	DISO	CAD	1427-1430
25726786_en	PHYS	cardiac contractility	792-813
25726786_en	DISO	depression	686-696
25726786_en	PHYS	cardiac contractility	1197-1218
25726786_en	FINDING	lower cardiac contractility	786-813
25726786_en	FINDING	low cardiac contractility	1193-1218
25726786_en	FINDING	severity of coronary artery lesions	1153-1188
25726786_en	FINDING	higher spectral power	826-847
25726786_en	PHYS	theta activity	879-893
25726786_en	PHYS	parietooccipital theta activity	862-893
25726786_en	FINDING	topographical features	216-238
25726786_en	DISO	coronary lesions	765-781
25726786_en	FINDING	clinical factors	127-159
25726786_en	FINDING	demographic factors	140-159
25726786_en	FINDING	lower level of education	727-751
25726786_en	FINDING	efficacy of quantitative EEG analysis	1320-1357
25726786_en	PHYS	healthy	543-550
25726786_en	ANATOMY	Frontal	607-614
25726786_en	PHYS	Θ-rhythm	849-857
25726786_en	FINDING	an important factor to preserve cognitive abilities	1061-1112
25726786_en	FINDING	EEG power	1304-1313
25823269_en	ANATOMY	pulmonary	46-55
25823269_en	DISO	hypertension	56-68
25823269_en	DISO	stress-induced pulmonary hypertension	31-68
25823269_en	DISO	sclerosis	95-104
25823269_en	DISO	systemic sclerosis	86-104
25823269_en	ANATOMY	pulmonary	188-197
25823269_en	ANATOMY	artery	198-204
25823269_en	ANATOMY	pulmonary artery	188-204
25823269_en	PHYS	mean pulmonary artery pressure	183-213
25823269_en	PHYS	MPAP	215-219
25823269_en	ANATOMY	pulmonary	301-310
25823269_en	DISO	hypertension	311-323
25823269_en	DISO	stress-induced pulmonary hypertension	286-323
25823269_en	DISO	SIPH	325-329
25823269_en	DISO	sclerosis	400-409
25823269_en	DISO	systemic sclerosis	391-409
25823269_en	DISO	SDS	411-414
25823269_en	ANATOMY	pulmonary	443-452
25823269_en	DISO	hypertension	453-465
25823269_en	DISO	pulmonary hypertension	443-465
25823269_en	DISO	PH	467-469
25823269_en	ANATOMY	lung	472-476
25823269_en	ANATOMY	heart	486-491
25823269_en	ANATOMY	left heart	481-491
25823269_en	DISO	heart injuries	486-500
25823269_en	DISO	left heart injuries	481-500
25823269_en	DISO	thromboembolism	505-520
25823269_en	ANATOMY	pulmonary	565-574
25823269_en	ANATOMY	artery	575-581
25823269_en	PHYS	hemodynamic	633-644
25823269_en	ANATOMY	atrial	652-658
25823269_en	ANATOMY	right atrial	646-658
25823269_en	PHYS	right atrial pressure	646-667
25823269_en	PHYS	RAP	669-672
25823269_en	PHYS	systolic pressure	675-706
25823269_en	PHYS	MPAP	708-712
25823269_en	ANATOMY	pulmonary	714-723
25823269_en	ANATOMY	artery	724-730
25823269_en	ANATOMY	pulmonary artery	714-730
25823269_en	PHYS	pulmonary artery wedge pressure	714-745
25823269_en	PHYS	PAWP	747-751
25823269_en	ANATOMY	cardiac	754-761
25823269_en	PHYS	cardiac output	754-768
25823269_en	PHYS	CO	770-772
25823269_en	LABPROC	thermodilution technique	779-803
25823269_en	ANATOMY	pulmonary	903-912
25823269_en	ANATOMY	arterial	913-921
25823269_en	DISO	hypertension	922-934
25823269_en	DISO	pulmonary arterial hypertension	903-934
25823269_en	DISO	PAH	936-939
25823269_en	DISO	SIPH	978-982
25823269_en	DISO	PAH	1115-1118
25823269_en	DISO	PH	1172-1174
25823269_en	PHYS	MPAP	1241-1245
25823269_en	DISO	SIPH	1324-1328
25823269_en	PHYS	MPAP	1339-1343
25823269_en	PHYS	MPAP	1506-1510
25823269_en	DISO	SIPH	1565-1569
25823269_en	PHYS	MPAP	1613-1617
25823269_en	ANATOMY	pulmonary	1631-1640
25823269_en	ANATOMY	vascular	1641-1649
25823269_en	PHYS	pulmonary vascular resistance	1631-1660
25823269_en	PHYS	PVR	1662-1665
25823269_en	PHYS	PAWP	1671-1675
25823269_en	DISO	SIPH	1737-1741
25823269_en	CHEM	uric acid	1763-1772
25823269_en	DISO	SIPH	1796-1800
25823269_en	PHYS	telangiectasias	1863-1878
25823269_en	LABPROC	EchoCG	1915-1921
25823269_en	ANATOMY	lung	1926-1930
25823269_en	PHYS	MPAP	2015-2019
25823269_en	PHYS	transpulmonary gradient	2024-2047
25823269_en	PHYS	MPAP	2074-2078
25823269_en	PHYS	CO	2079-2081
25823269_en	CHEM	NT-proBNP	2092-2101
25823269_en	CHEM	NT-proBNP	1845-1854
25823269_en	DISO	SDS	2162-2165
25823269_en	DISO	SIPH	2167-2171
25823269_en	ANATOMY	pulmonary	2190-2199
25823269_en	DISO	vasculopathy	2200-2212
25823269_en	DISO	pulmonary vasculopathy	2190-2212
25823269_en	DISO	PAH	2255-2258
25823269_en	DISO	PAH	2280-2283
25823269_en	DISO	SDS	2406-2409
25823269_en	DISO	PAH	2421-2424
25823269_en	PHYS	hemodynamic	124-135
25823269_en	LABPROC	exercise test	1458-1471
25823269_en	DISO	pulmonary hypertension	46-68
25823269_en	DISO	pulmonary hypertension	301-323
25823269_en	FINDING	tended to decrease	2109-2127
25823269_en	PHYS	NT-proBNP levels	1845-1861
25823269_en	LABPROC	lung test	1926-1935
25823269_en	FINDING	elevated mean pulmonary artery pressure	174-213
25823269_en	ANATOMY	pulmonary artery	565-581
25823269_en	ANATOMY	pulmonary arterial	903-921
25823269_en	CHEM	anti-centromere antibodies	1883-1909
25823269_en	FINDING	decrease	2003-2011
25823269_en	PHYS	diastolic pressure	688-706
25823269_en	FINDING	improve lifetime prognosis	2362-2388
25823269_en	CHEM	bosentan	266-274
25823269_en	CHEM	bosentan	11-19
25823269_en	CHEM	bosentan	1000-1008
25823269_en	CHEM	bosentan	1961-1969
25823269_en	FINDING	prognosis	2379-2388
25823269_en	FINDING	risk for PAH	1106-1118
25823269_en	FINDING	increased risk for PAH	1096-1118
25823269_en	DISO	lung injuries	472-500
25823269_en	FINDING	risk of pulmonary arterial hypertension	895-934
25823269_en	FINDING	no signs of PH	1160-1174
25823269_en	FINDING	signs of PH	1163-1174
25823269_en	ANATOMY	pulmonary vascular	1631-1649
25823269_en	FINDING	higher levels	1588-1601
25823269_en	FINDING	calculated DETECT risk was significantly higher	1682-1729
25823269_en	FINDING	level of uric acid was also higher	1754-1788
25823269_en	FINDING	no changes	1831-1841
25823269_en	CHEM	antibodies	1899-1909
25823269_en	PHYS	NT-proBNP levels	2092-2108
25823269_en	PHYS	PVR	2069-2072
25823269_en	PHYS	MPAP/CO ratio	2074-2087
25823269_en	FINDING	precedes the development of clinical PAH	2218-2258
25823269_en	CHEM	PAH-specific drugs	2280-2298
25823269_en	FINDING	no diagnostic changes	1387-1408
25823269_en	DISO	SDS-associated PAH	2406-2424
25823269_en	FINDING	correlations	1485-1497
25823269_en	PHYS	clinical changes	140-156
25823269_en	PHYS	pressure	659-667
25823269_en	PHYS	pressure	737-745
25823269_en	CHEM	acid	1768-1772
25823269_en	PHYS	level of uric acid	1754-1772
25823269_en	PHYS	lifetime	2370-2378
25823273_en	ANATOMY	Cardiovascular	1-15
25823273_en	ANATOMY	cardiovascular	173-187
25823273_en	DISO	cardiovascular diseases	173-196
25823273_en	DISO	Cardiovascular diseases	1-24
25823273_en	ANATOMY	blood	580-585
25823273_en	LABPROC	immunological tests	598-617
25823273_en	LABPROC	electrocardiography	623-642
25823273_en	ANATOMY	blood	728-733
25823273_en	LABPROC	blood biochemical test	728-750
25823273_en	DISO	hypertension	845-857
25823273_en	CHEM	sulfur dioxide	903-917
25823273_en	CHEM	sulfur	903-909
25823273_en	ANATOMY	heart	1002-1007
25823273_en	ANATOMY	coronary	993-1001
25823273_en	DISO	coronary heart disease	993-1015
25823273_en	DISO	CHD	1017-1020
25823273_en	CHEM	nitrogen	1055-1063
25823273_en	CHEM	nitrogen dioxide	1055-1071
25823273_en	DISO	hypertension	1219-1231
25823273_en	DISO	CHD	1236-1239
25823273_en	CHEM	copper	938-944
25823273_en	CHEM	zinc	968-972
25823273_en	LABPROC	biochemical test	734-750
25823273_en	CHEM	zinc	1095-1099
25823273_en	LABPROC	blood general tests	580-617
25823273_en	FINDING	high concentration of sulfur dioxide	881-917
25823273_en	FINDING	high levels of nitrogen dioxide	1040-1071
25823273_en	FINDING	development of hypertension	830-857
25823273_en	DISO	heart disease	1002-1015
25823273_en	PHYS	adult	332-337
25823273_en	DISO	chronic diseases	511-527
25823273_en	FINDING	may result from the influence of EFs	1277-1313
25823273_en	CHEM	dioxide	910-917
25823273_en	CHEM	dioxide	1064-1071
25823273_en	FINDING	development of cardiovascular diseases	158-196
25823273_en	FINDING	influence of environmental factors (EFs)	110-150
25823274_en	ANATOMY	Lung	1-5
25823274_en	LABPROC	ultrasonography	6-21
25823274_en	DISO	pneumonia	43-52
25823274_en	PHYS	pregnant	56-64
25823274_en	ANATOMY	blood	76-81
25823274_en	DISO	tumors	89-95
25823274_en	DISO	blood system tumors	76-95
25823274_en	LABPROC	ultrasonography	141-156
25823274_en	LABPROC	USG	158-161
25823274_en	ANATOMY	lung	183-187
25823274_en	DISO	lung injuries	183-196
25823274_en	PHYS	pregnant	200-208
25823274_en	ANATOMY	blood	220-225
25823274_en	DISO	tumors	233-239
25823274_en	DISO	blood system tumors	220-239
25823274_en	ANATOMY	Lung	263-267
25823274_en	LABPROC	ultrasound	268-278
25823274_en	PHYS	pregnant	298-306
25823274_en	ANATOMY	blood	321-326
25823274_en	DISO	cancers	327-334
25823274_en	DISO	blood cancers	321-334
25823274_en	PHYS	gestational	370-381
25823274_en	DISO	leukemia	444-452
25823274_en	DISO	acute leukemia	438-452
25823274_en	ANATOMY	mediastinal	470-481
25823274_en	ANATOMY	large B-cell	482-494
25823274_en	DISO	lymphoma	495-503
25823274_en	DISO	B-cell lymphoma	488-503
25823274_en	DISO	large B-cell lymphoma	482-503
25823274_en	DISO	mediastinal large B-cell lymphoma	470-503
25823274_en	ANATOMY	blood	546-551
25823274_en	DISO	cancer	552-558
25823274_en	DISO	blood cancer	546-558
25823274_en	ANATOMY	lung	586-590
25823274_en	DISO	lung injury	586-597
25823274_en	LABPROC	USG	599-602
25823274_en	DISO	respiratory failure	733-752
25823274_en	DISO	acute respiratory failure	727-752
25823274_en	ANATOMY	pleural	874-881
25823274_en	DISO	effusion	882-890
25823274_en	DISO	pleural effusion	874-890
25823274_en	DISO	pneumonia	924-933
25823274_en	DISO	bilateral pneumonia	914-933
25823274_en	ANATOMY	alveolar	938-946
25823274_en	DISO	alveolar-interstitial syndrome	938-968
25823274_en	DISO	pneumonia	995-1004
25823274_en	DISO	right-sided pneumonia	983-1004
25823274_en	ANATOMY	pulmonary	1056-1065
25823274_en	DISO	edema	1066-1071
25823274_en	DISO	pulmonary edema	1056-1071
25823274_en	DISO	transfusion-related pulmonary edema	1036-1071
25823274_en	ANATOMY	Lung	1079-1083
25823274_en	LABPROC	ultrasound	1084-1094
25823274_en	LABPROC	Lung ultrasound	1079-1094
25823274_en	LABPROC	Lung ultrasonography	1-21
25823274_en	DISO	pneumonia	1127-1136
25823274_en	LABPROC	USG	1165-1168
25823274_en	DISO	Pneumocystis	1256-1268
25823274_en	DISO	pneumonia	1269-1278
25823274_en	DISO	Pneumocystis pneumonia	1256-1278
25823274_en	ANATOMY	lung	1408-1412
25823274_en	LABPROC	ultrasound	1413-1423
25823274_en	LABPROC	lung ultrasound	1408-1423
25823274_en	PHYS	pregnant	1443-1451
25823274_en	PHYS	gestation	1530-1539
25823274_en	DISO	infectious	1597-1607
25823274_en	ANATOMY	Lung	1654-1658
25823274_en	ANATOMY	lung	1689-1693
25823274_en	DISO	lung injury	1689-1700
25823274_en	PHYS	pregnant	1704-1712
25823274_en	ANATOMY	blood	1724-1729
25823274_en	DISO	cancers	1730-1737
25823274_en	DISO	blood cancers	1724-1737
25823274_en	FINDING	gestational age	370-385
25823274_en	DISO	left-sided one pneumonia	1011-1004
25823274_en	DISO	infectious complications	1597-1621
25823274_en	LABPROC	Lung ultrasound	263-278
25823274_en	FINDING	clinical improvements	1361-1382
25823274_en	FINDING	normalization of the lung ultrasound pattern	1387-1431
25823274_en	ANATOMY	lavage fluid	1324-1336
25823274_en	ANATOMY	blood system	220-232
25823274_en	ANATOMY	blood system	76-88
25823274_en	FINDING	no pathogens in lavage fluid	1308-1336
25823274_en	LABPROC	Lung sound	1654-1664
25823274_en	FINDING	lung ultrasound pattern	1408-1431
25823274_en	LABPROC	dynamic air bronchogram	846-869
25823274_en	FINDING	USG data	1165-1173
25823274_en	LABPROC	air bronchogram	854-869
25823274_en	DISO	primary mediastinal large B-cell lymphoma	462-503
25823274_en	PHYS	respiratory	733-744
25823274_en	ANATOMY	interstitial	947-959
25823274_en	PHYS	delivered	1478-1487
25823274_en	PHYS	healthy	1558-1565
25823274_en	PHYS	died	1587-1591
25823274_en	PHYS	birth	1549-1554
25823274_en	DISO	complications	1608-1621
25823275_en	CHEM	arbidol	22-29
25823275_en	CHEM	umifenovir	31-41
25823275_en	DISO	influenza	61-70
25823275_en	CHEM	Arbidol	223-230
25823275_en	CHEM	umifenovir	232-242
25823275_en	DISO	influenza	267-276
25823275_en	DISO	influenza	494-503
25823275_en	ANATOMY	respiratory tract	513-530
25823275_en	DISO	infection	531-540
25823275_en	DISO	acute respiratory tract infection	507-540
25823275_en	CHEM	umifenovir	663-673
25823275_en	CHEM	umifenovir	903-913
25823275_en	DISO	influenza	970-979
25823275_en	FINDING	laboratory-confirmed influenza	998-1028
25823275_en	DISO	influenza	1019-1028
25823275_en	DISO	influenza	1063-1072
25823275_en	CHEM	Umifenovir	1127-1137
25823275_en	FINDING	laboratory-confirmed influenza	1297-1327
25823275_en	DISO	influenza	1318-1327
25823275_en	CHEM	umifenovir	1335-1345
25823275_en	DISO	catarrhal symptoms	1448-1466
25823275_en	CHEM	umifenovir	1501-1511
25823275_en	CHEM	Umifenovir	1643-1653
25823275_en	DISO	influenza	1742-1751
25823275_en	FINDING	shedding influenza virus	1733-1757
25823275_en	FINDING	viral shedding	1682-1696
25823275_en	CHEM	umifenovir	1800-1810
25823275_en	CHEM	umifenovir	1918-1928
25823275_en	DISO	influenza	1949-1958
25823275_en	CHEM	placebo	1524-1531
25823275_en	CHEM	placebo	1393-1400
25823275_en	CHEM	placebo	384-391
25823275_en	CHEM	placebo	145-152
25823275_en	CHEM	placebo	1829-1836
25823275_en	DISO	intoxication	1471-1483
25823275_en	CHEM	placebo	712-719
25823275_en	DISO	respiratory tract infection	513-540
25823275_en	FINDING	durations of virus shedding	849-876
25823275_en	FINDING	time to resolution of all symptoms	779-813
25823275_en	FINDING	severity of symptoms and illness	815-847
25823275_en	FINDING	time to resolution of all symptoms	1159-1193
25823275_en	FINDING	reduced with umifenovir compared to placebo	1488-1531
25823275_en	FINDING	reduction of time to resolution of all symptoms of the disease	2041-2103
25823275_en	FINDING	reducing the severity of symptoms of the disease and durations of virus shedding	2105-2185
25823275_en	FINDING	efficacy and safety of Arbidol	200-230
25823275_en	FINDING	efficacy of umifenovir	891-913
25823275_en	FINDING	Severity of illness	1427-1446
25823275_en	FINDING	Clinical efficacy of arbidol	1-29
25823275_en	PHYS	adult	247-252
25823275_en	PHYS	respiratory	513-524
25823275_en	FINDING	efficacy	755-763
25823275_en	FINDING	clinical and epidemiological data	1091-1124
25823275_en	FINDING	reater compared to placebo group	1374-1406
25823275_en	FINDING	All symptoms were resolved	1196-1222
25823275_en	FINDING	ignificantly reduced in the umifenovir group compared to placebo	1772-1836
25823275_en	FINDING	most pronounced in the acute stage of the disease	1972-2021
25823275_en	FINDING	durations of virus shedding	2158-2185
25823275_en	FINDING	the severity of symptoms of the disease	2114-2153
25842921_en	DISO	ischemic cardiomyopathy	26-49
25842921_en	DISO	ischemic cardiomyopathy	75-98
25842921_en	DISO	chronic heart disease	151-172
25842921_en	DISO	CHD	283-286
25842921_en	LABPROC	cardiac biopsies	315-331
25842921_en	DISO	CHD	395-398
25842921_en	ANATOMY	myocardia	403-412
25842921_en	DISO	atherosclerosis	466-481
25842921_en	CHEM	vasopressin	565-576
25842921_en	LABPROC	immunohistological procedures	661-690
25842921_en	LABPROC	electron microscopic	692-712
25842921_en	LABPROC	morphometry	753-764
25842921_en	LABPROC	ECG	876-879
25842921_en	CHEM	vasopressin	931-942
25842921_en	ANATOMY	microvessels	1285-1297
25842921_en	ANATOMY	cardiomyocytes	1299-1313
25842921_en	ANATOMY	stroma	1315-1321
25842921_en	ANATOMY	lymph capillaries	1323-1340
25842921_en	ANATOMY	nerve endings	1346-1359
25842921_en	PHYS	secretion	1375-1384
25842921_en	ANATOMY	vascular bed	1468-1480
25842921_en	ANATOMY	myocardial tissue	1485-1502
25842921_en	DISO	lesions	1544-1551
25842921_en	PHYS	lymphocirculatory	1608-1625
25842921_en	PHYS	innervation	1627-1638
25842921_en	ANATOMY	cardiomyocyte	1683-1696
25842921_en	FINDING	myocardial changes	1738-1756
25842921_en	DISO	coronary atherosclerosis	1836-1860
25842921_en	ANATOMY	myocardium	1893-1903
25842921_en	DISO	hypoxia	1966-1973
25842921_en	DISO	CHD	2070-2073
25842921_en	DISO	CHD	2101-2104
25842921_en	DISO	CHD	2257-2260
25842921_en	DISO	ischemic	26-34
25842921_en	DISO	cardiomyopathy	35-49
25842921_en	DISO	ICM	100-103
25842921_en	DISO	ischemic	75-83
25842921_en	DISO	cardiomyopathy	84-98
25842921_en	ANATOMY	heart	159-164
25842921_en	DISO	heart disease	159-172
25842921_en	DISO	CHD	174-177
25842921_en	ANATOMY	heart	206-211
25842921_en	DISO	heart failure	206-219
25842921_en	LABPROC	biopsies	323-331
25842921_en	ANATOMY	aortocoronary	362-375
25842921_en	ANATOMY	coronary	536-544
25842921_en	DISO	coronary insufficiency	536-558
25842921_en	LABPROC	histochemical	642-655
25842921_en	ANATOMY	blood	830-835
25842921_en	DISO	CHD	985-988
25842921_en	ANATOMY	endothelial	1001-1012
25842921_en	CHEM	triglyceride	852-864
25842921_en	ANATOMY	blood	1112-1117
25842921_en	PHYS	blood flow	1112-1122
25842921_en	DISO	impaired blood flow	1103-1122
25842921_en	DISO	hypoxia	1130-1137
25842921_en	ANATOMY	myocardial	1158-1168
25842921_en	ANATOMY	capillaries	1329-1340
25842921_en	ANATOMY	lymph	1323-1328
25842921_en	ANATOMY	nerve	1346-1351
25842921_en	ANATOMY	myocardial	1485-1495
25842921_en	ANATOMY	tissue	1496-1502
25842921_en	DISO	occurring lesions	1534-1551
25842921_en	DISO	cardiosclerosis	1580-1595
25842921_en	DISO	diffuse cardiosclerosis	1572-1595
25842921_en	ANATOMY	myocardial	1738-1748
25842921_en	DISO	ICM	1783-1786
25842921_en	ANATOMY	coronary	1836-1844
25842921_en	DISO	atherosclerosis	1845-1860
25842921_en	DISO	ICM	2145-2148
25842921_en	ANATOMY	heart	2183-2188
25842921_en	DISO	heart failure	2183-2196
25842921_en	ANATOMY	cardiac	315-322
25842921_en	CHEM	cholesterol	836-847
25842921_en	ANATOMY	microhemocirculatory bed	1053-1077
25842921_en	ANATOMY	fascicules	1201-1211
25842921_en	PHYS	conduction	1644-1654
25842921_en	DISO	damaged myocardium	1885-1903
25842921_en	LABPROC	electron histochemical studies	717-747
25842921_en	PHYS	microhemocirculatory	1053-1073
25842921_en	CHEM	trophic	1028-1035
25842921_en	CHEM	trophic component	1028-1045
25842921_en	LABPROC	biochemical monitoring	804-826
25842921_en	LABPROC	ECG monitoring	876-890
25842921_en	PHYS	triglyceride levels	852-871
25842921_en	PHYS	adaptive responses	1404-1422
25842921_en	DISO	damage to the vascular bed	1454-1480
25842921_en	LABPROC	histological	628-640
25842921_en	PHYS	morphological changes	1927-1948
25842921_en	DISO	chronic heart failure	198-219
25842921_en	PHYS	levels	865-871
25842921_en	FINDING	changes in secretion	1364-1384
25842921_en	FINDING	symptoms of damage to the vascular bed and myocardial tissue	1442-1502
25842921_en	DISO	damage to microvessels	1275-1297
25842921_en	DISO	damage to cardiomyocytes	1275-1313
25842921_en	DISO	damage to stroma	1275-1321
25842921_en	DISO	damage to lymph capillaries	1275-1340
25842921_en	DISO	damage to nerve endings	1275-1359
25842921_en	DISO	damage to the myocardial tissue	1454-1502
25842921_en	DISO	irregular diffuse cardiosclerosis	1562-1595
25842921_en	DISO	conduction disturbances	1644-1667
25842921_en	DISO	innervation disturbances	1627-1667
25842921_en	DISO	lymphocirculatory disturbances	1608-1667
25842921_en	DISO	micro disturbances	1597-1667
25842921_en	DISO	cardiomyocyte damage	1683-1703
25842921_en	FINDING	Functional morphology of ischemic cardiomyopathy	1-49
25842921_en	PHYS	Compensatory responses	1387-1422
25842921_en	DISO	chronic CHD	2093-2104
25842921_en	DISO	chronic heart failure	2175-2196
25842921_en	FINDING	pathogenesis and morphogenesis of CHD	2223-2260
25842921_en	FINDING	endothelial changes	1001-1020
25842921_en	FINDING	progression of chronic CHD	2078-2104
25842921_en	FINDING	coronary atherosclerosis progresses	1836-1871
25842921_en	LABPROC	histochemical studies	726-747
25842921_en	DISO	insufficiency	545-558
25842923_en	ANATOMY	lung biopsies	629-642
25842923_en	DISO	NSIP	702-706
25842923_en	DISO	COP	740-743
25842923_en	DISO	BO	746-748
25842923_en	CHEM	hematoxylin	798-809
25842923_en	CHEM	eosin	814-819
25842923_en	LABPROC	immunohistochemical reactions	854-883
25842923_en	CHEM	MMP-1	911-916
25842923_en	CHEM	MMP-2	918-923
25842923_en	CHEM	MMP-7	925-930
25842923_en	CHEM	vimentin	963-971
25842923_en	CHEM	SMA	1004-1007
25842923_en	CHEM	TGF-β	1030-1035
25842923_en	CHEM	TNF-α	1037-1042
25842923_en	CHEM	CD34	1044-1048
25842923_en	CHEM	Ost-4	1050-1055
25842923_en	CHEM	LSAB	1188-1192
25842923_en	DISO	IIPs	1365-1369
25842923_en	ANATOMY	respiratory acinus	1439-1457
25842923_en	DISO	inflammatory infiltrate	1501-1524
25842923_en	ANATOMY	lung tissue	1607-1618
25842923_en	ANATOMY	mesenchymal cell	1624-1640
25842923_en	ANATOMY	myofibroblast	1646-1659
25842923_en	ANATOMY	mesenchymal stem cell	1713-1734
25842923_en	CHEM	Oct-4	1752-1757
25842923_en	CHEM	Vimentin	1759-1767
25842923_en	CHEM	SMA	1769-1772
25842923_en	CHEM	CD117	1774-1779
25842923_en	CHEM	CD34	1785-1789
25842923_en	ANATOMY	SCN	1863-1866
25842923_en	ANATOMY	SCN	2030-2033
25842923_en	ANATOMY	respiratory acinus	2047-2065
25842923_en	ANATOMY	stem cell	132-141
25842923_en	ANATOMY	cell	137-141
25842923_en	ANATOMY	lung	187-191
25842923_en	DISO	idiopathic interstitial pneumonias	271-305
25842923_en	DISO	IIP	307-310
25842923_en	DISO	idiopathic pulmonary fibrosis	323-352
25842923_en	DISO	pulmonary fibrosis	334-352
25842923_en	DISO	fibrosis	344-352
25842923_en	ANATOMY	pulmonary	334-343
25842923_en	DISO	IPF	354-357
25842923_en	DISO	pneumonia	386-395
25842923_en	DISO	desquamative interstitial pneumonia	360-395
25842923_en	DISO	interstitial pneumonia	373-395
25842923_en	DISO	DIP	397-400
25842923_en	DISO	pneumonia	426-435
25842923_en	DISO	COP	437-440
25842923_en	DISO	cryptogenic organizing pneumonia	403-435
25842923_en	DISO	organizing pneumonia	415-435
25842923_en	DISO	bronchiolitis obliterans	447-471
25842923_en	DISO	bronchiolitis	447-460
25842923_en	DISO	BO	473-475
25842923_en	DISO	pneumonia	507-516
25842923_en	DISO	interstitial pneumonia	494-516
25842923_en	DISO	nonspecific interstitial pneumonia	482-516
25842923_en	DISO	NSIP	518-522
25842923_en	DISO	IPF	683-686
25842923_en	DISO	DIP	722-725
25842923_en	CHEM	paraffin	762-770
25842923_en	LABPROC	van Gieson's picrofuchsin	824-849
25842923_en	CHEM	Vimentin	973-981
25842923_en	CHEM	CD117	1061-1066
25842923_en	CHEM	CD68	1083-1087
25842923_en	CHEM	EMA	1093-1096
25842923_en	CHEM	PEROXIDASE	1200-1210
25842923_en	ANATOMY	acinus	1451-1457
25842923_en	DISO	respiratory acinus damages	1439-1465
25842923_en	ANATOMY	stem cell niches	132-148
25842923_en	ANATOMY	SCN	150-153
25842923_en	ANATOMY	lung	1607-1611
25842923_en	ANATOMY	tissue	1612-1618
25842923_en	ANATOMY	cell	1636-1640
25842923_en	ANATOMY	mesenchymal	1624-1635
25842923_en	ANATOMY	cell	1730-1734
25842923_en	ANATOMY	stem cell	1725-1734
25842923_en	DISO	SCN damage	1863-1873
25842923_en	DISO	damage to the SCN areas	2016-2039
25842923_en	DISO	IPP	1967-1970
25842923_en	ANATOMY	lung	629-633
25842923_en	DISO	pneumonias	295-305
25842923_en	CHEM	immunoglobulin	1154-1168
25842923_en	LABPROC	Biotinylated	1114-1126
25842923_en	CHEM	immunoglobulin antibodies	1154-1179
25842923_en	ANATOMY	SCN	1565-1568
25842923_en	FINDING	spread of a lesion to different SCN areas	1533-1574
25842923_en	DISO	damage to the stem cell niches	118-148
25842923_en	DISO	interstitial pneumonias	282-305
25842923_en	CHEM	Apo-Cas	932-939
25842923_en	PHYS	regeneration of lung tissue	1591-1618
25842923_en	ANATOMY	SCN areas	2030-2039
25842923_en	ANATOMY	respiratory acini	162-179
25842923_en	ANATOMY	biopsies	634-642
25842923_en	ANATOMY	mesenchymal	1713-1724
25842923_en	FINDING	morphological and molecular biological features	67-114
25842923_en	PHYS	morphological changes	1942-1963
25842923_en	DISO	chronic idiopathic interstitial pneumonias	263-305
25842923_en	CHEM	antibodies	1169-1179
25842923_en	CHEM	antibodies	1235-1245
25842923_en	DISO	lesion	1545-1551
25842923_en	PHYS	myofibroblast differentiation	1646-1675
25842923_en	FINDING	degree of morphological changes	1932-1963
25842923_en	FINDING	severity and depth of damage to the SCN areas of the respiratory acinus	1994-2065
25842923_en	LABPROC	stained	785-792
25842923_en	PHYS	expression	1790-1800
25842923_en	FINDING	changes in the pathogenesis	232-259
25842923_en	PHYS	marker cell	1843-1854
25842923_en	CHEM	MMP	911-914
25842923_en	CHEM	MMP	918-921
25842923_en	CHEM	MMP	925-928
25842923_en	PHYS	respiratory	162-173
25842923_en	DISO	cryptogenic organizing pneumonia (COP) with bronchiolitis obliterans	403-471
25842923_en	DISO	COP + BO	740-748
25842923_en	ANATOMY	sections	771-779
25842923_en	FINDING	clinical course	1912-1927
25842923_en	PHYS	respiratory	2047-2058
25842923_en	ANATOMY	acinus	2059-2065
25842923_en	ANATOMY	acini	174-179
25842923_en	FINDING	differ in the site and degree of initial and secondary respiratory acinus damages	1384-1465
25842923_en	DISO	infiltrate	1514-1524
25842923_en	DISO	inflammatory	1501-1513
25842923_en	FINDING	aggressiveness of an inflammatory infiltrate	1480-1524
25842923_en	PHYS	regeneration	1591-1603
25842923_en	ANATOMY	cells	1810-1815
25842923_en	ANATOMY	cell	1850-1854
25864346_en	DISO	ulcerative colitis	76-94
25864346_en	DISO	UC	255-257
25864346_en	DISO	UC	392-394
25864346_en	DISO	UC	441-443
25864346_en	CHEM	glucocorticosteroids	526-546
25864346_en	CHEM	GCS	548-551
25864346_en	CHEM	prednisolone	554-566
25864346_en	CHEM	mesalasine	616-626
25864346_en	CHEM	azathioprine	638-650
25864346_en	CHEM	AZA	652-655
25864346_en	CHEM	AZA	810-813
25864346_en	CHEM	INF	819-822
25864346_en	CHEM	GCS	1048-1051
25864346_en	CHEM	INF	1082-1085
25864346_en	CHEM	GCS	1217-1220
25864346_en	CHEM	GCS	1286-1289
25864346_en	CHEM	AZA	1340-1343
25864346_en	CHEM	AZA	1507-1510
25864346_en	DISO	SA of UC	1731-1739
25864346_en	CHEM	GCS	1780-1783
25864346_en	DISO	UC	1898-1900
25864346_en	CHEM	AZA	1941-1944
25864346_en	CHEM	GCS	1994-1997
25864346_en	DISO	colitis	87-94
25864346_en	DISO	ulcerative colitis	195-213
25864346_en	DISO	colitis	206-213
25864346_en	DISO	UC	215-217
25864346_en	CHEM	5-ASA	628-633
25864346_en	CHEM	GCS	671-674
25864346_en	CHEM	infliximab	705-715
25864346_en	CHEM	INF	717-720
25864346_en	CHEM	5-ASA	803-808
25864346_en	DISO	UC	1186-1188
25864346_en	CHEM	5-ASA	1412-1417
25864346_en	PHYS	age	1925-1928
25864346_en	DISO	severe attack	173-186
25864346_en	DISO	SA	188-190
25864346_en	DISO	SA	386-388
25864346_en	DISO	SA	435-437
25864346_en	DISO	SA	1731-1733
25864346_en	DISO	SA	1892-1894
25864346_en	DISO	severe attack	59-72
25864346_en	PHYS	clinical remission	965-983
25864346_en	FINDING	long-term clinical response	2034-2061
25864346_en	FINDING	stopped without using GCS, immunosuppressive agents, or INF	1026-1085
25864346_en	CHEM	immunosuppressive agents	1053-1077
25864346_en	DISO	recurrent UC	1176-1188
25864346_en	FINDING	decreasing the dose of GCS	1194-1220
25864346_en	CHEM	anti-recurrent drug	1517-1536
25864346_en	PHYS	age	1645-1648
25864346_en	CHEM	anti-recurrence agent	1951-1972
25864346_en	FINDING	increases the probability of long-term clinical response	2005-2061
25864346_en	FINDING	poor treatment outcome	1577-1599
25864346_en	FINDING	long-term result of medical treatmen	116-152
25864346_en	FINDING	Long-term results of medical treatment	1-39
25864346_en	FINDING	long-term result of medical therapy	1448-1483
25864346_en	PHYS	GCS-resistant	671-684
25864346_en	FINDING	satisfactory treatment outcome	1560-1599
25864346_en	FINDING	declines with advancing age	1901-1928
25864346_en	FINDING	long-term efficiency of medical therapy	1846-1885
25864346_en	DISO	ulcerative	76-86
25864346_en	DISO	severe attack of ulcerative colitis	59-94
25864346_en	DISO	attack	66-72
25864346_en	DISO	severe attack (SA) of ulcerative colitis	173-213
25864346_en	DISO	ulcerative	195-205
25864346_en	DISO	attack	180-186
25864346_en	DISO	SA of UC	386-394
25864346_en	DISO	SA of UC	435-443
25864346_en	DISO	attacks	1018-1025
25864346_en	FINDING	treatment outcome	1582-1599
25864346_en	DISO	UC	1737-1739
25864346_en	DISO	SA of UC	1892-1900
25868364_en	ANATOMY	aortic wall	42-53
25868364_en	DISO	aneurysm]	68-77
25868364_en	ANATOMY	aorta	133-138
25868364_en	ANATOMY	fragments of the wall	313-334
25868364_en	ANATOMY	ascending aorta	342-357
25868364_en	CHEM	formalin solution	376-393
25868364_en	CHEM	orsein	547-553
25868364_en	DISO	aortic aneurysm	632-647
25868364_en	ANATOMY	aortic wall	719-730
25868364_en	LABPROC	electron microscopy	800-819
25868364_en	PHYS	elastic skeleton changes	905-929
25868364_en	CHEM	collagen	957-965
25868364_en	PHYS	maturation	983-993
25868364_en	PHYS	vascular aging	1020-1034
25868364_en	DISO	aortic dissection	1054-1071
25868364_en	ANATOMY	smooth muscle cells	1128-1147
25868364_en	DISO	hypertension	1193-1205
25868364_en	DISO	aortic dissection	1226-1243
25868364_en	DISO	genetically determined disorder	1276-1307
25868364_en	ANATOMY	elastic skeleton	1315-1331
25868364_en	DISO	dissecting aneurysm	57-76
25868364_en	ANATOMY	aorta	270-275
25868364_en	DISO	dissection	284-294
25868364_en	ANATOMY	aorta	352-357
25868364_en	CHEM	formalin	376-384
25868364_en	CHEM	paraffin	491-499
25868364_en	LABPROC	Van-Gieson	561-571
25868364_en	LABPROC	MSB	573-576
25868364_en	LABPROC	Leigh methods	582-595
25868364_en	DISO	aneurysm	639-647
25868364_en	LABPROC	biopsy	648-654
25868364_en	LABPROC	microscopy	809-819
25868364_en	ANATOMY	skeleton	913-921
25868364_en	PHYS	aging	1029-1034
25868364_en	ANATOMY	muscle	1135-1141
25868364_en	ANATOMY	cells	1142-1147
25868364_en	ANATOMY	skeleton	1323-1331
25868364_en	DISO	sclerosis	1356-1365
25868364_en	ANATOMY	aortic	42-48
25868364_en	LABPROC	special stains	826-840
25868364_en	DISO	impaired maturation	974-993
25868364_en	ANATOMY	vascular	1020-1028
25868364_en	ANATOMY	aortic	719-725
25868364_en	ANATOMY	aortic	1054-1060
25868364_en	ANATOMY	aortic	1226-1232
25868364_en	PHYS	age-related changes	743-762
25868364_en	ANATOMY	aortic	632-638
25868364_en	PHYS	Age-related morphological changes	1-34
25868364_en	DISO	dissecting aortic aneurysm	621-647
25868364_en	ANATOMY	elastic skeleton	905-921
25868364_en	ANATOMY	smooth muscle	1128-1141
25868364_en	DISO	dissection	146-156
25868364_en	ANATOMY	biopsy specimens	648-664
25868364_en	DISO	deficiency of collagen	943-965
25868364_en	CHEM	hemotoxyllin	527-539
25868364_en	CHEM	eosin	540-545
25868364_en	DISO	substitutive sclerosis	1343-1365
25868364_en	PHYS	age	181-184
25868364_en	PHYS	age	1173-1176
25868364_en	PHYS	morphological changes	13-34
25868364_en	LABPROC	stained	514-521
25868364_en	PHYS	structural features	692-711
25868364_en	PHYS	morphological features	103-125
25868364_en	PHYS	Quantitative and qualitative changes in the smooth muscle cells	1084-1147
25868364_en	LABPROC	light microscopy	790-819
25868364_en	DISO	dissection	1061-1071
25868364_en	PHYS	age	743-746
25868364_en	PHYS	young	1210-1215
25868364_en	PHYS	Age	1-4
25868364_en	ANATOMY	operative material	219-237
25868364_en	ANATOMY	wall	330-334
25868364_en	CHEM	solution	385-393
25868364_en	LABPROC	fixed in 10% formalin solution	363-393
25868364_en	ANATOMY	sections	500-508
25868364_en	ANATOMY	specimens	655-664
25868364_en	PHYS	physiological or premature aging	855-887
25868364_en	PHYS	aging	882-887
25868366_en	DISO	vocal fold polyps	19-36
25868366_en	ANATOMY	mucosa	41-47
25868366_en	DISO	edema	60-65
25868366_en	DISO	vocal fold polyps	114-131
25868366_en	DISO	Reinke's edema	136-150
25868366_en	LABPROC	immunohistochemical	227-246
25868366_en	ANATOMY	microcirculatory bed	290-310
25868366_en	ANATOMY	vocal folds	398-409
25868366_en	CHEM	monoclonal antibodies	635-671
25868366_en	CHEM	polyclonal antibodies	650-671
25868366_en	CHEM	Toll-like receptors	737-756
25868366_en	CHEM	TLR2	758-762
25868366_en	CHEM	TLR4	764-768
25868366_en	CHEM	TLR9	774-778
25868366_en	DISO	polypoid hyperplasia	1022-1042
25868366_en	ANATOMY	microcirculatory vessels	1120-1144
25868366_en	ANATOMY	membranous vocal fold portion	1152-1181
25868366_en	ANATOMY	Reinke's space	1189-1203
25868366_en	CHEM	CD34	1242-1246
25868366_en	CHEM	VCAM-1	1248-1254
25868366_en	CHEM	MMP-1	1256-1261
25868366_en	CHEM	MMP-9	1266-1271
25868366_en	CHEM	TLR4	1284-1288
25868366_en	CHEM	TLR9	1293-1297
25868366_en	PHYS	microcirculatory	1339-1355
25868366_en	ANATOMY	vessels	1356-1363
25868366_en	ANATOMY	epithelial	1369-1379
25868366_en	CHEM	Toll-like receptors	1438-1457
25868366_en	CHEM	CD80	1489-1493
25868366_en	ANATOMY	T cell lymphocyte	1516-1533
25868366_en	CHEM	CD28	1552-1556
25868366_en	CHEM	CTLA-4	1582-1588
25868366_en	PHYS	innate immunity	1633-1661
25868366_en	PHYS	adaptive immunity	1644-1661
25868366_en	ANATOMY	vocal folds	1723-1734
25868366_en	ANATOMY	stromal	1764-1771
25868366_en	ANATOMY	integumentary	1892-1905
25868366_en	CHEM	Toll-like receptors	1928-1947
25868366_en	ANATOMY	vocal fold	19-29
25868366_en	DISO	polyps	30-36
25868366_en	DISO	Reinke's edema	51-65
25868366_en	ANATOMY	cell	707-711
25868366_en	ANATOMY	vocal fold	114-124
25868366_en	DISO	edema	145-150
25868366_en	DISO	polyps	125-131
25868366_en	ANATOMY	cells	1330-1335
25868366_en	DISO	edema	455-460
25868366_en	ANATOMY	vocal fold	1163-1173
25868366_en	ANATOMY	tissue	428-434
25868366_en	ANATOMY	mucosal tissue	420-434
25868366_en	DISO	Reinke's edema	446-460
25868366_en	ANATOMY	vessels	1137-1144
25868366_en	CHEM	receptors	747-756
25868366_en	DISO	permeability impairment	337-360
25868366_en	CHEM	DAB	673-676
25868366_en	CHEM	chromogen	677-686
25868366_en	CHEM	costimulatory molecule	785-807
25868366_en	CHEM	CD80	808-812
25868366_en	CHEM	B7- 1	814-819
25868366_en	PHYS	angiogenesis	838-850
25868366_en	CHEM	CD34	852-856
25868366_en	ANATOMY	vascular	859-867
25868366_en	ANATOMY	tissue	872-878
25868366_en	CHEM	metalloproteinases	900-918
25868366_en	CHEM	matrix metalloproteinases	893-918
25868366_en	CHEM	MMP-1	920-925
25868366_en	CHEM	MMP-9	930-935
25868366_en	ANATOMY	vascular	943-951
25868366_en	ANATOMY	cell	952-956
25868366_en	ANATOMY	vascular cell	943-956
25868366_en	CHEM	vascular cell adhesion molecule-1	943-976
25868366_en	CHEM	VCAM-1	978-984
25868366_en	DISO	hyperplasia	1031-1042
25868366_en	DISO	impaired permeability	1083-1104
25868366_en	ANATOMY	wall of microcirculatory vessels	1112-1144
25868366_en	PHYS	microcirculatory	1120-1136
25868366_en	ANATOMY	endothelial	1318-1329
25868366_en	ANATOMY	microcirculatory vessels	1339-1363
25868366_en	ANATOMY	endothelial cells of microcirculatory vessels	1318-1363
25868366_en	ANATOMY	cells	1387-1392
25868366_en	ANATOMY	epithelial lining cells	1369-1392
25868366_en	CHEM	receptors	1448-1457
25868366_en	CHEM	B7-1	1495-1499
25868366_en	CHEM	costimulatory molecule	1466-1488
25868366_en	ANATOMY	T cell	1516-1522
25868366_en	ANATOMY	cell	1518-1522
25868366_en	ANATOMY	lymphocyte	1523-1533
25868366_en	DISO	hyperplasia	1704-1715
25868366_en	DISO	polypoid hyperplasia of the vocal folds	1695-1734
25868366_en	ANATOMY	epithelial	1753-1763
25868366_en	PHYS	epithelial stromal interaction	1753-1783
25868366_en	ANATOMY	cells	1913-1918
25868366_en	CHEM	receptors	1938-1947
25868366_en	ANATOMY	Reinke's space	1981-1995
25868366_en	ANATOMY	integumentary lining cells	1892-1918
25868366_en	LABPROC	histological	210-222
25868366_en	ANATOMY	local microcirculatory bed	284-310
25868366_en	PHYS	microcirculatory	290-306
25868366_en	CHEM	peroxidase	616-626
25868366_en	ANATOMY	T cell	699-711
25868366_en	DISO	Polyps of the vocal folds	384-409
25868366_en	ANATOMY	B cell	705-711
25868366_en	CHEM	costimulatory molecule CD80	785-812
25868366_en	CHEM	MMP	920-923
25868366_en	CHEM	vascular cell adhesion molecule	943-974
25868366_en	CHEM	VCAM	978-982
25868366_en	CHEM	costimulatory molecule CD80	1466-1493
25868366_en	PHYS	activity	1534-1542
25868366_en	DISO	viral infections	1870-1886
25868366_en	INJURY_POISONING	exogenic intoxications	1842-1864
25868366_en	PHYS	state of the local microcirculatory bed	271-310
25868366_en	FINDING	poor etiological factors	1790-1814
25868366_en	ANATOMY	mucosa	461-467
25868366_en	PHYS	permeability	879-891
25868366_en	PHYS	expression of molecules	1209-1232
25868366_en	PHYS	markers for angiogenesis	826-850
25868366_en	PHYS	expressed	1408-1417
25868366_en	PHYS	modulated	1506-1515
25868366_en	PHYS	reactive alterations	1957-1977
25868366_en	CHEM	MMP	930-933
25868366_en	CHEM	MMP	1256-1259
25868366_en	CHEM	MMP	1266-1269
25868366_en	CHEM	VCAM	1248-1252
25868366_en	CHEM	antibodies	661-671
25868366_en	INJURY_POISONING	intoxications	1851-1864
25868366_en	PHYS	immunity.	1653-1662
25868366_en	DISO	infections	1876-1886
25868366_en	CHEM	CTLA	1582-1586
25868366_en	CHEM	B7	814-816
25868366_en	CHEM	B7	1495-1497
25868366_en	PHYS	morphology	5-15
25868366_en	PHYS	morphogenesis	97-110
25868366_en	PHYS	interaction of structures of innate and adaptive immunity	1604-1661
25868366_en	PHYS	permeability	337-349
25868366_en	DISO	Polyps	384-390
25868366_en	ANATOMY	mucosal tissue samples	420-442
25868366_en	PHYS	differentiation markers	712-735
25868366_en	PHYS	markers	728-735
25868366_en	PHYS	markers	826-833
25868366_en	ANATOMY	matrix	893-899
25868366_en	DISO	polypoid	1022-1030
25868366_en	PHYS	permeability	1092-1104
25868366_en	ANATOMY	membranous	1152-1162
25868366_en	ANATOMY	endothelial cells	1318-1335
25868366_en	PHYS	attenuation	1561-1572
25868366_en	PHYS	vocal	19-24
25868366_en	PHYS	vocal	114-119
25868366_en	PHYS	vocal	398-403
25868366_en	PHYS	vocal	1163-1168
25868366_en	PHYS	vocal	1723-1728
25868366_en	PHYS	vocal	1829-1834
25868366_en	DISO	polypoid hyperplasia	1695-1715
25868366_en	DISO	polypoid	1695-1703
25872388_en	CHEM	Diflucan	577-585
25872388_en	CHEM	asketin cefuroxime	623-641
25872388_en	CHEM	amikacin	653-661
25872388_en	CHEM	gentamicin	672-682
25872388_en	CHEM	amphotericin B	693-707
25872388_en	CHEM	BSS	718-721
25872388_en	ANATOMY	eye	751-754
25872388_en	CHEM	Diflucan	967-975
25872388_en	CHEM	asketin cefuroxime	986-1004
25872388_en	CHEM	gentamicin	1014-1024
25872388_en	CHEM	amikacin	1036-1044
25872388_en	CHEM	amphotericin B	1056-1070
25872388_en	FINDING	no toxic effects	1101-1117
25872388_en	CHEM	BSS	1135-1138
25872388_en	CHEM	Moxifloxacin	1143-1155
25872388_en	ANATOMY	anterior chamber	1186-1202
25872388_en	ANATOMY	corneal endothelium	1310-1329
25872388_en	ANATOMY	cytoplasmic	1356-1367
25872388_en	DISO	swelling	1368-1376
25872388_en	ANATOMY	endothelial cells	1384-1401
25872388_en	DISO	desquamation	1420-1432
25872388_en	ANATOMY	posterior chamber	1470-1487
25872388_en	FINDING	toxic reaction	1787-1801
25872388_en	CHEM	Moxifloxacin	1834-1846
25872388_en	ANATOMY	eye	29-32
25872388_en	ANATOMY	anterior eye segment	20-40
25872388_en	FINDING	toxicity	41-49
25872388_en	CHEM	Moxifloxacin	169-181
25872388_en	CHEM	cefuroxime	191-201
25872388_en	CHEM	asketin cefuroxime	183-201
25872388_en	CHEM	amikacin	203-211
25872388_en	CHEM	gentamicin	213-223
25872388_en	CHEM	Diflucan	225-233
25872388_en	CHEM	amphotericin B	239-253
25872388_en	ANATOMY	anterior chamber	289-305
25872388_en	CHEM	Moxifloxacin	553-565
25872388_en	CHEM	cefuroxime	631-641
25872388_en	ANATOMY	fellow eye	744-754
25872388_en	LABPROC	highly diluted	913-927
25872388_en	LABPROC	diluted	63-70
25872388_en	CHEM	cefuroxime	994-1004
25872388_en	ANATOMY	corneal	1310-1317
25872388_en	ANATOMY	endothelium	1318-1329
25872388_en	ANATOMY	endothelial	1384-1395
25872388_en	ANATOMY	cells	1396-1401
25872388_en	DISO	inflammatory	1554-1566
25872388_en	LABPROC	histopathological examination	1590-1619
25872388_en	LABPROC	diluted	1716-1723
25872388_en	FINDING	absence of toxic reaction	1776-1801
25872388_en	CHEM	Moxifloxacin	929-941
25872388_en	DISO	cytoplasmic swelling	1356-1376
25872388_en	DISO	fibrin exudation	1446-1462
25872388_en	LABPROC	diluted	920-927
25872388_en	CHEM	antibiotics	845-856
25872388_en	CHEM	antifungals	861-872
25872388_en	CHEM	antibiotics	466-477
25872388_en	CHEM	antifungals	482-493
25872388_en	CHEM	antibiotic	94-104
25872388_en	CHEM	antifungal drugs	109-125
25872388_en	CHEM	antibiotic	1242-1252
25872388_en	CHEM	antifungal drugs	1257-1273
25872388_en	LABPROC	high concentrations	1213-1232
25872388_en	CHEM	highly diluted medications	1709-1735
25872388_en	LABPROC	highly diluted	1709-1723
25872388_en	CHEM	generics	159-167
25872388_en	CHEM	generics	613-621
25872388_en	PHYS	changes in the corneal endothelium	1295-1329
25872388_en	CHEM	antifungal drugs generic	109-93
25872388_en	CHEM	brand name antibiotic	71-104
25872388_en	CHEM	generic antibiotic	86-104
25872388_en	CHEM	antifungal drugs brand name	109-81
25872388_en	CHEM	asketin	183-190
25872388_en	CHEM	asketin	623-630
25872388_en	CHEM	asketin	986-993
25872388_en	FINDING	toxic effects	1104-1117
25872388_en	LABPROC	concentrations	1218-1232
25872388_en	DISO	exudation	1453-1462
25872388_en	INJURY_POISONING	toxic	1534-1539
25872388_en	DISO	allergic	1541-1549
25872388_en	FINDING	neither of injected drugs caused toxic, allergic, or inflammatory reactions	1501-1576
25872388_en	INJURY_POISONING	toxic	1787-1792
25909557_en	DISO	Metastasis of colorectal cancer	0-31
25909557_en	ANATOMY	adrenal gland	44-57
25909557_en	DISO	liver metastatic lesion	134-157
25909557_en	ANATOMY	adrenal gland	277-290
25909557_en	DISO	tumor thrombosis	296-312
25909557_en	ANATOMY	inferior vena cava	316-334
25909557_en	DISO	CRC pT3N2M1	464-475
25909557_en	ANATOMY	liver right lobe	498-514
25909557_en	LABPROC	multi-layer spiral CT	691-712
25909557_en	ANATOMY	abdominal cavity	716-732
25909557_en	DISO	mass lesion	742-753
25909557_en	ANATOMY	right adrenal gland	761-780
25909557_en	DISO	metastatic lesion	802-819
25909557_en	ANATOMY	inferior vena cava	840-858
25909557_en	DISO	thrombosis	863-873
25909557_en	ANATOMY	lumen	881-886
25909557_en	ANATOMY	IVC	959-962
25909557_en	ANATOMY	adrenal gland	1077-1090
25909557_en	DISO	tumor thrombus	1113-1127
25909557_en	DISO	cancer	25-31
25909557_en	DISO	CRC	33-36
25909557_en	DISO	colorectal cancer	14-31
25909557_en	ANATOMY	gland	52-57
25909557_en	ANATOMY	liver	134-139
25909557_en	DISO	lesion	151-157
25909557_en	DISO	metastatic lesion	140-157
25909557_en	ANATOMY	gland	285-290
25909557_en	DISO	tumor	296-301
25909557_en	DISO	thrombosis	302-312
25909557_en	ANATOMY	IVC	336-339
25909557_en	ANATOMY	vena cava	325-334
25909557_en	DISO	lesion	488-494
25909557_en	ANATOMY	liver	498-503
25909557_en	DISO	metastatic lesion	477-494
25909557_en	LABPROC	spiral CT	703-712
25909557_en	LABPROC	CT	710-712
25909557_en	ANATOMY	abdominal	716-725
25909557_en	DISO	lesion	747-753
25909557_en	ANATOMY	adrenal gland	767-780
25909557_en	ANATOMY	gland	775-780
25909557_en	DISO	lesion	813-819
25909557_en	ANATOMY	vena cava	849-858
25909557_en	ANATOMY	vascular	1005-1013
25909557_en	ANATOMY	gland	1085-1090
25909557_en	DISO	tumor	1113-1118
25909557_en	DISO	thrombus	1119-1127
25909557_en	ANATOMY	retroliver segment level	890-914
25909557_en	DISO	metastasis	1045-1055
25909557_en	ANATOMY	colorectal	249-259
25909557_en	ANATOMY	colorectal	14-24
25909557_en	PHYS	long-term survival	199-217
25909557_en	PHYS	survival	209-217
25909557_en	FINDING	aggravates for certain prognosis for long-term survival	162-217
25909557_en	DISO	colorectal metastasis	249-270
25909557_en	DISO	metastasis	260-270
25909557_en	DISO	Metastasis	0-10
25909557_en	DISO	CRC	464-467
25909557_en	FINDING	respectability	1056-1070
25909557_en	FINDING	small extent of a tumor thrombus	1095-1127
25909608_en	CHEM	analgin	51-58
25909608_en	CHEM	paracetamol	60-71
25909608_en	CHEM	dexalgin	76-84
25909608_en	FINDING	analgesic activity	165-183
25909608_en	CHEM	paracetamol	187-198
25909608_en	CHEM	analgin	200-207
25909608_en	CHEM	dexalgin	209-217
25909608_en	CHEM	placebo	222-229
25909608_en	LABPROC	electrical pulp sensitivity testing	236-271
25909608_en	DEVICE	EOM-3	472-477
25909608_en	CHEM	analgin	593-600
25909608_en	CHEM	dexalgin	614-622
25909608_en	CHEM	paracetamol	636-647
25909608_en	CHEM	placebo	664-671
25909608_en	CHEM	Paracetamol	674-685
25909608_en	CHEM	placebo	723-730
25909608_en	CHEM	Placebo	1-8
25909608_en	LABPROC	electric pulp sensitivity testing	88-121
25909608_en	DISO	Pain	368-372
25909608_en	FINDING	placebo effect	723-737
25909608_en	FINDING	analgesic activity	29-47
25909608_en	FINDING	analgesic efficiency	693-713
25909608_en	PHYS	Pain threshold	368-382
25909608_en	ANATOMY	pulp	97-101
25909608_en	ANATOMY	pulp	247-251
25909608_en	FINDING	Height effect	543-556
25909608_en	PHYS	pulp sensitivity	97-113
25909608_en	PHYS	pulp sensitivity	247-263
25909608_en	LABPROC	Pain threshold was measured	368-395
25909675_en	ANATOMY	nasal cavity mucosa	58-77
25909675_en	DISO	acute rhinosinusitis	134-154
25909675_en	ANATOMY	nasal cavity mucosa	248-267
25909675_en	DISO	acute rhinosinusitis	345-365
25909675_en	PHYS	body temperature	442-458
25909675_en	PHYS	pain sensitivity	460-476
25909675_en	ANATOMY	mucous membrane	505-520
25909675_en	PHYS	mucociliary transport	522-543
25909675_en	PHYS	MCT	545-548
25909675_en	LABPROC	joulemetry	569-579
25909675_en	DISO	acute rhinosinusitis	633-653
25909675_en	ANATOMY	nasal cavity mucosa	733-752
25909675_en	PHYS	pain sensitivity	900-916
25909675_en	ANATOMY	epithelium	973-983
25909675_en	ANATOMY	nasal cavity mucosa	1191-1210
25909675_en	DISO	acute rhinosinusitis	1294-1314
25909675_en	ANATOMY	nasal cavity mucosa	1534-1553
25909675_en	FINDING	severity of inflammation	1596-1620
25909675_en	ANATOMY	nasal cavity	58-70
25909675_en	ANATOMY	mucosa	71-77
25909675_en	ANATOMY	nasal	58-63
25909675_en	DISO	rhinosinusitis	140-154
25909675_en	ANATOMY	nasal cavity	248-260
25909675_en	ANATOMY	mucosa	261-267
25909675_en	ANATOMY	nasal	248-253
25909675_en	DISO	pain	460-464
25909675_en	LABPROC	measurement	423-434
25909675_en	ANATOMY	intranasal	494-504
25909675_en	ANATOMY	body	442-446
25909675_en	ANATOMY	mucous	505-511
25909675_en	ANATOMY	membrane	512-520
25909675_en	ANATOMY	intranasal mucous membrane	494-520
25909675_en	ANATOMY	nasal	733-738
25909675_en	ANATOMY	mucosa	746-752
25909675_en	ANATOMY	nasal cavity	733-745
25909675_en	ANATOMY	mucosal	845-852
25909675_en	PHYS	mucosal temperature	845-864
25909675_en	DISO	pain	900-904
25909675_en	ANATOMY	ciliary epithelium	965-983
25909675_en	PHYS	ciliary epithelium activity	965-992
25909675_en	LABPROC	joulemetry	1082-1092
25909675_en	LABPROC	direct joulemetry	1075-1092
25909675_en	ANATOMY	nasal	1191-1196
25909675_en	ANATOMY	mucosa	1204-1210
25909675_en	ANATOMY	nasal cavity	1191-1203
25909675_en	DISO	pathological changes	1167-1187
25909675_en	DISO	rhinosinusitis	1300-1314
25909675_en	ANATOMY	nasal	1534-1539
25909675_en	ANATOMY	mucosa	1547-1553
25909675_en	ANATOMY	nasal cavity	1534-1546
25909675_en	PHYS	age-specific features	1219-1240
25909675_en	PHYS	age-specific features	1350-1371
25909675_en	DISO	rhinosinusitis	351-365
25909675_en	DISO	rhinosinusitis	639-653
25909675_en	ANATOMY	intranasal mucous	494-511
25909675_en	PHYS	pH	438-440
25909675_en	FINDING	lowered mucosal temperature	837-864
25909675_en	FINDING	elevated pain sensitivity threshold	891-926
25909675_en	FINDING	long duration of the recovery of ciliary epithelium activity	932-992
25909675_en	DISO	inflammation	1608-1620
25909675_en	PHYS	pain sensitivity threshold	460-486
25909675_en	PHYS	pain sensitivity threshold	900-926
25909675_en	PHYS	age	107-110
25909675_en	PHYS	functional properties	223-244
25909675_en	PHYS	age	318-321
25909675_en	FINDING	mucociliary transport (MCT) time	522-554
25909675_en	PHYS	functional conditions	708-729
25909675_en	PHYS	age	1060-1063
25909675_en	PHYS	functional state	1514-1530
25909675_en	PHYS	functional characteristics	28-54
25909675_en	FINDING	changes in the functional properties	208-244
25909675_en	FINDING	marked differences in the functional conditions	682-729
25909675_en	PHYS	non-responsiveness inherent	1008-1035
25909675_en	DISO	clinical manifestations	1267-1290
25909675_en	PHYS	clinical characteristics	15-54
25909675_en	PHYS	age	1350-1353
25909675_en	PHYS	age	1219-1222
25909675_en	PHYS	elderly	798-805
25909675_en	PHYS	aged	789-793
25909792_en	LABPROC	EEG	1-4
25909792_en	DISO	paranoid schizophrenia: effects	56-87
25909792_en	LABPROC	EEG	152-155
25909792_en	DISO	schizophrenic	167-180
25909792_en	LABPROC	EEG	327-330
25909792_en	LABPROC	EEG	533-536
25909792_en	DISO	negative disorders	586-604
25909792_en	DISO	negative disorders	668-686
25909792_en	LABPROC	EEG	798-801
25909792_en	DISO	paranoid schizophrenia	869-891
25909792_en	DISO	negative symptomatology	1006-1029
25909792_en	DISO	volitional disorders	1160-1180
25909792_en	DISO	Positive symptomatology	1347-1370
25909792_en	LABPROC	EEG	1404-1407
25909792_en	DISO	negative	1421-1429
25909792_en	LABPROC	EEG	1549-1552
25909792_en	DISO	delusion	1589-1597
25909792_en	ANATOMY	left hemisphere	1671-1686
25909792_en	DISO	paranoid syndrome with primary interpretative delusion	1700-1754
25909792_en	DISO	delusion	1746-1754
25909792_en	ANATOMY	right hemisphere	1782-1798
25909792_en	DISO	schizophrenia: effects	65-87
25909792_en	LABPROC	EEG spectral analysis	327-348
25909792_en	DISO	schizophrenia	878-891
25909792_en	DISO	paranoid	869-877
25909792_en	ANATOMY	left hemisphere	1272-1287
25909792_en	DISO	delusion disturbances	1589-1610
25909792_en	ANATOMY	cortical	1760-1768
25909792_en	ANATOMY	cortical areas	1760-1774
25909792_en	ANATOMY	frontal areas	1650-1663
25909792_en	ANATOMY	frontal areas	1313-1326
25909792_en	FINDING	Spectral characteristics of background EEG	759-801
25909792_en	LABPROC	background EEG	787-801
25909792_en	DISO	productive disorders	571-604
25909792_en	DISO	psychopathological symptom complexes	1462-1498
25909792_en	PHYS	delta range	1296-1307
25909792_en	DISO	symptomatology positive	113-99
25909792_en	DISO	negative symptomatology	104-127
25909792_en	FINDING	diffuse increase of spectral power of gamma and delta ranges	1056-1116
25909792_en	FINDING	EEG changes	1404-1415
25909792_en	FINDING	less reflected in EEG changes	1386-1415
25909792_en	PHYS	delta ranges	1104-1116
25909792_en	PHYS	gamma ranges	1094-1116
25909792_en	FINDING	main index of negative symptomatology	992-1029
25909792_en	FINDING	EEG frequency and regional properties	1-38
25909792_en	FINDING	summary prevalence of positive/negative disorders	637-686
25909792_en	FINDING	spatially structured EEG patterns	1528-1561
25909792_en	FINDING	spatially structured EEG patterns in the beta range	1528-1579
25909792_en	FINDING	lateralized increase of spectral power	1205-1243
25909792_en	PHYS	beta-gamma ranges	1247-1264
25909792_en	FINDING	clinical heterogeneity of the disease	238-275
25909792_en	PHYS	state of patients	285-302
25909792_en	FINDING	EEG changes	152-163
25909792_en	PHYS	neurophysiological mechanisms	416-445
25909792_en	CHEM	psychoactive medication	902-925
25909792_en	DISO	Deficient states with the predominance of volitional disorders	1118-1180
25909792_en	DISO	primary interpretative delusion	1723-1754
25909792_en	PHYS	beta range	1569-1579
25909792_en	DISO	paranoid syndrome	1700-1717
25909792_en	DISO	paranoid	56-64
25909792_en	PHYS	healthy	936-943
25909792_en	DISO	positive disorders	659-686
25909792_en	FINDING	evidence of concrete clinical indices	691-728
25909792_en	DISO	Deficient states	1118-1134
25909792_en	ANATOMY	hemisphere	1277-1287
25909792_en	ANATOMY	hemisphere	1335-1345
25909792_en	ANATOMY	frontal	1313-1320
25909792_en	ANATOMY	hemisphere	1676-1686
25909792_en	ANATOMY	hemisphere	1788-1798
25909792_en	FINDING	frequency and regional EEG	510-536
26027241_en	DISO	Pulmonary paecilomycosis	1-25
26027241_en	DISO	pulmonary paecilomycosis	228-252
26027241_en	DISO	bronchopulmonary infection	344-370
26027241_en	LABPROC	laboratory diagnostic	500-521
26027241_en	LABPROC	lymphocyte antigen-binding test	580-611
26027241_en	DISO	Paecilomyces infection	649-671
26027241_en	LABPROC	microscopically examining	689-714
26027241_en	ANATOMY	blood	773-778
26027241_en	LABPROC	isolating the cultured fungi in the media	795-836
26027241_en	DISO	PP	897-899
26027241_en	DISO	atypical paecilomycosis-associated myocarditis	902-948
26027241_en	DISO	APAM	950-954
26027241_en	DISO	complicated	1005-1016
26027241_en	LABPROC	echocardiography	1081-1097
26027241_en	DISO	Bronchopulmonary paecilomycosis	1107-1138
26027241_en	DISO	recurrent pneumonia	1292-1311
26027241_en	DISO	allergic alveolitis	1331-1350
26027241_en	DISO	asthma	1362-1368
26027241_en	DISO	helminthiasis	1390-1403
26027241_en	DISO	Iodine deficiency	1411-1428
26027241_en	DISO	paecilomycosis	1456-1470
26027241_en	DISO	echinococcosis	1475-1489
26027241_en	DISO	Paecilomycosis infection	1497-1521
26027241_en	DISO	APAM	1645-1649
26027241_en	DISO	PP	1678-1680
26027241_en	DISO	PP	1714-1716
26027241_en	DISO	carditis	1732-1740
26027241_en	DISO	APAM	1760-1764
26027241_en	DISO	intermittent pain	1815-1832
26027241_en	ANATOMY	axilla	1895-1901
26027241_en	ANATOMY	left hand	1903-1912
26027241_en	ANATOMY	arm	1949-1952
26027241_en	ANATOMY	arms	2007-2011
26027241_en	DISO	faints	2064-2070
26027241_en	CHEM	meloxicam	2092-2101
26027241_en	CHEM	tizanidine	2103-2113
26027241_en	CHEM	nimesulide	2115-2125
26027241_en	CHEM	morphine	2127-2135
26027241_en	CHEM	promedole	2137-2146
26027241_en	CHEM	fluconazole	2168-2179
26027241_en	FINDING	pain relief	2340-2351
26027241_en	DISO	APAM	2365-2369
26027241_en	DISO	PP	2387-2389
26027241_en	ANATOMY	Pulmonary	1-10
26027241_en	DISO	paecilomycosis	11-25
26027241_en	DISO	paecilomycosis	136-150
26027241_en	ANATOMY	pulmonary	228-237
26027241_en	DISO	paecilomycosis	238-252
26027241_en	DISO	PP	254-256
26027241_en	DISO	infection	361-370
26027241_en	ANATOMY	lymphocyte	580-590
26027241_en	DISO	infection	662-671
26027241_en	ANATOMY	sputum	780-786
26027241_en	DISO	myocarditis	937-948
26027241_en	DISO	paecilomycosis	911-925
26027241_en	DISO	paecilomycosis-associated myocarditis	911-948
26027241_en	DISO	helminthiasis	991-1004
26027241_en	DISO	paecilomycosis	1124-1138
26027241_en	DISO	bronchitis	1272-1282
26027241_en	DISO	obstructive bronchitis	1260-1282
26027241_en	DISO	pneumonia	1302-1311
26027241_en	DISO	alveolitis	1340-1350
26027241_en	DISO	exogenous allergic alveolitis	1321-1350
26027241_en	CHEM	Iodine	1411-1417
26027241_en	DISO	infection	1512-1521
26027241_en	DISO	pain	1828-1832
26027241_en	ANATOMY	chest	1867-1872
26027241_en	ANATOMY	hand	1908-1912
26027241_en	ANATOMY	fingertips	1922-1932
26027241_en	DISO	paralyzing the arm	1934-1952
26027241_en	ANATOMY	abdominal	2017-2026
26027241_en	FINDING	positive effect	2201-2216
26027241_en	FINDING	temporary positive effect	2191-2216
26027241_en	DISO	pain	2340-2344
26027241_en	ANATOMY	pathological material	750-771
26027241_en	LABPROC	Czapek's	854-862
26027241_en	LABPROC	Sabouraud's	838-849
26027241_en	CHEM	lymphocyte antigen	580-598
26027241_en	PHYS	morphology	719-729
26027241_en	DISO	infection	1176-1185
26027241_en	DISO	pain	1976-1980
26027241_en	DISO	complication	881-893
26027241_en	DISO	chronic obstructive bronchitis	1252-1282
26027241_en	PHYS	mycelial form	1616-1629
26027241_en	DISO	complication	1662-1674
26027241_en	DISO	severe intermittent pain	1808-1832
26027241_en	CHEM	analgesics	2080-2090
26027241_en	FINDING	abdominal irradiation	2017-2038
26027241_en	DISO	paecilomycosis	1017-1031
26027241_en	ANATOMY	bronchopulmonary	344-360
26027241_en	PHYS	healthy	426-433
26027241_en	LABPROC	mycological	523-534
26027241_en	LABPROC	immunological studies	540-561
26027241_en	CHEM	antigen	591-598
26027241_en	ANATOMY	Bronchopulmonary	1107-1123
26027241_en	DISO	allergic	1331-1339
26027241_en	DISO	complicated	1375-1386
26027241_en	DISO	Paecilomycosis	1497-1511
26027241_en	FINDING	irradiated	1877-1887
26031946_en	DISO	bronchial carcinoid	53-72
26031946_en	ANATOMY	bronchus	84-92
26031946_en	DISO	exophytic tumor	199-214
26031946_en	DISO	carcinoid	352-361
26031946_en	ANATOMY	bronchus	526-534
26031946_en	ANATOMY	bronchus	761-769
26031946_en	ANATOMY	pulmonary parenchyma	794-814
26031946_en	ANATOMY	Lung	1-5
26031946_en	ANATOMY	bronchial	53-62
26031946_en	DISO	carcinoid	63-72
26031946_en	DISO	cancer	115-121
26031946_en	DISO	exophytic	199-208
26031946_en	DISO	tumor	209-214
26031946_en	ANATOMY	thoracic	243-251
26031946_en	FINDING	survival	624-632
26031946_en	ANATOMY	pulmonary	794-803
26031946_en	ANATOMY	parenchyma	804-814
26031946_en	FINDING	10-year survival	616-632
26031946_en	ANATOMY	mediastinal	463-474
26031946_en	DISO	Postoperative complications	492-519
26031946_en	LABPROC	morphological study	324-343
26031946_en	FINDING	no deaths	590-599
26031946_en	DISO	typical carcinoid	344-361
26031946_en	DISO	atypical	398-406
26031946_en	PHYS	deaths	593-599
26031946_en	FINDING	5- year survival	609-632
26031946_en	FINDING	preserves all pulmonary parenchyma	780-814
26031946_en	DISO	central cancer	107-121
26031946_en	DISO	Cancer	293-299
26031946_en	DISO	complications	506-519
26036067_en	INJURY_POISONING	injuries to the extremities	147-174
26036067_en	INJURY_POISONING	injuries	305-313
26036067_en	ANATOMY	corpses	647-654
26036067_en	ANATOMY	posterior left elbow region	1096-1123
26036067_en	ANATOMY	palm surface of the right wrist	1157-1188
26036067_en	ANATOMY	postrerior region of the left lower leg	1218-1257
26036067_en	ANATOMY	dorsal surface of the left wrist	1283-1315
26036067_en	ANATOMY	anterior surface of the left knee	1342-1375
26036067_en	INJURY_POISONING	bone fractures	1468-1482
26036067_en	INJURY_POISONING	tension of ligaments	1494-1514
26036067_en	ANATOMY	right talocrural joint	1538-1560
26036067_en	ANATOMY	left tibial epiphysis	1606-1627
26036067_en	INJURY_POISONING	hemorrhage	1639-1649
26036067_en	ANATOMY	anterior right knee region	1669-1695
26036067_en	ANATOMY	right posterior carpal region	1735-1764
26036067_en	ANATOMY	elbow	1111-1116
26036067_en	ANATOMY	left elbow	1106-1116
26036067_en	ANATOMY	posterior left elbow	1096-1116
26036067_en	INJURY_POISONING	bleeding	1078-1086
26036067_en	ANATOMY	skin	1135-1139
26036067_en	ANATOMY	palm surface	1157-1169
26036067_en	ANATOMY	wrist	1183-1188
26036067_en	ANATOMY	right wrist	1177-1188
26036067_en	INJURY_POISONING	skin scratches	1135-1149
26036067_en	ANATOMY	lower leg	1248-1257
26036067_en	ANATOMY	left lower leg	1243-1257
26036067_en	INJURY_POISONING	bleeding	1200-1208
26036067_en	ANATOMY	wrist	1310-1315
26036067_en	ANATOMY	left wrist	1305-1315
26036067_en	ANATOMY	dorsal	1283-1289
26036067_en	INJURY_POISONING	wounds	1269-1275
26036067_en	ANATOMY	knee	1371-1375
26036067_en	ANATOMY	left knee	1366-1375
26036067_en	INJURY_POISONING	bruises	1327-1334
26036067_en	ANATOMY	bone	1468-1472
26036067_en	ANATOMY	ligaments	1505-1514
26036067_en	ANATOMY	talocrural joint	1544-1560
26036067_en	INJURY_POISONING	dislocation	1519-1530
26036067_en	ANATOMY	kneecap	1594-1601
26036067_en	ANATOMY	left kneecap	1589-1601
26036067_en	ANATOMY	epiphysis	1618-1627
26036067_en	ANATOMY	tibial	1611-1617
26036067_en	ANATOMY	knee	1684-1688
26036067_en	ANATOMY	right knee	1678-1688
26036067_en	ANATOMY	skin	1713-1717
26036067_en	ANATOMY	carpal	1751-1757
26036067_en	ANATOMY	posterior carpal	1741-1757
26036067_en	ANATOMY	right posterior carpal	1735-1757
26036067_en	ANATOMY	upper extremities	321-348
26036067_en	ANATOMY	lower extremities	331-348
26036067_en	ANATOMY	extremities	163-174
26036067_en	INJURY_POISONING	skin scratches	1713-1727
26036067_en	INJURY_POISONING	bruises	1654-1661
26036067_en	INJURY_POISONING	fractures	1572-1581
26036067_en	INJURY_POISONING	scratches	1140-1149
26036067_en	INJURY_POISONING	fractures	1473-1482
26036067_en	INJURY_POISONING	scratches	1718-1727
26036067_en	FINDING	lethal outcome	1024-1038
26036067_en	ANATOMY	upper and lower extremities	321-348
26036067_en	INJURY_POISONING	injuries in the traffic accidents	690-723
26036067_en	INJURY_POISONING	injuries	690-698
26036067_en	FINDING	outcome	1031-1038
26036067_en	FINDING	expert conclusions	2117-2135
26036067_en	FINDING	circumstance of traffic accidents	2189-2222
26036067_en	ANATOMY	palm	1157-1161
26036067_en	INJURY_POISONING	injuries	1061-1069
26036067_en	ANATOMY	leg	1254-1257
26036067_en	ANATOMY	dorsal surface	1283-1297
26036067_en	ANATOMY	postrerior region	1218-1235
26036067_en	ANATOMY	anterior surface	1342-1358
26036067_en	ANATOMY	left tibial	1606-1617
26036067_en	INJURY_POISONING	injuries	147-155
26036067_en	ANATOMY	extremities	337-348
26036067_en	FINDING	improvement of the quality of expert conclusions and the results of forensic medical expertise	2087-2181
26036068_en	INJURY_POISONING	injuries	49-57
26036068_en	ANATOMY	bone	76-80
26036068_en	ANATOMY	larynx	82-88
26036068_en	ANATOMY	trachea	94-101
26036068_en	ANATOMY	neck	175-179
26036068_en	INJURY_POISONING	neck injuries	390-403
26036068_en	PHYS	death	492-497
26036068_en	ANATOMY	neck	609-613
26036068_en	INJURY_POISONING	neck trauma	609-620
26036068_en	INJURY_POISONING	fractures	748-757
26036068_en	ANATOMY	sublingual bone	765-780
26036068_en	ANATOMY	laryngeal	782-791
26036068_en	ANATOMY	tracheal cartilages	796-815
26036068_en	INJURY_POISONING	injuries to the greater horns of the hyoid bone	835-882
26036068_en	ANATOMY	hyoid bone	872-882
26036068_en	ANATOMY	thyroid cartilage	913-930
26036068_en	ANATOMY	arch of the cricoid cartilage	948-977
26036068_en	ANATOMY	tracheal cartilages	1026-1045
26036068_en	ANATOMY	hyoid bone	1089-1099
26036068_en	ANATOMY	body	1100-1104
26036068_en	ANATOMY	greater horns	1113-1126
26036068_en	ANATOMY	neck region	1161-1172
26036068_en	ANATOMY	neck	1269-1273
26036068_en	INJURY_POISONING	neck trauma	1269-1280
26036068_en	PHYS	death	1527-1532
26036068_en	ANATOMY	organs	1601-1607
26036068_en	ANATOMY	larynx	1635-1641
26036068_en	ANATOMY	trachea	1674-1681
26036068_en	ANATOMY	neck	1777-1781
26036068_en	INJURY_POISONING	fractures	1887-1896
26036068_en	ANATOMY	hyoid-laryngeal-tracheal complex	1924-1956
26036068_en	ANATOMY	sublungual bone	65-80
26036068_en	INJURY_POISONING	blunt neck trauma	169-186
26036068_en	ANATOMY	neck	390-394
26036068_en	ANATOMY	tracheal	463-471
26036068_en	INJURY_POISONING	blunt neck trauma	603-620
26036068_en	ANATOMY	tracheal	675-683
26036068_en	ANATOMY	bone	776-780
26036068_en	ANATOMY	bone	878-882
26036068_en	ANATOMY	greater horns of the hyoid bone	851-882
26036068_en	ANATOMY	inferior horns	891-905
26036068_en	ANATOMY	thyroid	913-920
26036068_en	ANATOMY	cartilage	921-930
26036068_en	ANATOMY	inferior horns of the thyroid cartilage	891-930
26036068_en	ANATOMY	cartilage	968-977
26036068_en	INJURY_POISONING	fissures	932-940
26036068_en	ANATOMY	tracheal	1026-1034
26036068_en	ANATOMY	cartilages	1035-1045
26036068_en	ANATOMY	bone	1095-1099
26036068_en	ANATOMY	hyoid bone body	1089-1104
26036068_en	ANATOMY	neck	1161-1165
26036068_en	INJURY_POISONING	injuries in the neck region	1145-1172
26036068_en	INJURY_POISONING	blunt neck trauma	1263-1280
26036068_en	ANATOMY	tracheal	1498-1506
26036068_en	ANATOMY	neck	1596-1600
26036068_en	ANATOMY	entire complex of the neck organs	1574-1607
26036068_en	ANATOMY	cervical	1650-1658
26036068_en	ANATOMY	tracheal	1737-1745
26036068_en	INJURY_POISONING	blunt neck trauma	1771-1788
26036068_en	INJURY_POISONING	external defects	1862-1878
26036068_en	ANATOMY	hyoid	1924-1929
26036068_en	ANATOMY	laryngeal	1930-1939
26036068_en	ANATOMY	tracheal	1940-1948
26036068_en	ANATOMY	constituents of the hyoid-laryngeal-tracheal complex	1904-1956
26036068_en	INJURY_POISONING	neck trauma	175-186
26036068_en	INJURY_POISONING	breaks of the connections	1051-1076
26036068_en	ANATOMY	cervical portion of the trachea	1650-1681
26036068_en	INJURY_POISONING	neck trauma	1777-1788
26036068_en	INJURY_POISONING	fractures	1009-1018
26036068_en	INJURY_POISONING	cracks	989-995
26036068_en	FINDING	scope of the injuries in the neck region is large	1132-1181
26036068_en	FINDING	severity higher	1193-1208
26036068_en	FINDING	absence of previous external injurious impacts	1337-1383
26036068_en	ANATOMY	corpses	1456-1463
26036068_en	PHYS	death	379-384
26036068_en	ANATOMY	neck organs	1596-1607
26036068_en	INJURY_POISONING	complete fractures	1000-1018
26036068_en	ANATOMY	hyoid	872-877
26036068_en	INJURY_POISONING	trauma	180-186
26036068_en	INJURY_POISONING	injuries	302-310
26036068_en	FINDING	harm to human health	334-354
26036068_en	PHYS	health	348-354
26036068_en	INJURY_POISONING	injuries	395-403
26036068_en	INJURY_POISONING	trauma	614-620
26036068_en	INJURY_POISONING	injuries	835-843
26036068_en	ANATOMY	tracheal	796-804
26036068_en	ANATOMY	cartilages	805-815
26036068_en	ANATOMY	greater horns	851-864
26036068_en	ANATOMY	cricoid cartilage	960-977
26036068_en	INJURY_POISONING	breaks	1051-1057
26036068_en	INJURY_POISONING	injuries	1145-1153
26036068_en	INJURY_POISONING	trauma	1274-1280
26036068_en	FINDING	external injurious impacts	1357-1383
26036068_en	INJURY_POISONING	injuries	1715-1723
26036068_en	INJURY_POISONING	trauma	1782-1788
26081319_en	DISO	pain	15-19
26081319_en	DISO	lumbar vertebral canal stenosis	82-113
26081319_en	DISO	lumbar vertebral canal stenosis	176-207
26081319_en	DISO	lumbar vertebral canal stenosis	409-440
26081319_en	DISO	Affective disorders	636-655
26081319_en	ANATOMY	Blood serum	700-711
26081319_en	CHEM	thrombocytic serotonin	716-738
26081319_en	LABPROC	ELISA	760-765
26081319_en	DISO	pain syndrome	975-988
26081319_en	DISO	neurological disorders	1043-1065
26081319_en	DISO	Neuropathic pain	1130-1146
26081319_en	DISO	depression	1151-1161
26081319_en	DISO	central canal stenosis	1246-1268
26081319_en	DISO	lateral stenosis	1295-1311
26081319_en	DISO	lumbar vertebral canal stenosis	1346-1377
26081319_en	PHYS	decompression of nervous structures	1391-1426
26081319_en	ANATOMY	nervous structures	1408-1426
26081319_en	DISO	pain syndrome	1455-1468
26081319_en	DISO	depression	1486-1496
26081319_en	ANATOMY	vertebral	89-98
26081319_en	ANATOMY	lumbar vertebral	82-98
26081319_en	DISO	stenosis	105-113
26081319_en	ANATOMY	vertebral	183-192
26081319_en	DISO	stenosis	199-207
26081319_en	ANATOMY	lumbar vertebral	176-192
26081319_en	DISO	pain	240-244
26081319_en	ANATOMY	vertebral	416-425
26081319_en	ANATOMY	lumbar vertebral	409-425
26081319_en	DISO	stenosis	432-440
26081319_en	DISO	Pain	550-554
26081319_en	DISO	pain	595-599
26081319_en	DISO	back pain	590-599
26081319_en	DISO	low back pain disability	586-610
26081319_en	ANATOMY	thrombocytic	716-728
26081319_en	ANATOMY	Blood	700-705
26081319_en	ANATOMY	serum	706-711
26081319_en	DISO	pain	975-979
26081319_en	DISO	pain	1142-1146
26081319_en	DISO	stenosis	1260-1268
26081319_en	DISO	stenosis	1303-1311
26081319_en	DISO	stenosis	1369-1377
26081319_en	ANATOMY	vertebral	1353-1362
26081319_en	ANATOMY	lumbar vertebral	1346-1362
26081319_en	DISO	pain	1455-1459
26081319_en	ANATOMY	low back	586-594
26081319_en	DISO	depression	681-691
26081319_en	ANATOMY	central canal	1246-1259
26081319_en	FINDING	significant reduction of pain syndrome and the level of depression	1430-1496
26081319_en	ANATOMY	lumbar vertebral canal	409-431
26081319_en	ANATOMY	lumbar vertebral canal	82-104
26081319_en	ANATOMY	lumbar vertebral canal	176-198
26081319_en	ANATOMY	lumbar vertebral canal	1346-1368
26081319_en	DISO	low back pain	586-599
26081319_en	FINDING	improvement of quality of life	1512-1542
26081319_en	PHYS	quality of life	1171-1186
26081319_en	PHYS	quality of life	1527-1542
26081319_en	PHYS	quality of life	1094-1109
26081319_en	PHYS	quality of life	267-282
26081319_en	PHYS	quality of life	23-38
26081319_en	PHYS	life	278-282
26081319_en	PHYS	life	34-38
26081319_en	PHYS	life	1105-1109
26081319_en	PHYS	life	1182-1186
26081319_en	PHYS	life	1538-1542
26081319_en	PHYS	work capacity	1114-1127
26081319_en	FINDING	reduced quality of life and daily activities	1163-1207
26081319_en	FINDING	level of disability before and after surgical treatment.	287-343
26081319_en	DISO	chronic pain syndrome of mixed etiology	967-1006
26081319_en	DISO	nociceptive	1008-1019
26081319_en	DISO	neurotic type	1024-1037
26081319_en	FINDING	efficacy of surgical treatment	142-172
26081319_en	DISO	disability	296-306
26081319_en	ANATOMY	back	590-594
26081319_en	DISO	disability	600-610
26081319_en	CHEM	serotonin	729-738
26081319_en	FINDING	significantly affected quality of life and work capacity	1071-1127
26081319_en	DISO	chronic pain syndrome	967-988
26081319_en	ANATOMY	nervous	1408-1415
26081319_en	PHYS	decompression	1391-1404
26081321_en	CHEM	valdoxan	14-22
26081321_en	PHYS	hemostasis	30-40
26081321_en	DISO	acute coronary syndrome	58-81
26081321_en	DISO	anxiety	106-113
26081321_en	DISO	anxiety and depressive disorders	106-138
26081321_en	PHYS	hemostasis	179-189
26081321_en	DISO	acute coronary syndrome	207-230
26081321_en	DISO	anxiety	261-268
26081321_en	DISO	depressive disorders	273-293
26081321_en	CHEM	valdoxan	320-328
26081321_en	CHEM	agomelatine	330-341
26081321_en	DISO	ACS	460-463
26081321_en	DISO	ACS	525-528
26081321_en	DISO	ADD	537-540
26081321_en	DISO	ACS	563-566
26081321_en	DISO	ADD	571-574
26081321_en	CHEM	valdoxan	583-591
26081321_en	DISO	ACS	625-628
26081321_en	DISO	ADD	633-636
26081321_en	CHEM	valdoxan	650-658
26081321_en	PHYS	Coagulation	667-678
26081321_en	PHYS	hemostasis	701-711
26081321_en	DISO	ACS	829-832
26081321_en	CHEM	fibrinogen	857-867
26081321_en	CHEM	fibrin-monomer complexes	877-901
26081321_en	CHEM	D-dimer	903-910
26081321_en	DISO	ADD	957-960
26081321_en	DISO	ADD	1034-1037
26081321_en	CHEM	D-dimer	1053-1060
26081321_en	DISO	ADD	1107-1110
26081321_en	CHEM	valdoxan	1124-1132
26081321_en	DISO	ACS	1154-1157
26081321_en	DISO	ADD	1166-1169
26081321_en	DISO	ADD	1203-1206
26081321_en	DISO	ACS	1369-1372
26081321_en	DISO	ADD	1381-1384
26081321_en	DISO	ACS	1404-1407
26081321_en	PHYS	platelet aggregation	1427-1447
26081321_en	CHEM	adenosine diphosphate	1462-1483
26081321_en	DISO	ACS	1518-1521
26081321_en	DISO	ADD	1526-1529
26081321_en	CHEM	valdoxan	1543-1551
26081321_en	ANATOMY	coronary	64-72
26081321_en	ANATOMY	coronary	213-221
26081321_en	DISO	ACS	232-235
26081321_en	DISO	ADD	295-298
26081321_en	PHYS	male	382-386
26081321_en	PHYS	female	391-397
26081321_en	ANATOMY	platelet	692-700
26081321_en	ANATOMY	vascular	683-691
26081321_en	CHEM	fibrin	877-883
26081321_en	CHEM	monomer	884-891
26081321_en	CHEM	soluble fibrin-monomer	869-891
26081321_en	CHEM	soluble fibrin-monomer complexes	869-901
26081321_en	ANATOMY	platelet	1427-1435
26081321_en	CHEM	adenosine	1462-1471
26081321_en	CHEM	diphosphate	1472-1483
26081321_en	PHYS	hemostatic	1732-1742
26081321_en	DISO	ACS	1815-1818
26081321_en	DISO	ADD	1823-1826
26081321_en	CHEM	valdoxan	1882-1890
26081321_en	DISO	anxiety and depressive disorders	261-293
26081321_en	FINDING	high values of platelet aggregation	1412-1447
26081321_en	FINDING	high levels of fibrinogen, soluble fibrin-monomer complexes, D-dimer	842-910
26081321_en	PHYS	levels of D-dimer	1043-1060
26081321_en	PHYS	levels of spontaneous aggregation	1212-1245
26081321_en	PHYS	procoagulant activity	1703-1724
26081321_en	FINDING	dynamics of hemostasis	167-189
26081321_en	FINDING	high procoagulant activity	1698-1724
26081321_en	PHYS	spontaneous aggregation	1222-1245
26081321_en	ANATOMY	hemostatic system	1732-1749
26081321_en	DISO	depressive disorders	118-138
26081321_en	DISO	coronary syndrome	64-81
26081321_en	DISO	coronary syndrome	213-230
26081321_en	FINDING	effect of valdoxan on the hemostasis	4-40
26081321_en	PHYS	levels of fibrinogen	847-867
26081321_en	PHYS	levels	847-853
26081321_en	FINDING	these parameters were significantly higher	962-1004
26081321_en	FINDING	similar in patients with ADD	1082-1110
26081321_en	FINDING	not significantly higher	1297-1321
26081321_en	FINDING	significant reduction of these parameters	1555-1596
26081328_en	DISO	autonomic syndrome	24-42
26081328_en	DISO	tension-type headache	60-81
26081328_en	DISO	psycho-vegetative violations	150-178
26081328_en	CHEM	anxiolitikami	179-192
26081328_en	DISO	headache	227-235
26081328_en	DISO	episodic headache	349-366
26081328_en	CHEM	ibuprofen	443-452
26081328_en	DISO	headaches	475-484
26081328_en	CHEM	tizanidine	505-515
26081328_en	CHEM	anvifen	533-540
26081328_en	CHEM	ibuprofen	609-618
26081328_en	CHEM	tizanidine	623-633
26081328_en	CHEM	anvifen	669-676
26081328_en	DISO	headaches	727-736
26081328_en	DISO	vegetative disorders	825-845
26081328_en	CHEM	anvifen	1074-1081
26081328_en	DISO	headache	73-81
26081328_en	ANATOMY	vegetative	157-167
26081328_en	DISO	headache	358-366
26081328_en	DISO	frequent episodic headache	340-366
26081328_en	DISO	chronic headache	371-387
26081328_en	DISO	anxiety	776-783
26081328_en	DISO	depression	800-810
26081328_en	PHYS	sleep	888-893
26081328_en	FINDING	severity of headaches	715-736
26081328_en	FINDING	level of anxiety	767-783
26081328_en	PHYS	quality of sleep	877-893
26081328_en	DISO	headache	379-387
26081328_en	FINDING	frequency and intensity of headache	200-235
26081328_en	DISO	abuses	398-404
26081328_en	ANATOMY	vegetative	825-835
26081328_en	PHYS	General state	995-1008
26081328_en	FINDING	expediency of inclusion of, anvifen	1046-1081
26081340_en	DISO	trigeminal neuralgia	23-43
26081340_en	DISO	multiple sclerosis	61-79
26081340_en	DISO	Trigeminal neuralgia	93-113
26081340_en	DISO	multiple sclerosis	143-161
26081340_en	DISO	MS	163-165
26081340_en	ANATOMY	trigeminal nerve	232-248
26081340_en	DISO	MS	252-254
26081340_en	DISO	MS	297-299
26081340_en	DISO	trigeminal neuralgia	314-334
26081340_en	ANATOMY	trigeminal nerve	384-400
26081340_en	ANATOMY	superior cerebellar artery	430-456
26081340_en	ANATOMY	vein	491-495
26081340_en	DISO	trigeminal pain syndrome	548-572
26081340_en	LABPROC	MRI	729-732
26081340_en	DISO	neuralgia	34-43
26081340_en	DISO	sclerosis	70-79
26081340_en	DISO	neuralgia	104-113
26081340_en	DISO	sclerosis	152-161
26081340_en	ANATOMY	nerve	243-248
26081340_en	DISO	neuralgia	325-334
26081340_en	ANATOMY	nerve	395-400
26081340_en	ANATOMY	artery	450-456
26081340_en	ANATOMY	cerebellar artery	439-456
26081340_en	DISO	pain	559-563
26081340_en	ANATOMY	microvascular	197-210
26081340_en	ANATOMY	microvascular	349-362
26081340_en	FINDING	no complications of surgical treatment	628-666
26081340_en	DISO	compressed	461-471
26081340_en	FINDING	no relapses of trigeminal pain syndrome were observed	533-586
26081340_en	ANATOMY	cerebellar	439-449
26081340_en	FINDING	efficacy of microvascular decompression	185-224
26081340_en	ANATOMY	trigeminal	23-33
26081340_en	ANATOMY	Trigeminal	93-103
26081340_en	ANATOMY	trigeminal	314-324
26081340_en	DISO	relapses	536-544
26081340_en	ANATOMY	trigeminal	548-558
26081340_en	DISO	complications	631-644
26081340_en	DISO	pain syndrome	559-572
26087637_en	DISO	knee osteoarthritis	15-34
26087637_en	DISO	oxalate nephropathy	52-71
26087637_en	CHEM	Alflutop	143-151
26087637_en	CHEM	diacerein	156-165
26087637_en	DISO	knee osteoarthrosis	218-237
26087637_en	DISO	oxalate nephropathy	260-279
26087637_en	DISO	chronic kidney disease	296-318
26087637_en	DISO	urinary syndrome	368-384
26087637_en	PHYS	renal function	389-403
26087637_en	PHYS	female	589-595
26087637_en	DISO	oxalate nephropathy	679-698
26087637_en	CHEM	diclofenac sodium	784-801
26087637_en	CHEM	glycozaminoglycans Alflutop	870-897
26087637_en	DISO	joint pain	1191-1201
26087637_en	PHYS	Renal function	1252-1266
26087637_en	PHYS	urinary sediment	1367-1383
26087637_en	CHEM	diclofenac	1437-1447
26087637_en	DISO	hyperuricemia	1525-1538
26087637_en	CHEM	lipid hydroperoxides	1623-1643
26087637_en	CHEM	Alflutop	1690-1698
26087637_en	CHEM	diacerein	1703-1712
26087637_en	PHYS	renal function	1744-1758
26087637_en	CHEM	diclofenac	1859-1869
26087637_en	FINDING	decrease in the pain score	1900-1926
26087637_en	FINDING	pain scores were reduced	2032-2056
26087637_en	CHEM	diclofenac	2120-2130
26087637_en	DISO	stiffness	2196-2205
26087637_en	CHEM	Alflutop	2294-2302
26087637_en	CHEM	diacerein	2307-2316
26087637_en	CHEM	diclofenac	2338-2348
26087637_en	CHEM	Diclofenac	2569-2579
26087637_en	CHEM	oxalate	2610-2617
26087637_en	DISO	nephropathy	2618-2629
26087637_en	ANATOMY	knee	15-19
26087637_en	DISO	osteoarthritis	20-34
26087637_en	CHEM	oxalate	52-59
26087637_en	DISO	nephropathy	60-71
26087637_en	ANATOMY	knee	218-222
26087637_en	DISO	osteoarthrosis	223-237
26087637_en	DISO	OA	239-241
26087637_en	CHEM	oxalate	260-267
26087637_en	DISO	nephropathy	268-279
26087637_en	ANATOMY	kidney	304-310
26087637_en	DISO	kidney disease	304-318
26087637_en	DISO	CKD	320-323
26087637_en	ANATOMY	renal	389-394
26087637_en	CHEM	cyclooxygenase	471-485
26087637_en	CHEM	diclofenac	498-508
26087637_en	DISO	gonarthritis	650-662
26087637_en	DISO	primary gonarthritis	642-662
26087637_en	CHEM	oxalate	679-686
26087637_en	DISO	nephropathy	687-698
26087637_en	DISO	CKD	715-718
26087637_en	CHEM	diclofenac	784-794
26087637_en	CHEM	sodium	795-801
26087637_en	CHEM	glycozaminoglycans	870-888
26087637_en	CHEM	Alflutop	889-897
26087637_en	CHEM	diacerein	1007-1016
26087637_en	CHEM	diaflex	1018-1025
26087637_en	FINDING	symptom- modifying effect	1131-1156
26087637_en	DISO	pain	1197-1201
26087637_en	ANATOMY	joint	1191-1196
26087637_en	DISO	morning stiffness	1206-1223
26087637_en	ANATOMY	Renal	1252-1257
26087637_en	ANATOMY	glomerular	1300-1310
26087637_en	PHYS	GFR	1328-1331
26087637_en	PHYS	glomerular filtration rate	1300-1326
26087637_en	CHEM	uric acid	1334-1343
26087637_en	PHYS	uric acid clearance	1334-1353
26087637_en	DISO	nephrotoxic effects	1467-1486
26087637_en	PHYS	GFR	1494-1497
26087637_en	DISO	secondary hyperuricemia	1515-1538
26087637_en	DISO	proteinuria	1552-1563
26087637_en	CHEM	lipid	1623-1628
26087637_en	CHEM	hydroperoxides	1629-1643
26087637_en	CHEM	calcium	1658-1665
26087637_en	CHEM	oxalate	1666-1673
26087637_en	DISO	crystalluria	1674-1686
26087637_en	DISO	calcium oxalate crystalluria	1658-1686
26087637_en	FINDING	no negative effects	1721-1740
26087637_en	ANATOMY	renal	1744-1749
26087637_en	DISO	pain	1843-1847
26087637_en	DISO	pain	1916-1920
26087637_en	DISO	pain	2032-2036
26087637_en	FINDING	stiffness score	2196-2211
26087637_en	CHEM	Alflutop	2368-2376
26087637_en	ANATOMY	knee	2413-2417
26087637_en	DISO	OA	2418-2420
26087637_en	DISO	knee OA	2413-2420
26087637_en	DISO	nephrotoxic effects	2436-2455
26087637_en	CHEM	diclofenac	2494-2504
26087637_en	FINDING	symptom-modifying effect	2505-2529
26087637_en	DISO	pain	2542-2546
26087637_en	DISO	stiffness	2551-2560
26087637_en	DISO	oxalate nephropathy	2610-2629
26087637_en	CHEM	cyclooxygenase inhibitors	471-496
26087637_en	PHYS	C(ua)	1355-1360
26087637_en	PHYS	C(ua)	1499-1504
26087637_en	FINDING	reduction in the WOMAC pain score	1820-1853
26087637_en	FINDING	oxalate nephropathy progress	2610-2638
26087637_en	FINDING	lower GFR, C(ua	1488-1503
26087637_en	PHYS	urinary levels	1599-1613
26087637_en	FINDING	enhanced calcium oxalate crystalluria	1649-1686
26087637_en	FINDING	reducing pain and stiffness scores	2533-2567
26087637_en	DISO	progressive proteinuria	1540-1563
26087637_en	FINDING	evolving secondary hyperuricemia	1506-1538
26087637_en	DISO	microhematuria	1574-1588
26087637_en	FINDING	elevated urinary levels of total lipid hydroperoxides	1590-1643
26087637_en	FINDING	lower values	2274-2286
26087637_en	FINDING	do not produce nephrotoxic effects	2421-2455
26087637_en	CHEM	diacerein	2381-2390
26087637_en	DISO	Kellgren-Lawrence Stages II-III knee osteoarthrosis	186-237
26087637_en	DISO	Stages I-II chronic kidney disease	284-318
26087637_en	CHEM	nonsteroidal anti-inflammatory drugs	433-469
26087637_en	CHEM	anti-inflammatory drugs	446-469
26087637_en	DISO	Kellgren-Lawrence Stages II-III primary gonarthritis	610-662
26087637_en	DISO	Stages I-II CKD	703-718
26087637_en	PHYS	inflammatory	451-463
26087637_en	CHEM	acid	1339-1343
26087637_en	CHEM	Alflutop	2004-2012
26087637_en	CHEM	diacerein	2017-2026
26087637_en	DISO	stiffness	1214-1223
26087637_en	CHEM	inhibitors	486-496
26087637_en	PHYS	glomerular filtration	1300-1321
26087637_en	FINDING	symptom-modifying effect	115-139
26087637_en	FINDING	changes in the joint pain and morning stiffness	1176-1223
26087637_en	ANATOMY	urinary	1599-1606
26087637_en	ANATOMY	urinary	368-375
26087637_en	FINDING	effect of these drugs	343-364
26087637_en	ANATOMY	urinary	1367-1374
26087638_en	DISO	colitis	35-42
26087638_en	DISO	microscopic colitis	167-186
26087638_en	DISO	MC	214-216
26087638_en	DISO	inflammatory bowel disease	223-249
26087638_en	DISO	chronic watery diarrhea	297-320
26087638_en	ANATOMY	large bowel	346-357
26087638_en	DISO	MC	455-457
26087638_en	DISO	collagenous colitis	547-566
26087638_en	DISO	lymphocytic colitis	576-595
26087638_en	DISO	MC	632-634
26087638_en	DISO	inflammatory bowel diseases	714-741
26087638_en	DISO	ulcerative colitis	751-769
26087638_en	DISO	Crohn's disease	774-789
26087638_en	DISO	MC	791-793
26087638_en	DISO	MC	876-878
26087638_en	DISO	Watery diarrhea	908-923
26087638_en	DISO	MC	991-993
26087638_en	DISO	CC	1049-1051
26087638_en	DISO	LC	1127-1129
26087638_en	ANATOMY	lymphocytes	1204-1215
26087638_en	ANATOMY	epitheliocytes	1220-1234
26087638_en	CHEM	topical glucocorticosteroid	1241-1268
26087638_en	CHEM	budesonide	1269-1279
26087638_en	DISO	MC	1407-1409
26087638_en	DISO	microscopic colitis	23-42
26087638_en	DISO	colitis	179-186
26087638_en	DISO	MC	188-190
26087638_en	ANATOMY	bowel	236-241
26087638_en	DISO	bowel disease	236-249
26087638_en	DISO	diarrhea	312-320
26087638_en	ANATOMY	bowel	352-357
26087638_en	DISO	colitis	559-566
26087638_en	DISO	CC	568-570
26087638_en	DISO	colitis	588-595
26087638_en	ANATOMY	lymphocytic	576-587
26087638_en	DISO	LC	597-599
26087638_en	ANATOMY	bowel	727-732
26087638_en	DISO	bowel diseases	727-741
26087638_en	DISO	colitis	762-769
26087638_en	DISO	diarrhea	915-923
26087638_en	ANATOMY	subepithelial	1055-1068
26087638_en	CHEM	collagen	1069-1077
26087638_en	FINDING	subepithelial collagen lining thickening	1055-1095
26087638_en	ANATOMY	lymphocyte	1156-1166
26087638_en	ANATOMY	intraepithelial	1140-1155
26087638_en	FINDING	higher intraepithelial lymphocyte counts	1133-1173
26087638_en	ANATOMY	intraepithelial	1188-1203
26087638_en	ANATOMY	intraepithelial lymphocytes	1188-1215
26087638_en	CHEM	glucocorticosteroid	1249-1268
26087638_en	CHEM	topical glucocorticosteroid budesonide	1241-1279
26087638_en	ANATOMY	intraepithelial lymphocyte	1140-1166
26087638_en	PHYS	remission	1380-1389
26087638_en	DISO	watery diarrhea	305-320
26087638_en	FINDING	no macroscopic signs of large bowel involvement	322-369
26087638_en	FINDING	prevalence of MC	618-634
26087638_en	FINDING	inducing and maintaining remission	1355-1389
26087638_en	DISO	pathomorphological changes	398-424
26087638_en	LABPROC	histological	1005-1017
26087638_en	LABPROC	histological	524-536
26087638_en	DISO	ulcerative	751-761
26087638_en	DISO	pathogenesis	860-872
26087638_en	DISO	pathogenesis	125-137
26087638_en	ANATOMY	subepithelial collagen lining	1055-1084
26087638_en	PHYS	intraepithelial lymphocyte counts	1140-1173
26087638_en	FINDING	efficacy	1313-1321
26120981_en	CHEM	succinic acid	19-32
26120981_en	DISO	dorsopathy	121-131
26120981_en	DISO	dorsopathy	226-236
26120981_en	CHEM	cytoflavin	250-260
26120981_en	CHEM	cytoflavin	489-499
26120981_en	CHEM	sodium chloride	584-599
26120981_en	CHEM	cytoflavin	813-823
26120981_en	DISO	pain syndrome	857-870
26120981_en	DISO	disturbed sensitivity	885-906
26120981_en	CHEM	isotonic solution of sodium chloride	563-599
26120981_en	CHEM	sodium	584-590
26120981_en	CHEM	chloride	591-599
26120981_en	DISO	pain	857-861
26120981_en	FINDING	improved emotional status	908-933
26120981_en	DISO	pain	978-982
26120981_en	DISO	neuropathic pain component	966-992
26120981_en	FINDING	decreased the severity of a neuropathic pain component	938-992
26120981_en	FINDING	restored the disturbed sensitivity	872-906
26120981_en	FINDING	earlier arresting of the pain syndrome	832-870
26120981_en	CHEM	nonsteroid anti-inflammatory drugs	379-413
26120981_en	CHEM	myorelaxants	415-427
26120981_en	CHEM	vitamins	429-437
26120981_en	DISO	inflammatory	395-407
26120981_en	CHEM	acid	28-32
26120981_en	CHEM	anti-inflammatory drugs	390-413
26120981_en	CHEM	isotonic solution	563-580
26120981_en	FINDING	dynamics of neurological and emotional disturbances	52-103
26120981_en	FINDING	dynamics of neurological and emotional disturbances	157-208
26120981_en	FINDING	effect of the succinic acid preparation	5-44
26120981_en	DISO	emotional disturbances	81-103
26120981_en	DISO	neurological disturbances	64-103
26120981_en	DISO	neurological disturbances	169-208
26120981_en	DISO	emotional disturbances	186-208
26120981_en	CHEM	succinic acid preparation	19-44
26120981_en	CHEM	solution	513-521
26120981_en	CHEM	solution	572-580
26120981_en	PHYS	sensitivity	895-906
26145744_en	ANATOMY	bone tissue	34-45
26145744_en	ANATOMY	middle facial region	55-75
26145744_en	ANATOMY	maxillary sinus cavity walls	170-198
26145744_en	ANATOMY	maxillary sinus cavity walls	367-395
26145744_en	PHYS	age-specific peculiarities	470-496
26145744_en	ANATOMY	bone tissue	532-543
26145744_en	ANATOMY	maxillary sinus cavity	565-587
26145744_en	LABPROC	spiral computed tomography	625-651
26145744_en	ANATOMY	upper portion of the alveolar process	881-918
26145744_en	ANATOMY	lower walls of the sinus	955-979
26145744_en	ANATOMY	inferior nasal passage	1023-1045
26145744_en	ANATOMY	maxillary sinus	1100-1115
26145744_en	ANATOMY	bone tissue	1266-1277
26145744_en	ANATOMY	maxillary sinus	1376-1391
26145744_en	ANATOMY	endonasal	1416-1425
26145744_en	ANATOMY	bone tissue	1551-1562
26145744_en	ANATOMY	canine	1648-1654
26145744_en	ANATOMY	canine fossa	1648-1660
26145744_en	ANATOMY	bone	1672-1676
26145744_en	ANATOMY	floor of the maxillary sinus	1738-1766
26145744_en	ANATOMY	bone	34-38
26145744_en	ANATOMY	tissue	39-45
26145744_en	ANATOMY	facial	62-68
26145744_en	PHYS	age-related features	126-146
26145744_en	ANATOMY	sinus	180-185
26145744_en	ANATOMY	sinus cavity	180-192
26145744_en	ANATOMY	sinus cavity walls	180-198
26145744_en	ANATOMY	maxillary	170-179
26145744_en	ANATOMY	maxillary sinus	170-185
26145744_en	ANATOMY	maxillary	367-376
26145744_en	ANATOMY	sinus	377-382
26145744_en	ANATOMY	sinus cavity	377-389
26145744_en	ANATOMY	sinus cavity walls	377-395
26145744_en	ANATOMY	maxillary sinus	367-382
26145744_en	ANATOMY	bone	532-536
26145744_en	ANATOMY	tissue	537-543
26145744_en	ANATOMY	maxillary	565-574
26145744_en	ANATOMY	sinus cavity	575-587
26145744_en	ANATOMY	maxillary sinus	565-580
26145744_en	LABPROC	tomography	641-651
26145744_en	LABPROC	computed tomography	632-651
26145744_en	ANATOMY	canine	845-851
26145744_en	ANATOMY	canine fossa	845-857
26145744_en	ANATOMY	canine fossa region	845-864
26145744_en	ANATOMY	alveolar process	902-918
26145744_en	ANATOMY	sinus	974-979
26145744_en	ANATOMY	nasal	1032-1037
26145744_en	ANATOMY	nasal passage	1032-1045
26145744_en	ANATOMY	bone	1083-1087
26145744_en	ANATOMY	maxillary	1100-1109
26145744_en	ANATOMY	sinus	1110-1115
26145744_en	ANATOMY	anterior part of the inferior nasal passage	1002-1045
26145744_en	ANATOMY	bone	1266-1270
26145744_en	ANATOMY	tissue	1271-1277
26145744_en	ANATOMY	maxillary	1376-1385
26145744_en	ANATOMY	sinus	1386-1391
26145744_en	ANATOMY	bone	1551-1555
26145744_en	ANATOMY	tissue	1556-1562
26145744_en	FINDING	risk of injury	1706-1720
26145744_en	ANATOMY	maxillary	1751-1760
26145744_en	ANATOMY	maxillary sinus	1751-1766
26145744_en	ANATOMY	upper walls of the sinus	945-979
26145744_en	ANATOMY	bone wall of the maxillary sinus	1083-1115
26145744_en	PHYS	fragile	1690-1697
26145744_en	PHYS	mechanical properties	5-26
26145744_en	PHYS	age	126-129
26145744_en	PHYS	age	470-473
26145744_en	PHYS	age	1212-1215
26145744_en	PHYS	mechanical structure of the bone tissue	504-543
26145744_en	ANATOMY	bone wall	1083-1092
26145744_en	PHYS	age-related physical and mechanical properties of the bone tissue	1212-1277
26145744_en	FINDING	minimally injurious	1519-1538
26145744_en	FINDING	bone wall of the maxillary sinus differently responds to the impacts of similar magnitude	1083-1172
26145744_en	ANATOMY	sinus	1761-1766
26145744_en	ANATOMY	sinus	575-580
26145744_en	ANATOMY	sinus	377-382
26145744_en	ANATOMY	sinus	180-185
26145744_en	ANATOMY	alveolar	902-910
26146046_en	LABPROC	angiography	242-253
26146046_en	LABPROC	SCT	258-261
26146046_en	LABPROC	angiography	262-273
26146046_en	DISO	cerebral aneurysms	295-313
26146046_en	LABPROC	angiographic examination	541-565
26146046_en	DISO	aneurysms	586-595
26146046_en	DISO	aneurysms	652-661
26146046_en	DISO	aneurysms	704-713
26146046_en	DISO	aneurysms	727-736
26146046_en	ANATOMY	circle of Willis	830-846
26146046_en	DISO	aneurysms	856-865
26146046_en	DISO	aneurysm	917-925
26146046_en	ANATOMY	middle cerebral artery	1006-1028
26146046_en	DISO	aneurysm	1162-1170
26146046_en	DISO	hypertension	1219-1231
26146046_en	ANATOMY	main artery	1358-1369
26146046_en	LABPROC	angiography	1474-1485
26146046_en	LABPROC	magnetic resonance angiography	1489-1519
26146046_en	LABPROC	angiographic	61-73
26146046_en	ANATOMY	cerebral	112-120
26146046_en	DISO	aneurysms	121-130
26146046_en	DISO	cerebral aneurysms	112-130
26146046_en	DISO	de novo aneurysm	143-159
26146046_en	ANATOMY	cerebral	233-241
26146046_en	LABPROC	cerebral angiography	233-253
26146046_en	LABPROC	SCT angiography	258-273
26146046_en	ANATOMY	cerebral	295-303
26146046_en	DISO	aneurysms	304-313
26146046_en	DISO	de novo aneurysms	578-595
26146046_en	DISO	de novo aneurysms	644-661
26146046_en	ANATOMY	anterior part of the circle of Willis	809-846
26146046_en	DISO	De novo aneurysms	848-865
26146046_en	DISO	de novo aneurysm	909-925
26146046_en	DISO	aneurysm	990-998
26146046_en	ANATOMY	cerebral	1013-1021
26146046_en	ANATOMY	artery	1022-1028
26146046_en	ANATOMY	cerebral artery	1013-1028
26146046_en	DISO	de novo aneurysm	1154-1170
26146046_en	PHYS	young	1200-1205
26146046_en	PHYS	young	1300-1305
26146046_en	ANATOMY	artery	1363-1369
26146046_en	LABPROC	angiographic	1446-1458
26146046_en	LABPROC	SCT	1470-1473
26146046_en	LABPROC	SCT angiography	1470-1485
26146046_en	LABPROC	angiography	1508-1519
26146046_en	LABPROC	angiographic examination	207-231
26146046_en	FINDING	reasonability and duration of angiographic follow-up	31-83
26146046_en	FINDING	high risk of de novo aneurysm formation	1141-1180
26146046_en	FINDING	follow-up duration	397-415
26146046_en	LABPROC	Dynamic angiographic follow-up	1438-1468
26146046_en	FINDING	de novo aneurysm formation	143-169
26146046_en	FINDING	mean duration	457-470
26146046_en	DISO	aneurysm	151-159
26146046_en	FINDING	de novo aneurysms were formed	578-607
26146046_en	DEVICE	spirals	944-951
26146046_en	FINDING	Neither lethal nor unfavorable outcomes were recorded	1046-1099
26146046_en	FINDING	outcomes	1077-1085
26146046_en	FINDING	lethal	1054-1060
26146046_en	FINDING	unfavorable outcomes	1065-1085
26226776_en	DISO	colorectal cancer	72-89
26226776_en	CHEM	E-cadherin	128-138
26226776_en	CHEM	β-catenin	143-152
26226776_en	DISO	colorectal cancer	167-184
26226776_en	DISO	liver metastases	191-207
26226776_en	ANATOMY	cells	309-314
26226776_en	CHEM	E-cadherin	588-598
26226776_en	CHEM	β-catenin	603-612
26226776_en	CHEM	β-catenin	970-979
26226776_en	CHEM	anti-VEGF agent	1067-1082
26226776_en	CHEM	E-cadherin	1266-1276
26226776_en	CHEM	β-catenin	1281-1290
26226776_en	ANATOMY	cells	1313-1318
26226776_en	CHEM	E-cadherin	1355-1365
26226776_en	ANATOMY	membrane	1366-1374
26226776_en	CHEM	β-catenin	1392-1401
26226776_en	CHEM	anti-VEGF agent	1589-1604
26226776_en	DISO	CRC	1639-1642
26226776_en	CHEM	β-catenin	1757-1766
26226776_en	ANATOMY	liver	90-95
26226776_en	DISO	cancer	83-89
26226776_en	DISO	liver metastases	90-106
26226776_en	DISO	cancer	178-184
26226776_en	DISO	CRC	186-189
26226776_en	ANATOMY	liver	191-196
26226776_en	DISO	tumor	303-308
26226776_en	DISO	CRC	363-366
26226776_en	ANATOMY	vascular	488-496
26226776_en	ANATOMY	endothelial	497-508
26226776_en	LABPROC	immunohistochemically examined	537-567
26226776_en	ANATOMY	membrane	832-840
26226776_en	CHEM	E-cadherin	857-867
26226776_en	CHEM	anti-VEGF	1067-1076
26226776_en	CHEM	anti-VEGF agents	736-752
26226776_en	DISO	tumor	1307-1312
26226776_en	ANATOMY	membrane	1402-1410
26226776_en	ANATOMY	cytoplasmic	1411-1422
26226776_en	DISO	metastatic CRC	1628-1642
26226776_en	CHEM	cadherin-catenin complex	1672-1696
26226776_en	CHEM	cadherin	1672-1680
26226776_en	CHEM	catenin	1681-1688
26226776_en	PHYS	proliferation	1830-1843
26226776_en	DISO	tumor	1819-1824
26226776_en	ANATOMY	cell	1825-1829
26226776_en	ANATOMY	colorectal	72-82
26226776_en	ANATOMY	colorectal	167-177
26226776_en	DISO	metastatic CRC	352-366
26226776_en	CHEM	vascular endothelial growth factor	488-522
26226776_en	CHEM	VEGF	482-486
26226776_en	CHEM	VEGF	1594-1598
26226776_en	PHYS	intercellular contacts	1719-1741
26226776_en	CHEM	adhesion molecule	40-57
26226776_en	PHYS	expression	58-68
26226776_en	PHYS	expression	153-163
26226776_en	PHYS	adhesive properties	280-299
26226776_en	CHEM	cytotoxic	419-428
26226776_en	CHEM	cytotoxic	454-463
26226776_en	CHEM	antibodies	574-584
26226776_en	CHEM	cytotoxic	722-731
26226776_en	PHYS	membrane localization	832-853
26226776_en	FINDING	significant increase in the number of cases of normal membrane localization of E-cadherin	778-867
26226776_en	CHEM	cytotoxic	911-920
26226776_en	PHYS	β-catenin levels	970-986
26226776_en	FINDING	no significant differences	1020-1046
26226776_en	PHYS	nuclear localization of the protein	1139-1174
26226776_en	CHEM	protein	1167-1174
26226776_en	FINDING	decrease in the number of cases of abnormal nuclear localization of the protein	1095-1174
26226776_en	PHYS	E-cadherin and β-catenin localization	1266-1303
26226776_en	PHYS	membrane localization	1366-1387
26226776_en	PHYS	membrane-cytoplasmic expression	1402-1433
26226776_en	CHEM	cytotoxic	1514-1523
26226776_en	FINDING	positive impact on the cadherin-catenin complex	1649-1696
26226776_en	FINDING	increased intercellular contacts	1709-1741
26226776_en	FINDING	suppressed β-catenin functioning as a transcription factor	1746-1804
26226776_en	CHEM	cytotoxic	1221-1230
26226776_en	ANATOMY	metastatic CRC samples	352-374
26226776_en	FINDING	combination of normal E-cadherin membrane localization and β-catenin membrane-cytoplasmic expression prevailed	1333-1443
26226776_en	CHEM	anti-VEGF	477-486
26226776_en	FINDING	enhances tumor cell proliferation	1810-1843
26226776_en	DISO	metastases	96-106
26226776_en	CHEM	cadherin	130-138
26226776_en	CHEM	catenin	145-152
26226776_en	DISO	metastases	197-207
26226776_en	DISO	metastatic	352-362
26226776_en	CHEM	growth factor	509-522
26226776_en	CHEM	cadherin	590-598
26226776_en	CHEM	catenin	605-612
26226776_en	ANATOMY	samples	367-374
26226776_en	FINDING	not received drug therapy	664-689
26226776_en	CHEM	VEGF	741-745
26226776_en	CHEM	cadherin	859-867
26226776_en	CHEM	catenin	972-979
26226776_en	ANATOMY	nuclear	1139-1146
26226776_en	FINDING	abnormal nuclear localization of the protein	1130-1174
26226776_en	CHEM	catenin	1283-1290
26226776_en	CHEM	cadherin	1268-1276
26226776_en	CHEM	cadherin	1357-1365
26226776_en	CHEM	catenin	1394-1401
26226776_en	DISO	metastatic	1628-1638
26226776_en	CHEM	catenin	1759-1766
26226776_en	CHEM	a transcription facto	1782-1803
26226776_en	PHYS	transcription	1784-1797
26245096_en	ANATOMY	vagus nerve system	18-36
26245096_en	DISO	sympathetic imbalance	66-87
26245096_en	ANATOMY	vagus nerve system	173-191
26245096_en	ANATOMY	atrioventricular ganglion	193-218
26245096_en	ANATOMY	cardiomyocytes	235-249
26245096_en	INJURY_POISONING	craniovertebral injury	331-353
26245096_en	DISO	acute coronary insufficiency	382-410
26245096_en	ANATOMY	vagus nerve system	483-501
26245096_en	DISO	lesions	522-529
26245096_en	ANATOMY	jugular ganglia	537-552
26245096_en	INJURY_POISONING	craniovertebral injuries	593-617
26245096_en	ANATOMY	ganglia	653-660
26245096_en	ANATOMY	nerve trunks	662-674
26245096_en	ANATOMY	jugular foramina	700-716
26245096_en	DISO	atrophic changes	736-752
26245096_en	ANATOMY	ganglia	771-778
26245096_en	ANATOMY	vagus nerve system	786-804
26245096_en	DISO	acute coronary insufficiency	835-863
26245096_en	DISO	hemosiderosis	892-905
26245096_en	ANATOMY	soft tissues	918-930
26245096_en	ANATOMY	medulla oblongata	938-955
26245096_en	ANATOMY	vagus nerve	18-29
26245096_en	ANATOMY	nerve	24-29
26245096_en	ANATOMY	cardiac	110-117
26245096_en	ANATOMY	vagus nerve	173-184
26245096_en	ANATOMY	nerve	179-184
26245096_en	ANATOMY	atrioventricular	193-209
26245096_en	ANATOMY	craniovertebral	331-346
26245096_en	ANATOMY	coronary	388-396
26245096_en	DISO	coronary insufficiency	388-410
26245096_en	ANATOMY	vagus nerve	483-494
26245096_en	ANATOMY	nerve	489-494
26245096_en	ANATOMY	jugular	537-544
26245096_en	ANATOMY	ganglia	545-552
26245096_en	ANATOMY	craniovertebral	593-608
26245096_en	ANATOMY	nerve	662-667
26245096_en	ANATOMY	tissues	685-692
26245096_en	ANATOMY	jugular	700-707
26245096_en	ANATOMY	foramina	708-716
26245096_en	ANATOMY	vagus nerve	786-797
26245096_en	ANATOMY	nerve	792-797
26245096_en	ANATOMY	coronary	841-849
26245096_en	DISO	coronary insufficiency	841-863
26245096_en	ANATOMY	tissues	923-930
26245096_en	PHYS	sudden cardiac death	103-123
26245096_en	ANATOMY	soft tissues	680-692
26245096_en	ANATOMY	pial soft tissues	913-930
26245096_en	PHYS	morphological marker	42-62
26245096_en	FINDING	fatal outcome	269-282
26245096_en	DISO	hemorrhage	633-643
26245096_en	PHYS	died	825-829
26245096_en	PHYS	cardiac death	110-123
26245096_en	DISO	Pathology of the vagus nerve system	1-36
26245096_en	PHYS	changes in cardiomyocytes	224-249
26245096_en	PHYS	death	118-123
26245096_en	ANATOMY	ganglion	210-218
26245096_en	INJURY_POISONING	injury	347-353
26245096_en	DISO	insufficiency	397-410
26245096_en	INJURY_POISONING	injuries	609-617
26245096_en	DISO	insufficiency	850-863
26245096_en	ANATOMY	pial	913-917
26245101_en	INJURY_POISONING	injuries to the extremities	108-135
26245101_en	ANATOMY	extremities	124-135
26245101_en	ANATOMY	lower extremities	317-334
26245101_en	ANATOMY	corpses	650-657
26245101_en	PHYS	live	666-670
26245101_en	INJURY_POISONING	fractures	1106-1115
26245101_en	ANATOMY	femur	1129-1134
26245101_en	ANATOMY	right femur	1123-1134
26245101_en	INJURY_POISONING	bleeding	1146-1154
26245101_en	INJURY_POISONING	wounds	1166-1172
26245101_en	ANATOMY	tissues	1185-1192
26245101_en	ANATOMY	thigh	1206-1211
26245101_en	ANATOMY	right thigh	1200-1211
26245101_en	ANATOMY	posterior surface of the right shoulder	1295-1334
26245101_en	ANATOMY	shoulder	1326-1334
26245101_en	ANATOMY	deltoid	1356-1363
26245101_en	ANATOMY	deltoid region	1356-1370
26245101_en	ANATOMY	right deltoid region	1350-1370
26245101_en	ANATOMY	forearm	1421-1428
26245101_en	ANATOMY	right forearm	1415-1428
26245101_en	ANATOMY	right shoulder	1320-1334
26245101_en	ANATOMY	posterior surface of the right forearm	1390-1428
26245101_en	INJURY_POISONING	fractures	1440-1449
26245101_en	ANATOMY	humerus	1463-1470
26245101_en	ANATOMY	right humerus	1457-1470
26245101_en	PHYS	survive	1527-1534
26245101_en	INJURY_POISONING	bleeding	1581-1589
26245101_en	INJURY_POISONING	scratches	1594-1603
26245101_en	ANATOMY	tissues	1649-1656
26245101_en	ANATOMY	shoulder	1695-1703
26245101_en	ANATOMY	right shoulder	1689-1703
26245101_en	ANATOMY	posterior surface of the right shoulder	1664-1703
26245101_en	ANATOMY	soft tissues	1644-1656
26245101_en	INJURY_POISONING	fractures	1705-1714
26245101_en	ANATOMY	humerus	1728-1735
26245101_en	ANATOMY	right humerus	1722-1735
26245101_en	INJURY_POISONING	bruises	1748-1755
26245101_en	ANATOMY	thigh	1793-1798
26245101_en	ANATOMY	right thigh	1787-1798
26245101_en	ANATOMY	anterior surface of the right thigh	1763-1798
26245101_en	ANATOMY	forearm	1846-1853
26245101_en	ANATOMY	right forearm	1840-1853
26245101_en	ANATOMY	posterior surface of the right forearm	1815-1853
26245101_en	ANATOMY	leg	1906-1909
26245101_en	ANATOMY	lower leg	1900-1909
26245101_en	ANATOMY	right lower leg	1894-1909
26245101_en	ANATOMY	fontal region of the right lower leg	1873-1909
26245101_en	INJURY_POISONING	bleeding	1922-1930
26245101_en	ANATOMY	forearm	1968-1975
26245101_en	ANATOMY	right forearm	1962-1975
26245101_en	ANATOMY	posterior region of the right forearm	1938-1975
26245101_en	ANATOMY	thigh	2022-2027
26245101_en	ANATOMY	left thigh	2017-2027
26245101_en	ANATOMY	anterior region of the left thigh	1994-2027
26245101_en	INJURY_POISONING	fractures	2039-2048
26245101_en	ANATOMY	femur	2062-2067
26245101_en	ANATOMY	right femur	2056-2067
26245101_en	ANATOMY	upper extremities	307-334
26245101_en	FINDING	lethal outcome	1068-1082
26245101_en	ANATOMY	anterior surface	1262-1278
26245101_en	INJURY_POISONING	injuries	291-299
26245101_en	FINDING	risk of injuries	972-988
26245101_en	INJURY_POISONING	bruises	1280-1287
26245101_en	ANATOMY	extremities	323-334
26245101_en	INJURY_POISONING	injuries	980-988
26245101_en	INJURY_POISONING	injuries	2467-2475
26245101_en	ANATOMY	soft tissues	1180-1192
26245101_en	ANATOMY	upper and lower extremities	307-334
26245101_en	FINDING	outcome	1075-1082
26245101_en	FINDING	improve the quality of expert conclusions and the results of forensic medical examination	2370-2459
26245101_en	FINDING	expert conclusions	2393-2411
26271422_en	ANATOMY	abdominal	44-53
26271422_en	ANATOMY	abdominal wall	44-58
26271422_en	ANATOMY	umbilical	75-84
26271422_en	ANATOMY	abdominal	187-196
26271422_en	ANATOMY	abdominal wall	187-201
26271422_en	ANATOMY	umbilical	252-261
26271422_en	ANATOMY	ventral	286-293
26271422_en	ANATOMY	ventral	103-110
26271422_en	DISO	hernias	111-118
26271422_en	DISO	ventral hernias	103-118
26271422_en	DISO	ventral hernias	286-301
26271422_en	DISO	large ventral hernias	280-301
26271422_en	ANATOMY	abdomen	316-323
26271422_en	DISO	ptosis	324-330
26271422_en	DISO	abdomen ptosis	316-330
26271422_en	ANATOMY	abdominal	441-450
26271422_en	ANATOMY	abdominal wall	441-455
26271422_en	DISO	abdominal wall defect	441-462
26271422_en	CHEM	polypropylene	478-491
26271422_en	ANATOMY	tissues	584-591
26271422_en	ANATOMY	musculoaponeurotic tissues	565-591
26271422_en	ANATOMY	hypogastric area	603-619
26271422_en	CHEM	polypropylenepolyvinylidenefluoride	653-688
26271422_en	CHEM	Polypropylene	720-733
26271422_en	DEVICE	prosthesis	492-502
26271422_en	DEVICE	polypropylene prosthesis	478-502
26271422_en	DEVICE	standard polypropylene prosthesis	469-502
26271422_en	DEVICE	prosthesis	689-699
26271422_en	DEVICE	polypropylenepolyvinylidenefluoride prosthesis	653-699
26271422_en	DEVICE	super lightweight polypropylenepolyvinylidenefluoride prosthesis	635-699
26271422_en	LABPROC	ultrasonic investigation	159-183
26271422_en	DEVICE	Endoprosthetic	1-15
26271422_en	DEVICE	Endoprosthetic	411-425
26271422_en	DEVICE	endoprosthetic	533-547
26271422_en	DEVICE	Polypropylene endoprosthesis	720-748
26271422_en	DISO	postoperative ventral hernias	89-118
26271422_en	DISO	hernias	294-301
26271422_en	DISO	hernias umbilical	111-84
26271422_en	DISO	umbilical hernias	252-301
26271422_en	FINDING	increased physical health	939-964
26271422_en	PHYS	physical health	949-964
26271422_en	FINDING	amount of satisfactory outcomes reduced	1087-1126
26271422_en	FINDING	amount of satisfactory outcomes	1087-1118
26271422_en	DISO	postoperative large ventral hernias	266-301
26271422_en	FINDING	number of excellent results	1036-1063
26271422_en	FINDING	number of excellent results increased	1036-1073
26271422_en	FINDING	increased psychic	939-996
26271422_en	PHYS	health	958-964
26271558_en	DISO	upper esophageal sphincter achalasia	14-50
26271558_en	DISO	upper esophageal sphincter achalasia	162-198
26271558_en	DISO	achalasia	215-224
26271558_en	DISO	stroke in brain stem	244-264
26271558_en	ANATOMY	muscles	562-569
26271558_en	ANATOMY	epiglottis	592-602
26271558_en	ANATOMY	pharyngeal constrictors	607-630
26271558_en	DISO	achalasia	41-50
26271558_en	ANATOMY	sphincter	31-40
26271558_en	ANATOMY	esophageal sphincter	20-40
26271558_en	ANATOMY	upper esophageal sphincter	14-40
26271558_en	DISO	achalasia	189-198
26271558_en	ANATOMY	sphincter	179-188
26271558_en	ANATOMY	esophageal sphincter	168-188
26271558_en	ANATOMY	upper esophageal sphincter	162-188
26271558_en	ANATOMY	brain	254-259
26271558_en	ANATOMY	brain stem	254-264
26271558_en	DISO	stroke	244-250
26271558_en	DISO	Zakharchenko-Wallenberg syndrome	266-298
26271558_en	ANATOMY	pharyngoesophageal junction	401-428
26271558_en	PHYS	innervation	547-558
26271558_en	ANATOMY	pharyngeal	607-617
26271558_en	PHYS	elderly age	665-676
26271558_en	FINDING	preservation of innervation	531-558
26271558_en	FINDING	Severe condition of patients	632-660
26271558_en	PHYS	age	673-676
26271558_en	ANATOMY	esophageal	20-30
26271558_en	ANATOMY	esophageal	168-178
26271558_en	ANATOMY	pharyngoesophageal	401-419
26271558_en	FINDING	Plastic myotomy gives excellent and good results	452-500
26271558_en	ANATOMY	constrictors	618-630
26281190_en	CHEM	Cystatin C	1-11
26281190_en	DISO	left ventricular hypertrophy	32-60
26281190_en	DISO	chronic kidney disease	78-100
26281190_en	DISO	CKD	388-391
26281190_en	PHYS	glomerular filtration rate	423-449
26281190_en	PHYS	GFR	451-454
26281190_en	PHYS	GFR	528-531
26281190_en	PHYS	GFR	562-565
26281190_en	PHYS	GFR	615-618
26281190_en	PHYS	GFR	682-685
26281190_en	LABPROC	transthoracic echocardiography	748-778
26281190_en	PHYS	cystatin C levels	804-821
26281190_en	DISO	LVH	868-871
26281190_en	PHYS	cystatin C levels	995-1012
26281190_en	CHEM	cystatin C	1147-1157
26281190_en	DISO	LVH	1162-1165
26281190_en	CHEM	cystatin C	1201-1211
26281190_en	DISO	LVH	1252-1255
26281190_en	DISO	CKD	1323-1326
26281190_en	PHYS	left ventricular mass index	1362-1389
26281190_en	DISO	hypertension	1438-1450
26281190_en	PHYS	cystatin C levels	1467-1484
26281190_en	PHYS	LVMI	1520-1524
26281190_en	PHYS	cystatin C levels	1586-1603
26281190_en	DISO	LVH	1632-1635
26281190_en	DISO	hypertrophy	49-60
26281190_en	ANATOMY	left ventricular	32-48
26281190_en	ANATOMY	ventricular	37-48
26281190_en	ANATOMY	kidney	86-92
26281190_en	DISO	kidney disease	86-100
26281190_en	CHEM	cystatin C	150-160
26281190_en	ANATOMY	serum	144-149
26281190_en	CHEM	cystatin	150-158
26281190_en	ANATOMY	ventricular	188-199
26281190_en	DISO	hypertrophy	200-211
26281190_en	DISO	ventricular hypertrophy	37-60
26281190_en	DISO	ventricular hypertrophy	188-211
26281190_en	ANATOMY	left ventricular	183-199
26281190_en	DISO	left ventricular hypertrophy	183-211
26281190_en	DISO	LVH	213-216
26281190_en	DISO	chronic kidney disease	235-257
26281190_en	DISO	CKD	259-262
26281190_en	ANATOMY	kidney	243-249
26281190_en	DISO	kidney disease	243-257
26281190_en	DISO	nondiabetic CKD	376-391
26281190_en	ANATOMY	serum	798-803
26281190_en	CHEM	cystatin	804-812
26281190_en	CHEM	cystatin C	804-814
26281190_en	ANATOMY	serum	989-994
26281190_en	CHEM	cystatin	995-1003
26281190_en	CHEM	cystatin C	995-1005
26281190_en	PHYS	level of cystatin C	1192-1211
26281190_en	DISO	predialysis CKD	1311-1326
26281190_en	PHYS	LVMI	1391-1395
26281190_en	ANATOMY	ventricular	1367-1378
26281190_en	ANATOMY	left ventricular	1362-1378
26281190_en	PHYS	E-velocity/A-velocity	1398-1419
26281190_en	CHEM	cystatin C	1467-1477
26281190_en	ANATOMY	Serum	1580-1585
26281190_en	CHEM	cystatin	1586-1594
26281190_en	CHEM	cystatin C	1586-1596
26281190_en	DISO	CKD	1694-1697
26281190_en	LABPROC	echocardiography	762-778
26281190_en	PHYS	early LVH marker	1626-1642
26281190_en	FINDING	magnitude of glomerular filtration rate (GFR) decrease	410-464
26281190_en	PHYS	marker	21-27
26281190_en	FINDING	predict the development of LVH	1225-1255
26281190_en	ANATOMY	glomerular	423-433
26281190_en	PHYS	glomerular filtration	423-444
26281190_en	FINDING	association	1117-1128
26281190_en	FINDING	sensitivity	1263-1274
26281190_en	FINDING	specificity	1288-1299
26281190_en	FINDING	independently correlated	1490-1514
26281190_en	PHYS	E/A	1422-1425
26281190_en	CHEM	Cystatin	1-9
26281190_en	CHEM	cystatin	1147-1155
26281190_en	CHEM	cystatin	1201-1209
26281190_en	CHEM	cystatin	1467-1475
26281190_en	PHYS	marker	1636-1642
26281191_en	CHEM	Endogenous erythropoietin	1-26
26281191_en	DISO	acute kidney injury	28-47
26281191_en	DISO	acute coronary syndrome	80-103
26281191_en	DISO	ACS	390-393
26281191_en	LABPROC	ECG	454-457
26281191_en	DISO	ST-segment elevation acute myocardial infarction	458-506
26281191_en	LABPROC	ECG	531-534
26281191_en	DISO	non-STSEAMI	535-546
26281191_en	DISO	unstable angina	565-580
26281191_en	DISO	STSEAMI	643-650
26281191_en	LABPROC	coronarography	688-702
26281191_en	CHEM	X-ray contrast agents	775-796
26281191_en	DISO	AKI	806-809
26281191_en	DISO	acute myocardial infarction	849-876
26281191_en	DISO	unstable angina	905-920
26281191_en	CHEM	EPO	974-977
26281191_en	DISO	AKI	1029-1032
26281191_en	DISO	ACS	1040-1043
26281191_en	DISO	ACS	1168-1171
26281191_en	ANATOMY	serum	1264-1269
26281191_en	DISO	ACS	1287-1290
26281191_en	DISO	AKI	1368-1371
26281191_en	CHEM	erythropoietin	12-26
26281191_en	ANATOMY	kidney	34-40
26281191_en	DISO	kidney injury	34-47
26281191_en	ANATOMY	coronary	86-94
26281191_en	DISO	coronary syndrome	86-103
26281191_en	CHEM	endogenous erythropoietin	156-181
26281191_en	ANATOMY	serum	150-155
26281191_en	CHEM	erythropoietin	167-181
26281191_en	CHEM	EPO	183-186
26281191_en	DISO	acute coronary syndrome	205-228
26281191_en	ANATOMY	coronary	211-219
26281191_en	DISO	coronary syndrome	211-228
26281191_en	DISO	ACS	230-233
26281191_en	DISO	acute kidney injury	273-292
26281191_en	ANATOMY	kidney	279-285
26281191_en	DISO	kidney injury	279-292
26281191_en	DISO	AKI	294-297
26281191_en	DISO	myocardial infarction	485-506
26281191_en	DISO	acute myocardial infarction	479-506
26281191_en	DISO	STSEAMI	508-515
26281191_en	DISO	angina	574-580
26281191_en	DISO	myocardial infarction	855-876
26281191_en	DISO	angina	914-920
26281191_en	CHEM	EPO	1270-1273
26281191_en	FINDING	High serum EPO levels	1259-1280
26281191_en	PHYS	EPO level	974-983
26281191_en	FINDING	high risk for AKI	1354-1371
26281191_en	FINDING	high death rates	1376-1392
26281191_en	PHYS	died	941-945
26281191_en	FINDING	predicted the development of AKI	1000-1032
26281191_en	PHYS	death	1155-1160
26281191_en	PHYS	EPO levels	1270-1280
26281191_en	PHYS	death	1381-1386
26281191_en	PHYS	biomarker	1338-1347
26281191_en	ANATOMY	myocardial	485-495
26281191_en	ANATOMY	myocardial	855-865
26281191_en	DISO	infarction	496-506
26281191_en	DISO	infarction	866-876
26281191_en	FINDING	nephrotoxic effect	753-771
26281191_en	FINDING	sensitivity	1060-1071
26281191_en	FINDING	specificity	1085-1096
26281191_en	FINDING	sensitivity	1188-1199
26281191_en	FINDING	specificity	1214-1225
26281191_en	FINDING	associated with hospital death	1130-1160
26281191_en	FINDING	death rates	1381-1392
26281196_en	DISO	acute kidney injury	18-37
26281196_en	DISO	CIAKI	490-495
26281196_en	DISO	STSEACS	621-628
26281196_en	DISO	hypertension	630-642
26281196_en	DISO	myocardial infarction	657-678
26281196_en	DISO	chronic kidney disease	687-709
26281196_en	DISO	type 2 diabetes mellitus	717-741
26281196_en	DISO	CIAKI	829-834
26281196_en	DISO	CIAKI	1002-1007
26281196_en	PHYS	older	1013-1018
26281196_en	PHYS	creatinine levels	1051-1068
26281196_en	PHYS	glomerular filtration rate	1149-1175
26281196_en	PHYS	left ventricular ejection fraction	1187-1221
26281196_en	DISO	CIAKI	1258-1263
26281196_en	DISO	chronic kidney disease	1292-1314
26281196_en	CHEM	mineralocorticoid receptor	1424-1450
26281196_en	DISO	CIAKI	1494-1499
26281196_en	DISO	cardiovascular disease	1584-1606
26281196_en	ANATOMY	kidney	24-30
26281196_en	DISO	kidney injury	24-37
26281196_en	DISO	Contrast-induced acute kidney injury	1-37
26281196_en	ANATOMY	coronary	65-73
26281196_en	DISO	contrast-induced acute kidney injury	219-255
26281196_en	ANATOMY	kidney	242-248
26281196_en	DISO	kidney injury	242-255
26281196_en	DISO	acute kidney injury	236-255
26281196_en	DISO	CIAKI	257-262
26281196_en	ANATOMY	coronary	308-316
26281196_en	DISO	ST-segment elevation acute coronary syndrome	281-325
26281196_en	DISO	acute coronary syndrome	302-325
26281196_en	DISO	STSEACS	327-334
26281196_en	ANATOMY	coronary	377-385
26281196_en	ANATOMY	myocardial	657-667
26281196_en	ANATOMY	kidney	695-701
26281196_en	DISO	kidney disease	695-709
26281196_en	DISO	diabetes	724-732
26281196_en	DISO	diabetes mellitus	724-741
26281196_en	DEVICE	phone	887-892
26281196_en	DISO	CIAKI	977-982
26281196_en	ANATOMY	serum	1045-1050
26281196_en	CHEM	creatinine	1051-1061
26281196_en	ANATOMY	glomerular	1149-1159
26281196_en	ANATOMY	left ventricular	1187-1203
26281196_en	ANATOMY	ventricular	1192-1203
26281196_en	ANATOMY	kidney	1300-1306
26281196_en	DISO	kidney disease	1300-1314
26281196_en	ANATOMY	coronary bed	1344-1356
26281196_en	DISO	multivascular injury	1316-1336
26281196_en	ANATOMY	cardiovascular	1584-1598
26281196_en	CHEM	loop diuretics	1380-1394
26281196_en	FINDING	higher 30-day mortality	1542-1565
26281196_en	FINDING	poor outcomes	1519-1532
26281196_en	FINDING	higher baseline serum creatinine levels	1029-1068
26281196_en	FINDING	higher ratio of contrast medium volume to glomerular filtration rate	1107-1175
26281196_en	FINDING	lower left ventricular ejection fraction	1181-1221
26281196_en	FINDING	higher volume of contrast agent	1072-1103
26281196_en	FINDING	prognosis was assessed	861-883
26281196_en	FINDING	30-day mortality	1549-1565
26281196_en	DISO	coronary syndrome	308-325
26281196_en	FINDING	incidence of CIAKI	477-495
26281196_en	FINDING	predictive factors for CIAKI	806-834
26281196_en	CHEM	contrast agent	1089-1103
26281196_en	CHEM	contrast medium	1123-1138
26281196_en	FINDING	predictive factors for CIAKI	1235-1263
26281196_en	CHEM	antibiotics	1408-1419
26281196_en	CHEM	nephrotoxic antibiotics	1396-1419
26281196_en	CHEM	mineralocorticoid receptor antagonists	1424-1462
26281196_en	FINDING	frequent cardiovascular disease readmissions	1575-1619
26281196_en	FINDING	development of CIAKI	1479-1499
26281196_en	ANATOMY	coronary	1344-1352
26281196_en	DISO	infarction	668-678
26281196_en	PHYS	glomerular filtration	1149-1170
26281196_en	PHYS	contrast medium volume	1123-1145
26281196_en	PHYS	volume of contrast agent	1079-1103
26281196_en	PHYS	ratio of contrast medium volume to glomerular filtration rate	1114-1175
26281196_en	CHEM	diuretics	1385-1394
26281196_en	FINDING	outcomes	1524-1532
26281196_en	FINDING	mortality	1556-1565
26288207_en	ANATOMY	pharynx	18-25
26288207_en	DISO	compromised nasal breathing	58-85
26288207_en	PHYS	nasal breathing	70-85
26288207_en	DISO	gastroesophageal reflux disease	148-179
26288207_en	DISO	gastroesophageal reflux disease	250-281
26288207_en	DISO	GERD	283-287
26288207_en	ANATOMY	pharynx	313-320
26288207_en	ANATOMY	nose	325-329
26288207_en	DISO	gastroesophageal reflux disease	533-564
26288207_en	DISO	chronic rhinosinusitis	569-591
26288207_en	DISO	CRS	637-640
26288207_en	DISO	GERD	659-663
26288207_en	DISO	nasal septum deformations	699-724
26288207_en	DISO	GERD	735-739
26288207_en	DISO	NSD	775-778
26288207_en	DISO	motor rhinitis	783-797
26288207_en	DISO	GERD	806-810
26288207_en	DISO	Gastroesophageal reflux disease	940-971
26288207_en	ANATOMY	pharynx	1079-1086
26288207_en	PHYS	nasal breathing	1120-1135
26288207_en	DISO	GERD	1170-1174
26288207_en	DISO	GERD	1209-1213
26288207_en	DISO	pharyngo-laryngeal reflux	1319-1344
26288207_en	DISO	gastroesophageal reflux disease	1377-1408
26288207_en	PHYS	breathing	76-85
26288207_en	ANATOMY	nasal	70-75
26288207_en	PHYS	pH values	1-10
26288207_en	ANATOMY	gastroesophageal	148-164
26288207_en	ANATOMY	gastroesophageal	250-266
26288207_en	ANATOMY	gastroesophageal	533-549
26288207_en	DISO	rhinosinusitis	577-591
26288207_en	DISO	CRS	593-596
26288207_en	ANATOMY	nasal	699-704
26288207_en	ANATOMY	nasal septum	699-711
26288207_en	DISO	NSD	726-729
26288207_en	DISO	rhinitis	789-797
26288207_en	ANATOMY	Gastroesophageal	940-956
26288207_en	ANATOMY	nasal	1120-1125
26288207_en	PHYS	breathing	1126-1135
26288207_en	PHYS	pH values	1062-1071
26288207_en	DISO	compromised nasal breathing	1108-1135
26288207_en	ANATOMY	pharyngo	1319-1327
26288207_en	ANATOMY	laryngeal	1328-1337
26288207_en	ANATOMY	pharyngo-laryngeal	1319-1337
26288207_en	ANATOMY	gastroesophageal	1377-1393
26288207_en	PHYS	pH values	296-305
26288207_en	LABPROC	contact method	885-899
26288207_en	PHYS	pH	862-864
26288207_en	FINDING	lower	1180-1185
26288207_en	PHYS	pH	1062-1064
26288207_en	PHYS	pH	1269-1271
26288207_en	PHYS	pH	1-3
26288207_en	PHYS	pH	296-298
26288207_en	LABPROC	pH measurements	1269-1284
26288207_en	DISO	inflammatory	89-101
26288207_en	PHYS	healthy	1225-1232
26288285_en	CHEM	melatonin	11-20
26288285_en	DISO	low back pain	41-54
26288285_en	CHEM	melatonin	98-107
26288285_en	DISO	low back pain	128-141
26288285_en	DISO	low back pain	227-240
26288285_en	CHEM	APTPA	417-422
26288285_en	CHEM	glucosamine hydrochloride	451-476
26288285_en	CHEM	chondroitin sulfate	491-510
26288285_en	CHEM	melaxen	597-604
26288285_en	CHEM	melatonin	614-623
26288285_en	PHYS	sleep	641-646
26288285_en	CHEM	APTPA	702-707
26288285_en	CHEM	APTPA	780-785
26288285_en	CHEM	diclofenac	821-831
26288285_en	CHEM	melaxen	923-930
26288285_en	CHEM	melatonin	940-949
26288285_en	PHYS	sleep	967-972
26288285_en	CHEM	APTPA	1039-1044
26288285_en	CHEM	diclofenac	1077-1087
26288285_en	CHEM	melaxen	1124-1131
26288285_en	CHEM	melatonin	1141-1150
26288285_en	PHYS	sleep	1168-1173
26288285_en	CHEM	melaxen	1234-1241
26288285_en	FINDING	pain intensity	1394-1408
26288285_en	CHEM	melatonin	1549-1558
26288285_en	DISO	low back pain	1591-1604
26288285_en	ANATOMY	low back	41-49
26288285_en	ANATOMY	low back	128-136
26288285_en	ANATOMY	low back	227-235
26288285_en	CHEM	glucosamine	451-462
26288285_en	CHEM	hydrochloride	463-476
26288285_en	CHEM	sulfate	503-510
26288285_en	ANATOMY	low back	1591-1599
26288285_en	DISO	pain	1394-1398
26288285_en	DISO	back pain	132-141
26288285_en	DISO	back pain	45-54
26288285_en	DISO	back pain	231-240
26288285_en	FINDING	reduction in pain intensity	1381-1408
26288285_en	DISO	chronic low back pain	1583-1604
26288285_en	FINDING	analgesic role	80-94
26288285_en	FINDING	analgesic properties	1525-1545
26288285_en	ANATOMY	back	45-49
26288285_en	ANATOMY	back	132-136
26288285_en	ANATOMY	back	231-235
26288285_en	ANATOMY	back	1595-1599
26288285_en	DISO	pain	236-240
26288285_en	DISO	back pain	1595-1604
26288285_en	FINDING	VAS score	274-283
26288285_en	DISO	pain	50-54
26288285_en	DISO	pain	137-141
26288285_en	CHEM	chondroitin	491-502
26288285_en	DISO	pain	1600-1604
26310014_en	DISO	bilateral panuveitis	183-203
26310014_en	DISO	keratomalacia	219-232
26310014_en	CHEM	Methylprednisolone	293-311
26310014_en	CHEM	azathioprine	327-339
26310014_en	DISO	uveitis	408-415
26310014_en	DISO	retinal detachment	458-476
26310014_en	DISO	cataract	492-500
26310014_en	ANATOMY	right eye	508-517
26310014_en	ANATOMY	neuroepithelium	577-592
26310014_en	FINDING	reattachment	604-616
26310014_en	ANATOMY	eyes	625-629
26310014_en	CHEM	Metypred	648-656
26310014_en	CHEM	prednisolone	681-693
26310014_en	CHEM	azathioprine	698-710
26310014_en	DISO	panuveitis	722-732
26310014_en	CHEM	prednisolone	796-808
26310014_en	CHEM	methylprednisolone	930-948
26310014_en	CHEM	azathioprine	953-965
26310014_en	CHEM	Metypred	1030-1038
26310014_en	DISO	VKH syndrome	1075-1087
26310014_en	DISO	autoimmune uveitis	1120-1138
26310014_en	CHEM	azathioprine	1157-1169
26310014_en	CHEM	prednisolone	1217-1229
26310014_en	DISO	VKH	1274-1277
26310014_en	DISO	Vogt-Koyanagi-Harada syndrome	1-30
26310014_en	DISO	Vogt-Koyanagi-Harada (VKH) syndrome	92-127
26310014_en	DISO	VKH	114-117
26310014_en	DISO	panuveitis	193-203
26310014_en	DISO	unilateral keratomalacia	208-232
26310014_en	ANATOMY	left eye	234-242
26310014_en	ANATOMY	eye	239-242
26310014_en	CHEM	Metypred	313-321
26310014_en	ANATOMY	eye	514-517
26310014_en	DISO	bilateral detachment of neuroepithelium	553-592
26310014_en	DISO	Bilateral panuveitis	712-732
26310014_en	DISO	pupil occlusion	738-753
26310014_en	ANATOMY	pupil	738-743
26310014_en	DISO	uveitis	1131-1138
26310014_en	DISO	side effects	1238-1250
26310014_en	FINDING	cessation of prednisolone	783-808
26310014_en	ANATOMY	retinal	458-465
26310014_en	DISO	occlusion	744-753
26310014_en	FINDING	slows progression of the disease	1170-1202
26310014_en	FINDING	rapid resolution of acute condition	975-1010
26310014_en	FINDING	minimizes prednisolone-induced side effects	1207-1250
26310014_en	FINDING	regression of uveitis	394-415
26310014_en	DISO	detachment of neuroepithelium	563-592
26355933_en	DEVICE	homografts	31-41
26355933_en	ANATOMY	aortofemoral	50-62
26355933_en	DISO	infection of vascular prostheses	75-107
26355933_en	DEVICE	vascular prostheses	88-107
26355933_en	DEVICE	implant	233-240
26355933_en	PHYS	male	268-272
26355933_en	DISO	Infection of the prosthesis	283-310
26355933_en	DEVICE	prosthesis	300-310
26355933_en	DEVICE	MSCT	359-363
26355933_en	LABPROC	angiography	364-375
26355933_en	ANATOMY	infrarenal portion	403-421
26355933_en	ANATOMY	aorta	429-434
26355933_en	ANATOMY	lower limbs	451-462
26355933_en	DISO	Pseudoaneurysms	464-479
26355933_en	ANATOMY	distal anastomoses	483-501
26355933_en	ANATOMY	bifurcation	614-625
26355933_en	DISO	infected implant	693-709
26355933_en	DEVICE	implant	702-709
26355933_en	LABPROC	inoculation	726-737
26355933_en	DEVICE	implants	755-763
26355933_en	ANATOMY	aortofemoral segment	1051-1071
26355933_en	LABPROC	cryopreserved	17-30
26355933_en	ANATOMY	vascular	88-96
26355933_en	DEVICE	prostheses	97-107
26355933_en	DISO	infection of the implant	216-240
26355933_en	LABPROC	MSCT angiography	359-375
26355933_en	ANATOMY	limbs	457-462
26355933_en	ANATOMY	arteries of lower limbs	439-462
26355933_en	LABPROC	duplex scanning	380-395
26355933_en	ANATOMY	aortic	607-613
26355933_en	LABPROC	cryopreserved	593-606
26355933_en	DEVICE	aortic bifurcation homograft	607-635
26355933_en	ANATOMY	aortofemoral segment	192-212
26355933_en	DISO	infection	75-84
26355933_en	DISO	infection	216-225
26355933_en	PHYS	died	863-867
26355933_en	FINDING	clinical data	332-345
26355933_en	DISO	Infection	283-292
26355933_en	ANATOMY	arteries	439-447
26355933_en	ANATOMY	anastomoses	490-501
26355933_en	DEVICE	homograft	626-635
26355933_en	DEVICE	bifurcation homograft	614-635
26355933_en	DISO	infected	693-701
26355933_en	DISO	reinfection	1006-1017
26355933_en	DISO	steno-occlusive lesion	1021-1043
26355933_en	FINDING	no findings suggesting reinfection or steno-occlusive lesion of the aortofemoral segment have been revealed	983-1090
26355936_en	ANATOMY	upper mesenteric artery	42-65
26355936_en	ANATOMY	upper superior mesenteric artery	175-207
26355936_en	LABPROC	contrast-enhanced multispiral computed tomography	228-277
26355936_en	ANATOMY	superior mesenteric artery	339-365
26355936_en	DISO	aneurysm	415-423
26355936_en	ANATOMY	pancreas	475-483
26355936_en	DISO	aneurysm	609-617
26355936_en	DISO	aneurysm	623-631
26355936_en	DISO	stenosis	723-731
26355936_en	DEVICE	synthetic patch	753-768
26355936_en	ANATOMY	micropreparation	895-911
26355936_en	DISO	fibromuscular dysplasia	946-969
26355936_en	ANATOMY	superior mesenteric artery	987-1013
26355936_en	ANATOMY	artery	59-65
26355936_en	ANATOMY	mesenteric artery	48-65
26355936_en	DISO	aneurysm	26-34
26355936_en	ANATOMY	artery	201-207
26355936_en	ANATOMY	mesenteric artery	190-207
26355936_en	ANATOMY	superior mesenteric artery	181-207
26355936_en	DISO	aneurysm	159-167
26355936_en	LABPROC	multispiral computed tomography	246-277
26355936_en	LABPROC	computed tomography	258-277
26355936_en	ANATOMY	mesenteric artery	348-365
26355936_en	ANATOMY	artery	359-365
26355936_en	DISO	aneurysm	323-331
26355936_en	ANATOMY	body of the pancreas	463-483
26355936_en	DISO	dysplasia	960-969
26355936_en	ANATOMY	mesenteric artery	996-1013
26355936_en	ANATOMY	artery	1007-1013
26355936_en	DISO	aneurysm	971-979
26355936_en	LABPROC	morphological examination	862-887
26355936_en	FINDING	satisfactory condition	825-847
26355936_en	DISO	infiltration	526-538
26355936_en	DISO	residual stenosis	714-731
26355937_en	CHEM	polymethylmethacrylate	7-29
26355937_en	DISO	bone lesions	80-92
26355937_en	DISO	Arteriovenous dysplasia	95-118
26355937_en	PHYS	young age	199-208
26355937_en	ANATOMY	osseous	229-236
26355937_en	ANATOMY	limb	349-353
26355937_en	DISO	trophic impairments	430-449
26355937_en	ANATOMY	lower limb	595-605
26355937_en	ANATOMY	tibial bone	615-626
26355937_en	DISO	arteriovenous reflux	765-785
26355937_en	DISO	angiomatous tissues	824-843
26355937_en	ANATOMY	bone	905-909
26355937_en	ANATOMY	tibial bone	949-960
26355937_en	ANATOMY	intramedullary canal	965-985
26355937_en	CHEM	polymethylmethacrylate	1016-1038
26355937_en	ANATOMY	arteries	1176-1184
26355937_en	DISO	angiomatous tissues	1200-1219
26355937_en	ANATOMY	limbs	1330-1335
26355937_en	ANATOMY	bone	80-84
26355937_en	DISO	angiodysplasia	60-74
26355937_en	DISO	arteriovenous angiodysplasia	46-74
26355937_en	DISO	dysplasia	109-118
26355937_en	DISO	arteriovenous shunt	406-425
26355937_en	PHYS	female	539-545
26355937_en	DISO	angiodysplasia	573-587
26355937_en	ANATOMY	limb	601-605
26355937_en	ANATOMY	bone	622-626
26355937_en	DISO	arteriovenous angiodysplasia	559-587
26355937_en	ANATOMY	arteriovenous	765-778
26355937_en	ANATOMY	arteriovenous	46-59
26355937_en	ANATOMY	Arteriovenous	95-108
26355937_en	ANATOMY	tissues	836-843
26355937_en	ANATOMY	affected limb	340-353
26355937_en	ANATOMY	bone	956-960
26355937_en	CHEM	PMMA	1040-1044
26355937_en	ANATOMY	afferent arteries	1167-1184
26355937_en	ANATOMY	tissues	1212-1219
26355937_en	FINDING	salvage of the supporting function of limbs	1292-1335
26355937_en	PHYS	supporting function of limbs	1307-1335
26355937_en	ANATOMY	arteriovenous	406-419
26355937_en	ANATOMY	arteriovenous	559-572
26355937_en	ANATOMY	osseous apparatus	229-246
26355937_en	FINDING	failing however to achieve complete liquidation of the arteriovenous reflux	710-785
26355937_en	PHYS	age	205-208
26355937_en	FINDING	liquidation of the arteriovenous reflux	746-785
26355937_en	FINDING	removing arteriovenous shunt and trophic impairments	397-449
26355937_en	ANATOMY	extremity	381-390
26355937_en	FINDING	salvage of the extremity	366-390
26355937_en	DISO	complications	177-190
26355937_en	ANATOMY	axis of the tibial bone	937-960
26355937_en	FINDING	increase radical nature of interventions	1246-1286
26356060_en	DISO	atherosclerosis obliterans	486-512
26356060_en	ANATOMY	toes	585-589
26356060_en	CHEM	pentoxifylline	673-687
26356060_en	CHEM	rheopolyglukin	697-711
26356060_en	CHEM	heparins	813-821
26356060_en	CHEM	actovegin	879-888
26356060_en	PHYS	microcirculation	1089-1105
26356060_en	LABPROC	polarography	1112-1124
26356060_en	LABPROC	laser Doppler imaging	1129-1150
26356060_en	LABPROC	histological studies	1198-1218
26356060_en	PHYS	microcirculation	1313-1329
26356060_en	ANATOMY	tissue	1384-1390
26356060_en	PHYS	perfusion	1391-1400
26356060_en	PHYS	transcutaneous oxygen tension	1466-1495
26356060_en	CHEM	actovegin	1571-1580
26356060_en	PHYS	skin perfusion	1590-1604
26356060_en	PHYS	microcirculation	1639-1655
26356060_en	PHYS	tissue oxygenation	1684-1702
26356060_en	CHEM	actovegin	1735-1744
26356060_en	PHYS	collateral blood flow	1767-1788
26356060_en	ANATOMY	lower limbs	1830-1841
26356060_en	ANATOMY	lower limbs	51-62
26356060_en	ANATOMY	limbs	57-62
26356060_en	DISO	distal occlusion	27-43
26356060_en	CHEM	actovegin	305-314
26356060_en	DISO	critical ischemia	331-348
26356060_en	ANATOMY	lower extremities	352-369
26356060_en	DISO	critical ischemia of lower extremities	331-369
26356060_en	DISO	atherosclerosis	486-501
26356060_en	ANATOMY	limb	523-527
26356060_en	DISO	necrotic processes	555-573
26356060_en	DISO	critical limb ischemia	514-536
26356060_en	CHEM	low molecular weight heparins	792-821
26356060_en	LABPROC	Cytological	1182-1193
26356060_en	PHYS	regional tissue perfusion	1375-1400
26356060_en	CHEM	oxygen	1481-1487
26356060_en	PHYS	oxygen tension	1481-1495
26356060_en	ANATOMY	skin	1590-1594
26356060_en	PHYS	perfusion	1595-1604
26356060_en	ANATOMY	tissue	1684-1690
26356060_en	FINDING	activated microcirculation	1629-1655
26356060_en	FINDING	increased tissue oxygenation	1674-1702
26356060_en	FINDING	improved skin perfusion	1581-1604
26356060_en	PHYS	blood flow	1778-1788
26356060_en	ANATOMY	blood	1778-1783
26356060_en	DISO	occlusion	1813-1822
26356060_en	ANATOMY	limbs	1836-1841
26356060_en	DISO	distal occlusion	1806-1822
26356060_en	PHYS	index of regional tissue perfusion	1366-1400
26356060_en	FINDING	Positive effect of actovegin	1716-1744
26356060_en	DISO	critical limb ischemia stage III-IV	514-549
26356060_en	CHEM	antiplatelet agents	724-743
26356060_en	DISO	occlusion	34-43
26356060_en	DISO	pain	1058-1062
26356060_en	DISO	ischemia	528-536
26356060_en	FINDING	improvement of transcutaneous oxygen tension has not been received	1451-1517
26356060_en	ANATOMY	extremities	358-369
26356060_en	FINDING	effectiveness of actovegin	288-314
26356060_en	DISO	ischemia	340-348
26356060_en	DISO	ischemia of lower extremities	340-369
26356060_en	DISO	limb ischemia	523-536
26356060_en	CHEM	statins	845-852
26356060_en	FINDING	double control of therapy's effectiveness	1236-1277
26356060_en	FINDING	therapy's effectiveness	1254-1277
26356060_en	FINDING	pain-free walking distance	1058-1084
26356162_en	CHEM	cerebrolysin	18-30
26356162_en	PHYS	BDNF level	41-51
26356162_en	DISO	aphasia	81-88
26356162_en	PHYS	carbohydrate metabolism	102-125
26356162_en	FINDING	speech recovery	232-247
26356162_en	CHEM	BDNF	252-256
26356162_en	DISO	left-hemisphere stroke	289-311
26356162_en	DISO	carbohydrate metabolism disorders	316-349
26356162_en	DISO	prediabetes	378-389
26356162_en	CHEM	cerebrolysin	404-416
26356162_en	DISO	aphasia	641-648
26356162_en	DISO	speech impairment	731-748
26356162_en	CHEM	cerebrolysin	821-833
26356162_en	CHEM	physiological solution	876-898
26356162_en	DISO	aphasia	1018-1025
26356162_en	DISO	speech impairment	1141-1158
26356162_en	DISO	carbohydrate metabolism disorders	1329-1362
26356162_en	CHEM	BDNF	1390-1394
26356162_en	CHEM	cerebrolysin	1480-1492
26356162_en	DISO	aphasia	1547-1554
26356162_en	CHEM	BDNF	41-45
26356162_en	DISO	stroke	74-80
26356162_en	DISO	post stroke aphasia	69-88
26356162_en	CHEM	carbohydrate	102-114
26356162_en	DISO	carbohydrate metabolism disorders	102-135
26356162_en	DISO	stroke	305-311
26356162_en	CHEM	carbohydrate	316-328
26356162_en	PHYS	carbohydrate metabolism	316-339
26356162_en	DISO	diabetes mellitus type2	351-374
26356162_en	DISO	diabetes mellitus	351-368
26356162_en	DISO	diabetes	351-359
26356162_en	CHEM	BDNF	750-754
26356162_en	ANATOMY	serum	755-760
26356162_en	DISO	stroke	1011-1017
26356162_en	DISO	post stroke aphasia	1006-1025
26356162_en	CHEM	carbohydrate	1329-1341
26356162_en	PHYS	carbohydrate metabolism	1329-1352
26356162_en	FINDING	increase in BDNF concentrations	1378-1409
26356162_en	DISO	stroke	1540-1546
26356162_en	DISO	post stroke aphasia	1535-1554
26356162_en	FINDING	improves the prognosis of their rehabilitation	1577-1623
26356162_en	FINDING	improvement of speech	1202-1223
26356162_en	ANATOMY	left-hemisphere	289-304
26356162_en	FINDING	severity of speech impairment	719-748
26356162_en	PHYS	metabolism	115-125
26356162_en	PHYS	metabolism	329-339
26356162_en	PHYS	metabolism	1342-1352
26356162_en	FINDING	cerebrolysin effect	18-37
26356162_en	FINDING	Clinical efficacy of cerebrolysin	800-833
26356162_en	PHYS	BDNF serum concentrations	750-775
26356162_en	PHYS	BDNF concentrations	252-271
26356162_en	FINDING	changes in the rate of speech recovery and BDNF concentrations	209-271
26356162_en	PHYS	BDNF concentrations	1390-1409
26356162_en	ANATOMY	hemisphere	294-304
26356162_en	DISO	Speech Pathology	488-504
26356162_en	CHEM	solution	890-898
26356163_en	CHEM	taurine	16-23
26356163_en	PHYS	oxidative processes	27-46
26356163_en	CHEM	lipids	114-120
26356163_en	PHYS	protein activity	148-164
26356163_en	CHEM	glutathione peroxidase	168-190
26356163_en	CHEM	glutathione reductase	195-216
26356163_en	CHEM	nitric oxide	247-259
26356163_en	ANATOMY	brain	277-282
26356163_en	ANATOMY	mitochondrial	283-296
26356163_en	DISO	cerebral edema	345-359
26356163_en	CHEM	taurine	382-389
26356163_en	DISO	brain edema	419-430
26356163_en	CHEM	tetra-ethyl lead	485-501
26356163_en	PHYS	peroxidation	553-565
26356163_en	CHEM	hydroperoxide	583-596
26356163_en	CHEM	malonic aldehyde	601-617
26356163_en	DISO	brain edema	714-725
26356163_en	CHEM	proteins	793-801
26356163_en	CHEM	lipids	806-812
26356163_en	CHEM	nitrogen oxide	814-828
26356163_en	CHEM	glutathione	838-849
26356163_en	PHYS	activity of enzymes	878-897
26356163_en	CHEM	enzymes	890-897
26356163_en	CHEM	glutathione	909-920
26356163_en	CHEM	glutathione reductase	949-970
26356163_en	CHEM	glutathione	1035-1046
26356163_en	CHEM	enzymes	1070-1077
26356163_en	CHEM	glutathione	1089-1100
26356163_en	CHEM	taurine	1114-1121
26356163_en	CHEM	taurine	1174-1181
26356163_en	PHYS	lipid peroxidation	1240-1258
26356163_en	CHEM	proteins	1312-1320
26356163_en	ANATOMY	mitochondrial	1328-1341
26356163_en	DISO	cerebral edema	1381-1395
26356163_en	DISO	brain edema	50-61
26356163_en	DISO	edema	56-61
26356163_en	ANATOMY	brain	50-55
26356163_en	PHYS	free radical oxidation	88-110
26356163_en	ANATOMY	cerebral	345-353
26356163_en	DISO	edema	354-359
26356163_en	ANATOMY	brain mitochondrial fraction	277-305
26356163_en	CHEM	nitrite	262-269
26356163_en	DISO	Toxic brain edema	413-430
26356163_en	ANATOMY	brain	419-424
26356163_en	DISO	edema	425-430
26356163_en	CHEM	lead	497-501
26356163_en	PHYS	weight	526-532
26356163_en	ANATOMY	brain	714-719
26356163_en	DISO	edema	720-725
26356163_en	CHEM	nitrogen	814-822
26356163_en	CHEM	glutathione peroxidase	922-944
26356163_en	CHEM	lipid	1240-1245
26356163_en	FINDING	activating enzymes containing glutathione	1059-1100
26356163_en	PHYS	oxidative modification	1286-1308
26356163_en	FINDING	normalization of oxidative modification	1269-1308
26356163_en	ANATOMY	cerebral	1381-1389
26356163_en	DISO	edema	1390-1395
26356163_en	CHEM	glutathione	168-179
26356163_en	CHEM	glutathione	195-206
26356163_en	CHEM	glutathione	922-933
26356163_en	CHEM	glutathione	949-960
26356163_en	ANATOMY	mitochondrial fraction	1328-1350
26356163_en	FINDING	reduction of lipid peroxidation products	1227-1267
26356163_en	FINDING	decrease in the activity of enzymes containing glutathione	862-920
26356163_en	FINDING	reduced glutathione content	830-857
26356163_en	CHEM	protein	148-155
26356163_en	PHYS	oxidative modification	122-144
26356163_en	PHYS	intensity of peroxidation	540-565
26356163_en	CHEM	proteins	691-699
26356163_en	PHYS	oxidative modification	767-789
26356163_en	FINDING	increased levels of oxidative modification	747-789
26356163_en	PHYS	glutathione content	838-857
26356163_en	FINDING	increasing glutathione content	1024-1054
26356163_en	PHYS	glutathione content	1035-1054
26356163_en	PHYS	oxidation	101-110
26356163_en	ANATOMY	mitochondrial fraction	283-305
26356163_en	CHEM	peroxidase	180-190
26356163_en	CHEM	peroxidase	934-944
26356163_en	PHYS	peroxidation	1246-1258
26356163_en	PHYS	oxidative modification	665-687
26356163_en	PHYS	oxidative	122-131
26356163_en	CHEM	oxide	254-259
26356163_en	CHEM	nitric	247-253
26356163_en	CHEM	reductase	207-216
26356163_en	CHEM	aldehyde	609-617
26356163_en	PHYS	malonic aldehyde contents	601-626
26356163_en	PHYS	contents	618-626
26356163_en	PHYS	oxidative	665-674
26356163_en	CHEM	oxide	823-828
26356163_en	CHEM	reductase	961-970
26356163_en	PHYS	oxidative	1286-1295
26356398_en	CHEM	baclofen	68-76
26356398_en	CHEM	Baclosan	78-86
26356398_en	DISO	alcohol dependence	93-111
26356398_en	CHEM	baclofen	150-158
26356398_en	DISO	alcohol dependence	176-194
26356398_en	DISO	alcohol dependence	235-253
26356398_en	CHEM	baclofen	374-382
26356398_en	CHEM	placebo	467-474
26356398_en	CHEM	riboflavin	625-635
26356398_en	DISO	psychiatric evaluations	668-691
26356398_en	DISO	anxiety	726-733
26356398_en	DISO	depression	738-748
26356398_en	CHEM	gamma-glutamiltranspeptidase	818-846
26356398_en	PHYS	gamma-glutamiltranspeptidase activity	818-855
26356398_en	ANATOMY	blood	859-864
26356398_en	DISO	anxiety	876-883
26356398_en	DISO	Depression	949-959
26356398_en	CHEM	Baclofen	1277-1285
26356398_en	CHEM	placebo	1319-1326
26356398_en	CHEM	baclofen	1483-1491
26356398_en	ANATOMY	liver	1675-1680
26356398_en	PHYS	enzymes activity	1681-1697
26356398_en	CHEM	baclofen	1754-1762
26356398_en	DISO	alcohol dependent	1766-1783
26356398_en	CHEM	baclofen	1814-1822
26356398_en	DISO	alcohol dependence	1827-1845
26356398_en	PHYS	liver enzymes activity	1675-1697
26356398_en	CHEM	liver enzymes	1675-1688
26356398_en	CHEM	placebo	1510-1517
26356398_en	DISO	craving for alcohol	705-724
26356398_en	DISO	carving for alcohol	1016-1035
26356398_en	ANATOMY	urine	646-651
26356398_en	FINDING	safety and good tolerability	1722-1750
26356398_en	CHEM	enzymes	1681-1688
26356398_en	CHEM	placebo	14-21
26356398_en	FINDING	efficacy and safety of baclofen	127-158
26356398_en	FINDING	retention in treatment and drinking were slightly better	1419-1475
26356398_en	DISO	Obsessive-Compulsive	1041-1061
26356398_en	FINDING	Overall treatment effect	1142-1166
26356398_en	FINDING	did no differ significantly	1286-1313
26356398_en	FINDING	differences were close to the level of statistical significance	1529-1592
26356398_en	FINDING	rate of adverse events	1649-1671
26356515_en	CHEM	anxiolytics	68-79
26356515_en	CHEM	hypnotics	84-93
26356515_en	DISO	psychiatric	210-221
26356515_en	CHEM	anxiolytic	252-262
26356515_en	CHEM	hypnotic	267-275
26356515_en	CHEM	benzodiazepines	276-291
26356515_en	CHEM	benzodiazepines	472-487
26356515_en	CHEM	benzodiazepine	769-783
26356515_en	DISO	drug dependence	836-851
26356515_en	CHEM	benzodiazepine	924-938
26356515_en	CHEM	benzodiazepine	940-954
26356515_en	CHEM	benzodiazepine	1074-1088
26356515_en	CHEM	anxiolytics	1089-1100
26356515_en	CHEM	hypnotics	1105-1114
26356515_en	CHEM	diazepam	1293-1301
26356515_en	CHEM	phenazepam	1349-1359
26356515_en	DISO	drug dependence	119-134
26356515_en	DISO	psychopathological	167-185
26356515_en	CHEM	hypnotic benzodiazepines	267-291
26356515_en	DISO	psychiatric disorder	412-432
26356515_en	DISO	psychopathological	666-684
26356515_en	DISO	pathological dependence	897-920
26356515_en	DISO	pathological dependence of benzodiazepine	897-938
26356515_en	DISO	somatic/autonomic symptoms	987-1013
26356515_en	DISO	benzodiazepine withdrawal syndrome	940-974
26356515_en	FINDING	exacerbation of dependence	1018-1044
26356515_en	FINDING	increase in tolerability to benzodiazepine	1046-1088
26356515_en	DISO	benzodiazepine dependence	769-794
26356515_en	FINDING	clinical/psychopathological characteristics	158-201
26356515_en	PHYS	aged	205-209
26356515_en	PHYS	tolerability	1058-1070
26356515_en	FINDING	higher risk in patients aged ≤ 60 years	1231-1270
26356515_en	FINDING	risk was higher	1307-1322
26356526_en	DISO	Migraine	31-39
26356526_en	DISO	headache	84-92
26356526_en	DISO	Neurological symptoms	162-183
26356526_en	DISO	migraine	253-261
26356526_en	PHYS	mutations	301-310
26356526_en	DISO	familial hemiplegic migraine	314-342
26356526_en	DISO	migraine	413-421
26356526_en	DISO	migraine-like headache	470-492
26356526_en	PHYS	serotonin metabolism	516-536
26356526_en	DISO	celiac disease	554-568
26356526_en	DISO	Celiac disease	570-584
26356526_en	DISO	enteropathy	620-631
26356526_en	DISO	Arteriopathies associated with migraine	634-673
26356526_en	DISO	migraine	665-673
26356526_en	DISO	cerebral autosomal dominant arteriopathy	678-718
26356526_en	DISO	subcortical infarcts	724-744
26356526_en	DISO	leukoencephalopathy	749-768
26356526_en	DISO	retinal vasculopathy	789-809
26356526_en	DISO	cerebral leukodystrophy	815-838
26356526_en	DISO	hereditary systemic angiopathy	847-877
26356526_en	DISO	mitochondrial encephalomyopathy	885-916
26356526_en	DISO	lactic acidosis	922-937
26356526_en	DISO	stroke-like episodes	942-962
26356526_en	DISO	migraine	20-28
26356526_en	DISO	severe headache	77-92
26356526_en	DISO	nausea	98-104
26356526_en	DISO	vomiting	106-114
26356526_en	DISO	hypersensitivity to sounds	119-145
26356526_en	DISO	aura period	191-202
26356526_en	DISO	hemiplegic migraine	323-342
26356526_en	DISO	migraine	334-342
26356526_en	CHEM	serotonin	372-381
26356526_en	CHEM	serotonin	516-525
26356526_en	DISO	impaired serotonin metabolism	507-536
26356526_en	DISO	headache	484-492
26356526_en	DISO	migraine	470-478
26356526_en	ANATOMY	cerebral	678-686
26356526_en	DISO	arteriopathy	706-718
26356526_en	ANATOMY	subcortical	724-735
26356526_en	DISO	infarcts	736-744
26356526_en	DISO	CADASIL	779-786
26356526_en	DISO	cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy	678-768
26356526_en	ANATOMY	retinal	789-796
26356526_en	DISO	leukodystrophy	824-838
26356526_en	ANATOMY	cerebral	815-823
26356526_en	DISO	vasculopathy	797-809
26356526_en	DISO	retinal vasculopathy with cerebral leukodystrophy	789-838
26356526_en	DISO	RVCL	840-844
26356526_en	DISO	angiopathy	867-877
26356526_en	DISO	HSA	879-882
26356526_en	ANATOMY	mitochondrial	885-898
26356526_en	DISO	encephalomyopathy	899-916
26356526_en	DISO	acidosis	929-937
26356526_en	CHEM	lactic	922-928
26356526_en	DISO	stroke	942-948
26356526_en	DISO	MELAS	964-969
26356526_en	DISO	mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes	885-962
26356526_en	PHYS	metabolism	526-536
26356526_en	DISO	hypersensitivity to sounds, light, smell	119-159
26356526_en	DISO	hypersensitivity	119-135
26356526_en	ANATOMY	serotonin system	372-388
26356526_en	DISO	pathogenesis	422-434
26356526_en	DISO	chronic polysyndrome disease	590-618
26356526_en	FINDING	Genes responsible for migraine	231-261
26356615_en	DISO	ischemic stroke	244-259
26356615_en	ANATOMY	carotid territory	535-552
26356615_en	CHEM	ascorbic acid	697-710
26356615_en	CHEM	cytoflavin	727-737
26356615_en	CHEM	cytoflavin	781-791
26356615_en	DISO	ischemic lesion	1268-1283
26356615_en	CHEM	ascorbic acid	1338-1351
26356615_en	CHEM	cytoflavin	1370-1380
26356615_en	CHEM	cytoflavin	1535-1545
26356615_en	CHEM	cytoflavin	1669-1679
26356615_en	CHEM	cytoflavin	1822-1832
26356615_en	DISO	brain infarction	115-131
26356615_en	ANATOMY	brain	115-120
26356615_en	DISO	infarction	121-131
26356615_en	DISO	stroke	253-259
26356615_en	DISO	ischemic	244-252
26356615_en	DISO	stroke	521-527
26356615_en	DISO	ischemic	512-520
26356615_en	LABPROC	CT	1028-1030
26356615_en	DISO	cerebral ischemic lesion	1104-1128
26356615_en	DISO	lesion	1122-1128
26356615_en	ANATOMY	cerebral	1104-1112
26356615_en	CHEM	cytoflavin	1157-1167
26356615_en	CHEM	ascorbic acid	1215-1228
26356615_en	DISO	ischemic lesion	1113-1128
26356615_en	DISO	lesion	1277-1283
26356615_en	PHYS	neurologic	1606-1616
26356615_en	PHYS	functional	1618-1628
26356615_en	FINDING	significant 1,5-1,7- fold decrease	1062-1096
26356615_en	DISO	ischemic stroke	512-527
26356615_en	DISO	ischemic	1113-1121
26356615_en	DISO	ischemic	1268-1276
26356615_en	FINDING	more prominent improvement	1576-1602
26356615_en	ANATOMY	vascular	425-433
26356615_en	CHEM	acid	1224-1228
26356615_en	CHEM	acid	1347-1351
26356615_en	FINDING	Clinical and morphologic efficacy	1-34
26356615_en	FINDING	clinical and morphological results	193-227
26356615_en	CHEM	acid	706-710
26356615_en	PHYS	Patient's condition	872-891
26356615_en	FINDING	no significant morphologic changes	1173-1207
26356615_en	FINDING	2-fold higher	1317-1330
26356615_en	FINDING	percentage of patients with ischemic lesion, increased	1240-1294
26356615_en	FINDING	No differences in clinical variables	1691-1727
26356616_en	CHEM	escitalopram	34-46
26356616_en	DISO	dementia	68-76
26356616_en	DISO	depression	94-104
26356616_en	DISO	moderate cognitive dysfunction	109-139
26356616_en	CHEM	escitalopram	222-234
26356616_en	DISO	dementia	267-275
26356616_en	DISO	depression	293-303
26356616_en	DISO	moderate cognitive dysfunction	308-338
26356616_en	DISO	chronic brain ischemia	355-377
26356616_en	DISO	chronic brain ischemia	448-470
26356616_en	DISO	mild or moderate depression	475-502
26356616_en	DISO	cognitive dysfunction	517-538
26356616_en	CHEM	escitalopram:	576-589
26356616_en	CHEM	escitalopram	857-869
26356616_en	DISO	depression	916-926
26356616_en	DISO	cognitive dysfunction	943-964
26356616_en	DISO	chronic brain ischemia	982-1004
26356616_en	DISO	dementia	1037-1045
26356616_en	DISO	chronic brain ischemia	156-178
26356616_en	DISO	ischemia	170-178
26356616_en	ANATOMY	brain	164-169
26356616_en	CHEM	cipralex	236-244
26356616_en	DISO	ischemia	369-377
26356616_en	ANATOMY	brain	363-368
26356616_en	DISO	ischemia	462-470
26356616_en	ANATOMY	brain	456-461
26356616_en	DISO	ischemia	996-1004
26356616_en	ANATOMY	brain	990-995
26356616_en	DISO	dysfunction	128-139
26356616_en	DISO	cognitive dysfunction	317-338
26356616_en	DISO	dysfunction	527-538
26356616_en	DISO	dysfunction	953-964
26356616_en	DISO	brain ischemia	456-470
26356616_en	DISO	brain ischemia	990-1004
26356616_en	FINDING	efficacy of escitalopram	845-869
26356616_en	DISO	brain ischemia	164-178
26356616_en	DISO	brain ischemia	363-377
26356616_en	FINDING	decrease of the risk of dementia	1013-1045
26356616_en	DISO	cognitive dysfunction	118-139
26356616_en	DISO	dysfunction	327-338
26356616_en	DISO	depression	492-502
26356617_en	DISO	venous dysfunction	52-70
26356617_en	ANATOMY	brain	78-83
26356617_en	ANATOMY	extremities	88-99
26356617_en	PHYS	venous circulation	194-212
26356617_en	ANATOMY	brain	220-225
26356617_en	ANATOMY	limbs	230-235
26356617_en	LABPROC	dynamic teletermography	614-637
26356617_en	ANATOMY	head	659-663
26356617_en	ANATOMY	neck	665-669
26356617_en	ANATOMY	extremity vessels	674-691
26356617_en	DISO	venous dysfunction	789-807
26356617_en	ANATOMY	brain	815-820
26356617_en	DISO	venous insufficiency	881-901
26356617_en	PHYS	venous circulation	939-957
26356617_en	ANATOMY	brain	965-970
26356617_en	ANATOMY	extremities	975-986
26356617_en	ANATOMY	venous	52-58
26356617_en	ANATOMY	venous	194-200
26356617_en	ANATOMY	extra-intracerebral venous	369-395
26356617_en	ANATOMY	extra-intracerebral	369-388
26356617_en	ANATOMY	venous	389-395
26356617_en	DISO	extra-intracerebral venous insufficiency	369-409
26356617_en	ANATOMY	venous	463-469
26356617_en	DISO	encephalopathy	470-484
26356617_en	DISO	venous encephalopathy	463-484
26356617_en	DISO	varicose disease	503-519
26356617_en	LABPROC	teletermography	622-637
26356617_en	ANATOMY	venous	789-795
26356617_en	ANATOMY	venous	881-887
26356617_en	ANATOMY	venous	939-945
26356617_en	ANATOMY	vessels	684-691
26356617_en	DISO	dysfunction	59-70
26356617_en	DISO	dysfunction	796-807
26356617_en	PHYS	healthy	319-326
26356617_en	LABPROC	triplex study	642-655
26356617_en	ANATOMY	extremity	674-683
26356617_en	DISO	systemic pathology	907-925
26390722_en	DISO	acute myeloid leukemias	49-72
26390722_en	DISO	acute myeloid leukemias	186-209
26390722_en	DISO	AML	361-364
26390722_en	PHYS	complete remissions	472-491
26390722_en	PHYS	deaths	511-517
26390722_en	FINDING	relapse-free survival	547-568
26390722_en	DISO	AML	720-723
26390722_en	CHEM	cytarabine	1037-1047
26390722_en	CHEM	hypomethylating agents	1076-1098
26390722_en	DISO	primary refractory disease	1388-1414
26390722_en	PHYS	CR	1436-1438
26390722_en	CHEM	LDC	1503-1506
26390722_en	CHEM	HA	1523-1525
26390722_en	DISO	Recurrences	1527-1538
26390722_en	PHYS	CR	1596-1598
26390722_en	CHEM	LDC	1756-1759
26390722_en	CHEM	LDC	1860-1863
26390722_en	DISO	leukemias	63-72
26390722_en	ANATOMY	myeloid	55-62
26390722_en	DISO	myeloid leukemias	55-72
26390722_en	DISO	leukemias	200-209
26390722_en	DISO	myeloid leukemias	192-209
26390722_en	DISO	AML	211-214
26390722_en	ANATOMY	myeloid	192-199
26390722_en	PHYS	CR	493-495
26390722_en	FINDING	survival	560-568
26390722_en	FINDING	RFS	570-573
26390722_en	DISO	recurrences	498-509
26390722_en	FINDING	4-year overall survival	523-568
26390722_en	DISO	non-M3 types	725-737
26390722_en	CHEM	low-dose cytarabine	1028-1047
26390722_en	CHEM	LDC	1049-1052
26390722_en	CHEM	HA	1100-1102
26390722_en	ANATOMY	stem cell	1230-1239
26390722_en	ANATOMY	cell	1235-1239
26390722_en	ANATOMY	hematopoietic stem cell	1216-1239
26390722_en	PHYS	deaths	1357-1363
26390722_en	PHYS	deaths	1427-1433
26390722_en	FINDING	OS	1647-1649
26390722_en	FINDING	Four-year OS	1637-1649
26390722_en	FINDING	OS	539-541
26390722_en	FINDING	RFS	1778-1781
26390722_en	FINDING	4-year RFS	1771-1781
26390722_en	FINDING	High mortality rates in the induction	1884-1921
26390722_en	DISO	AML	2087-2090
26390722_en	FINDING	notified incidence rate	844-867
26390722_en	FINDING	mortality	1327-1336
26390722_en	FINDING	mortality	1889-1898
26390722_en	FINDING	Clinical and epidemiological characteristics	1-45
26390722_en	FINDING	median follow-up	1604-1620
26390722_en	DISO	M3 types	729-737
26390722_en	FINDING	efficiency of their treatment	253-282
26390722_en	FINDING	efficiency of their treatment	410-439
26390722_en	PHYS	remissions	481-491
26390722_en	DISO	relapse	547-554
26390722_en	FINDING	rates of complete remissions	463-491
26390722_en	ANATOMY	allogeneic hematopoietic stem cell	1205-1239
26390722_en	PHYS	hematopoietic	1216-1229
26390722_en	FINDING	none of the patients underwent	1174-1204
26390722_en	FINDING	limited resources of accompanying therapy	1947-1988
26390722_en	FINDING	poor sanitary conditions	1990-2014
26390722_en	FINDING	no own opportunities to perform allo-HSCT	2020-2061
26485774_en	DISO	thrombophilia	23-36
26485774_en	DISO	connective tissue dysplasia syndrome	58-94
26485774_en	PHYS	endometrial receptivity	196-219
26485774_en	FINDING	reproductive losses	240-259
26485774_en	ANATOMY	embryo	314-320
26485774_en	DISO	inherited thrombophilia	382-405
26485774_en	DISO	undifferentiated connective tissue dysplasia syndrome	415-468
26485774_en	ANATOMY	endometrial	487-498
26485774_en	LABPROC	immunohistochemical	583-602
26485774_en	PHYS	endometrial receptivity	626-649
26485774_en	DISO	uCTDS	664-669
26485774_en	DISO	IT	671-673
26485774_en	PHYS	ER	738-740
26485774_en	CHEM	PgR	742-745
26485774_en	CHEM	LIF	747-750
26485774_en	CHEM	VEGF	752-756
26485774_en	CHEM	PAI-1	762-767
26485774_en	LABPROC	immunohistochemically	801-822
26485774_en	PHYS	ovulation	935-944
26485774_en	DISO	uCTDS	1053-1058
26485774_en	DISO	miscarriage	1301-1312
26485774_en	PHYS	gestation	1344-1353
26485774_en	ANATOMY	endometrium	1395-1406
26485774_en	PHYS	secretion	1489-1498
26485774_en	ANATOMY	pinopodes	1559-1568
26485774_en	ANATOMY	endometrial	1600-1611
26485774_en	PHYS	endometrial receptivity	1600-1623
26485774_en	CHEM	LIF	1726-1729
26485774_en	ANATOMY	epithelium	1757-1767
26485774_en	ANATOMY	stroma	1801-1807
26485774_en	DISO	uCTDS	1846-1851
26485774_en	CHEM	PAI-1	1902-1907
26485774_en	CHEM	VEGF	1912-1916
26485774_en	ANATOMY	epithelium	1924-1934
26485774_en	ANATOMY	stroma	1936-1942
26485774_en	ANATOMY	endothelium	1948-1959
26485774_en	PHYS	fibrinolysis	2085-2097
26485774_en	PHYS	endometrial receptivity	2170-2193
26485774_en	DISO	infertility	2217-2228
26485774_en	PHYS	endometrial receptivity	2261-2284
26485774_en	ANATOMY	pinopodes	2323-2332
26485774_en	ANATOMY	surface epithelium	2340-2358
26485774_en	DISO	focal stromal sclerosis	2360-2383
26485774_en	PHYS	receptivity marker	2411-2429
26485774_en	CHEM	LIF	2430-2433
26485774_en	ANATOMY	surface epithelium	2443-2461
26485774_en	ANATOMY	stroma	2469-2475
26485774_en	DISO	inherited thrombophilia	13-36
26485774_en	DISO	connective tissue dysplasia	58-85
26485774_en	ANATOMY	connective tissue	58-75
26485774_en	ANATOMY	tissue	69-75
26485774_en	DISO	undifferentiated connective tissue dysplasia syndrome	41-94
26485774_en	DISO	undifferentiated connective tissue dysplasia	41-85
26485774_en	DISO	pathogenesis	102-114
26485774_en	ANATOMY	endometrial	196-207
26485774_en	DISO	Impaired endometrial receptivity	187-219
26485774_en	PHYS	endometrial receptivity	487-510
26485774_en	PHYS	female	118-124
26485774_en	DISO	thrombophilia	392-405
26485774_en	DISO	IT	407-409
26485774_en	DISO	uCTDS	470-475
26485774_en	DISO	connective tissue dysplasia syndrome	432-468
26485774_en	DISO	connective tissue dysplasia	432-459
26485774_en	DISO	dysplasia	76-85
26485774_en	DISO	dysplasia	450-459
26485774_en	ANATOMY	connective tissue	432-449
26485774_en	ANATOMY	tissue	443-449
26485774_en	ANATOMY	endometrial	626-637
26485774_en	DISO	impaired endometrial receptivity	617-649
26485774_en	ANATOMY	endometrial	839-850
26485774_en	LABPROC	endometrial biopsy	839-857
26485774_en	ANATOMY	endometrial biopsy specimens	839-867
26485774_en	LABPROC	pipelle endometrial biopsy	831-857
26485774_en	DISO	IT	1097-1099
26485774_en	DISO	IT	1072-1074
26485774_en	PHYS	proliferation	1466-1479
26485774_en	PHYS	late proliferation	1461-1479
26485774_en	PHYS	early secretion phases	1483-1505
26485774_en	ANATOMY	mature pinopodes	1552-1568
26485774_en	FINDING	endometrial receptivity was very low	1600-1636
26485774_en	LABPROC	Immunohistochemical examination	1638-1669
26485774_en	PHYS	receptivity	1707-1718
26485774_en	FINDING	lower expression of the receptivity marker LIF	1683-1729
26485774_en	ANATOMY	endometrial	1737-1748
26485774_en	ANATOMY	endometrial surface epithelium	1737-1767
26485774_en	FINDING	higher expression	1776-1793
26485774_en	DISO	impaired fibrinolysis	2076-2097
26485774_en	FINDING	intensity of neoangiogenetic processes	2033-2071
26485774_en	DISO	uCTDS	2128-2133
26485774_en	DISO	IT	2138-2140
26485774_en	ANATOMY	endometrial	2170-2181
26485774_en	DISO	impaired endometrial receptivity	2161-2193
26485774_en	ANATOMY	endometrial	2261-2272
26485774_en	DISO	impaired endometrial receptivity	2252-2284
26485774_en	ANATOMY	mature pinopodes	2316-2332
26485774_en	ANATOMY	epithelium	2348-2358
26485774_en	DISO	stromal sclerosis	2366-2383
26485774_en	DISO	sclerosis	2374-2383
26485774_en	ANATOMY	epithelium	2451-2461
26485774_en	FINDING	decrease in mature pinopodes	2304-2332
26485774_en	LABPROC	biopsy	851-857
26485774_en	PHYS	receptivity	2411-2422
26485774_en	LABPROC	morphologically	781-796
26485774_en	FINDING	no mature pinopodes	1549-1568
26485774_en	DISO	uCTDS	1087-1092
26485774_en	PHYS	implantation window	1370-1389
26485774_en	PHYS	expression of the receptivity marker LIF	1689-1729
26485774_en	FINDING	redistribution of the receptivity marker LIF	2389-2433
26485774_en	CHEM	Antibodies against ER	719-740
26485774_en	PHYS	immature	1411-1419
26485774_en	DISO	uCTDS	1856-1861
26485774_en	DISO	IT	1862-1864
26485774_en	PHYS	neoangiogenetic processes	2046-2071
26485774_en	ANATOMY	stromal	2366-2373
26485774_en	CHEM	Antibodies	719-729
26485774_en	ANATOMY	surface epithelium	1749-1767
26485774_en	PHYS	receptivity	2273-2284
26485774_en	PHYS	receptivity	2182-2193
26485774_en	PHYS	receptivity	1612-1623
26485774_en	PHYS	receptivity	638-649
26485774_en	CHEM	PAI	1902-1905
26485774_en	CHEM	PAI	762-765
26485774_en	PHYS	expression	1888-1898
26485774_en	ANATOMY	biopsy specimens	851-867
26485774_en	PHYS	receptivity marker	1707-1725
26485774_en	DISO	female infertility	118-136
26485774_en	DISO	infertility	125-136
26485774_en	PHYS	reproductive	240-252
26485774_en	LABPROC	morphological	565-578
26485774_en	PHYS	receptivity	499-510
26485774_en	PHYS	receptivity	208-219
26485774_en	DISO	concurrence	685-696
26485774_en	ANATOMY	specimens	858-867
26485774_en	PHYS	implantation window	896-915
26485774_en	PHYS	healthy	1106-1113
26485774_en	PHYS	mature	1552-1558
26485774_en	PHYS	mature	2316-2322
26485774_en	ANATOMY	substrates	603-613
26485774_en	FINDING	unsuccessful	1232-1244
26485774_en	PHYS	expression	1783-1793
26485774_en	PHYS	expression	1689-1699
26485774_en	FINDING	higher expression of PAI-1 and VEGF	1881-1916
26485774_en	DISO	pathogenesis	2201-2213
26485778_en	ANATOMY	skin	13-17
26485778_en	CHEM	neuropeptides	32-45
26485778_en	CHEM	neurotrophins	47-60
26485778_en	CHEM	neurotransmitters	149-166
26485778_en	DISO	itch	209-213
26485778_en	ANATOMY	skin	242-246
26485778_en	DISO	inflammatory response	247-268
26485778_en	DISO	psoriasis	286-295
26485778_en	DISO	atopic dermatitis	300-317
26485778_en	ANATOMY	Skin biopsy specimens	341-362
26485778_en	DISO	psoriasis	385-394
26485778_en	DISO	atopic dermatitis	416-433
26485778_en	LABPROC	immunoperoxidase	469-485
26485778_en	LABPROC	indirect immunofluorescence assays	491-525
26485778_en	CHEM	protein gene product 9.5	575-599
26485778_en	CHEM	TrkA	748-752
26485778_en	CHEM	substance P	758-769
26485778_en	CHEM	SP-R	792-796
26485778_en	LABPROC	indirect immunofluorescence assay	802-835
26485778_en	LABPROC	Immunoperoxidase examination	953-981
26485778_en	ANATOMY	skin biopsy specimens	989-1010
26485778_en	DISO	atopic dermatitis	1030-1047
26485778_en	DISO	psoriasis	1052-1061
26485778_en	CHEM	amphiregulin	1094-1106
26485778_en	CHEM	NGF	1108-1111
26485778_en	CHEM	PGP9.5	1117-1123
26485778_en	ANATOMY	epidermal nerve fibers	1158-1180
26485778_en	CHEM	semaphorin 3A	1237-1250
26485778_en	DISO	atopic dermatitis	1284-1301
26485778_en	DISO	psoriasis	1306-1315
26485778_en	CHEM	CGRP	1347-1351
26485778_en	CHEM	CGRP-R	1356-1362
26485778_en	CHEM	SP	1364-1366
26485778_en	CHEM	SP-R	1368-1372
26485778_en	CHEM	TrkA	1378-1382
26485778_en	DISO	inflammatory response	1397-1418
26485778_en	CHEM	neuropeptides	1715-1728
26485778_en	CHEM	neurotrophins	1733-1746
26485778_en	ANATOMY	skin	1790-1794
26485778_en	DISO	inflammatory response	1795-1816
26485778_en	ANATOMY	body's	1903-1909
26485778_en	PHYS	sensitization	1910-1923
26485778_en	DISO	dermatoses	104-114
26485778_en	ANATOMY	skin	989-993
26485778_en	DISO	dermatitis	307-317
26485778_en	ANATOMY	Skin	341-345
26485778_en	DISO	dermatitis	423-433
26485778_en	LABPROC	immunofluorescence assays	500-525
26485778_en	CHEM	PGP9.5	601-607
26485778_en	CHEM	amphiregulin	610-622
26485778_en	CHEM	semaphorin	624-634
26485778_en	CHEM	semaphorin 3A	624-637
26485778_en	CHEM	calcitonin gene-related peptide	639-670
26485778_en	CHEM	CGRP	672-676
26485778_en	CHEM	calcitonin	639-649
26485778_en	CHEM	CGRP-R	696-702
26485778_en	CHEM	nerve growth factor	705-724
26485778_en	CHEM	NGF	726-729
26485778_en	CHEM	SP	771-773
26485778_en	LABPROC	immunofluorescence assay	811-835
26485778_en	DEVICE	Statistica 10	922-935
26485778_en	DISO	dermatitis	1037-1047
26485778_en	ANATOMY	epidermal	1158-1167
26485778_en	ANATOMY	nerve	1168-1173
26485778_en	ANATOMY	nerve fibers	1168-1180
26485778_en	DISO	dermatitis	1291-1301
26485778_en	DISO	atopic dermatitis	1512-1529
26485778_en	DISO	dermatitis	1519-1529
26485778_en	DISO	psoriasis	1534-1543
26485778_en	FINDING	larger number of epidermal nerve fibers	1567-1606
26485778_en	ANATOMY	epidermal nerve fibers	1584-1606
26485778_en	ANATOMY	epidermal	1584-1593
26485778_en	ANATOMY	nerve	1594-1599
26485778_en	ANATOMY	nerve fibers	1594-1606
26485778_en	DISO	itch	1681-1685
26485778_en	PHYS	body's sensitization	1903-1923
26485778_en	ANATOMY	nerve	1214-1219
26485778_en	LABPROC	histological	455-467
26485778_en	LABPROC	Immunoperoxidase	953-969
26485778_en	LABPROC	biopsy	346-352
26485778_en	ANATOMY	biopsy specimens	346-362
26485778_en	ANATOMY	biopsy specimens	994-1010
26485778_en	ANATOMY	nerve	705-710
26485778_en	CHEM	CGRP	1356-1360
26485778_en	CHEM	SP	792-794
26485778_en	CHEM	SP	1368-1370
26485778_en	CHEM	semaphorin	1237-1247
26485778_en	CHEM	receptors	71-80
26485778_en	CHEM	receptors	177-186
26485778_en	CHEM	protein	575-582
26485778_en	LABPROC	biopsy	994-1000
26485778_en	PHYS	expression	1196-1206
26485778_en	CHEM	nerve reduction factor	1214-1236
26485778_en	PHYS	expression	1080-1090
26485778_en	FINDING	enhanced expression	1071-1090
26485778_en	FINDING	decreased expression of the nerve reduction factor	1186-1236
26485778_en	PHYS	expression	1333-1343
26485778_en	FINDING	increased expression	1323-1343
26485778_en	FINDING	disease severity	1659-1675
26485778_en	FINDING	direct correlation	1616-1634
26485778_en	FINDING	itch intensity	1681-1695
26485778_en	DISO	pathogenesis	88-100
26485778_en	FINDING	appearance of positively stained epidermal nerve fibers	1125-1180
26485778_en	CHEM	reduction factor	1220-1236
26485778_en	PHYS	number of epidermal nerve fibers	1574-1606
26485778_en	FINDING	closely related to the development of a skin inflammatory response	1750-1816
26485778_en	PHYS	production of neuropeptides and neurotrophins	1701-1746
26485778_en	FINDING	favor the body's sensitization and the chronic pattern the course of diseases	1893-1970
26489117_en	PHYS	hemodynamic	17-28
26489117_en	ANATOMY	magistral vessels	45-62
26489117_en	DISO	optic neuropathy	66-82
26489117_en	PHYS	ocular tension	99-113
26489117_en	DISO	endocrine ophthalmopathy	125-149
26489117_en	PHYS	hemodynamic	200-211
26489117_en	ANATOMY	magistral vessels	228-245
26489117_en	DISO	optic neuropathy	249-265
26489117_en	DISO	ON	267-269
26489117_en	PHYS	ocular tension	287-301
26489117_en	DISO	endocrine ophthalmopathy	313-337
26489117_en	ANATOMY	eyes	394-398
26489117_en	DISO	Graves' disease	472-487
26489117_en	ANATOMY	eyes	500-504
26489117_en	DISO	autoimmune thyroiditis	509-531
26489117_en	ANATOMY	eyes	543-547
26489117_en	LABPROC	Orbit echography	564-580
26489117_en	PHYS	Blood flow	612-622
26489117_en	DEVICE	ultrasound diagnostic system	659-687
26489117_en	LABPROC	triplex mode	710-722
26489117_en	LABPROC	pulse-wave Doppler	779-797
26489117_en	PHYS	hemodynamic	814-825
26489117_en	ANATOMY	ophthalmic artery	840-857
26489117_en	ANATOMY	central retinal artery	859-881
26489117_en	ANATOMY	central retinal vein	889-909
26489117_en	ANATOMY	short posterior ciliary arteries	917-949
26489117_en	ANATOMY	long posterior ciliary arteries	962-993
26489117_en	PHYS	hemodynamic	1038-1049
26489117_en	ANATOMY	vessels	1086-1093
26489117_en	DISO	ON	1097-1099
26489117_en	PHYS	eye pressure	1116-1128
26489117_en	ANATOMY	eyes	1194-1198
26489117_en	PHYS	diastolic blood flow	1278-1298
26489117_en	PHYS	Intraocular pressure	1364-1384
26489117_en	DISO	optic neuropathy	1444-1460
26489117_en	PHYS	perfusion	1635-1644
26489117_en	DISO	chronic ocular ischemia	1673-1696
26489117_en	PHYS	IOP	1718-1721
26489117_en	ANATOMY	CRA	1784-1787
26489117_en	ANATOMY	SPCA	1789-1793
26489117_en	ANATOMY	LPCA	1799-1803
26489117_en	PHYS	blood flow	1818-1828
26489117_en	ANATOMY	eyes	1908-1912
26489117_en	DISO	EOP-associated ON	1918-1935
26489117_en	PHYS	IOP	1998-2001
26489117_en	PHYS	blood supply	2068-2080
26489117_en	ANATOMY	eyeball	2088-2095
26489117_en	PHYS	ocular tension	2118-2132
26489117_en	DISO	optic neuropathy	2152-2168
26489117_en	PHYS	perfusion	2179-2188
26489117_en	ANATOMY	CRA	2205-2208
26489117_en	ANATOMY	LPCA	2213-2217
26489117_en	ANATOMY	CRA	2232-2235
26489117_en	ANATOMY	LPCA	2237-2241
26489117_en	ANATOMY	SPCA	2247-2251
26489117_en	ANATOMY	SPCA	2296-2300
26489117_en	ANATOMY	LPCA	2308-2312
26489117_en	DISO	hemodynamic disturbances	17-41
26489117_en	ANATOMY	vessels	55-62
26489117_en	DISO	neuropathy	72-82
26489117_en	ANATOMY	ocular	99-105
26489117_en	ANATOMY	endocrine	125-134
26489117_en	DISO	ophthalmopathy	135-149
26489117_en	DISO	hemodynamic disturbances	200-224
26489117_en	ANATOMY	vessels	238-245
26489117_en	DISO	neuropathy	255-265
26489117_en	ANATOMY	ocular	287-293
26489117_en	FINDING	ocular tension changes	287-309
26489117_en	DISO	ophthalmopathy	323-337
26489117_en	DISO	EOP	339-342
26489117_en	ANATOMY	endocrine	313-322
26489117_en	DISO	EOP	417-420
26489117_en	DISO	thyroiditis	520-531
26489117_en	LABPROC	echography	570-580
26489117_en	ANATOMY	Blood	612-617
26489117_en	DEVICE	Voluson 730 PRO	643-658
26489117_en	DEVICE	Voluson 730 PRO ultrasound diagnostic system	643-687
26489117_en	LABPROC	B-scan	724-730
26489117_en	LABPROC	color Doppler flow mapping	732-758
26489117_en	ANATOMY	artery	851-857
26489117_en	ANATOMY	retinal artery	867-881
26489117_en	ANATOMY	artery	875-881
26489117_en	ANATOMY	retinal	867-874
26489117_en	ANATOMY	CRA	883-886
26489117_en	ANATOMY	retinal vein	897-909
26489117_en	ANATOMY	retinal	897-904
26489117_en	ANATOMY	vein	905-909
26489117_en	ANATOMY	CRV	911-914
26489117_en	ANATOMY	ciliary arteries	933-949
26489117_en	ANATOMY	SPCA	951-955
26489117_en	ANATOMY	ciliary arteries	977-993
26489117_en	ANATOMY	LPCA	995-999
26489117_en	DISO	hemodynamic disturbances	1038-1062
26489117_en	ANATOMY	eye	1116-1119
26489117_en	PHYS	blood flow	1288-1298
26489117_en	ANATOMY	blood	1288-1293
26489117_en	ANATOMY	Intraocular	1364-1375
26489117_en	DISO	neuropathy	1450-1460
26489117_en	ANATOMY	optic	1444-1449
26489117_en	DISO	perfusion disturbances	1635-1657
26489117_en	DISO	ischemia	1688-1696
26489117_en	ANATOMY	ocular	1681-1687
26489117_en	ANATOMY	blood	1818-1823
26489117_en	DISO	blood flow disturbance	1818-1840
26489117_en	DISO	EOP	1918-1921
26489117_en	DISO	ON	1933-1935
26489117_en	DISO	ON	1949-1951
26489117_en	ANATOMY	blood	2068-2073
26489117_en	DISO	impairment of blood supply	2054-2080
26489117_en	ANATOMY	ocular	2118-2124
26489117_en	FINDING	reduction in ocular tension	2105-2132
26489117_en	DISO	neuropathy	2158-2168
26489117_en	DISO	Combined perfusion disturbances	2170-2201
26489117_en	FINDING	decrease in IOP	1706-1721
26489117_en	ANATOMY	Orbit	564-569
26489117_en	FINDING	baseline IOP values	1989-2008
26489117_en	ANATOMY	ciliary	977-984
26489117_en	ANATOMY	posterior	967-976
26489117_en	ANATOMY	arteries	941-949
26489117_en	ANATOMY	arteries	985-993
26489117_en	FINDING	progression of optic neuropathy	2137-2168
26489117_en	FINDING	ON progression	1097-1111
26489117_en	PHYS	hemodynamic parameters	814-836
26489117_en	FINDING	peripheral indices were increased	1206-1239
26489117_en	FINDING	diastolic blood flow decreased	1278-1308
26489117_en	FINDING	optic neuropathy progression	1444-1472
26489117_en	FINDING	rate of ON progression	1941-1963
26489117_en	DISO	chronic impairment of blood supply	2046-2080
26489117_en	FINDING	optic neuropathy (ON) progression	249-282
26489117_en	LABPROC	ultrasound	659-669
26489117_en	ANATOMY	ciliary	933-940
26489117_en	PHYS	pressure	1120-1128
26489117_en	PHYS	pressure	1376-1384
26489117_en	DISO	scotomas	1531-1539
26489117_en	FINDING	depth (dB) and number of scotomas	1506-1539
26489117_en	DISO	ocular ischemia	1681-1696
26489117_en	FINDING	qualitative and quantitative changes in eyes with EOP-associated ON	1868-1935
26489117_en	FINDING	directly correlates	1964-1983
26489117_en	FINDING	high-risk factor	2272-2288
26489117_en	FINDING	moderate-risk	2328-2341
26489117_en	DISO	perfusion disturbances	2179-2201
26525473_en	ANATOMY	nasal cavity	78-90
26525473_en	ANATOMY	nasopharynx	92-103
26525473_en	ANATOMY	larynx	109-115
26525473_en	CHEM	topical anesthetics	121-140
26525473_en	LABPROC	fibroendoscopy	306-320
26525473_en	ANATOMY	nose	328-332
26525473_en	ANATOMY	nasopharynx	334-345
26525473_en	ANATOMY	larynx	351-357
26525473_en	PHYS	age	532-535
26525473_en	PHYS	sex	540-543
26525473_en	LABPROC	fibroendoscopy	613-627
26525473_en	CHEM	xylometazoline	671-685
26525473_en	CHEM	lidocaine solution	712-730
26525473_en	CHEM	xylometazoline	765-779
26525473_en	CHEM	lidocaine solutions	788-807
26525473_en	ANATOMY	nasal cavity	878-890
26525473_en	CHEM	lidocaine	896-905
26525473_en	CHEM	lidocaine	910-919
26525473_en	CHEM	xylometazoline	925-939
26525473_en	LABPROC	fibroendoscopy	1057-1071
26525473_en	LABPROC	fibroendoscopy	1207-1221
26525473_en	CHEM	physiological solution	1270-1292
26525473_en	CHEM	lidocaine	1353-1362
26525473_en	CHEM	xylometazoline	1367-1381
26525473_en	LABPROC	fibroendoscopy	1503-1517
26525473_en	ANATOMY	nasal cavity	1573-1585
26525473_en	CHEM	lidocaine solution	1613-1631
26525473_en	LABPROC	fibroendoscopy	1639-1653
26525473_en	CHEM	xylometazoline	1706-1720
26525473_en	CHEM	lidocaine	1764-1773
26525473_en	CHEM	xylometazoline	1872-1886
26525473_en	LABPROC	fibroendoscopic study	49-70
26525473_en	CHEM	physiological solution	629-651
26525473_en	CHEM	xylometazoline solution	671-694
26525473_en	CHEM	lidocaine	712-721
26525473_en	CHEM	lidocaine	788-797
26525473_en	ANATOMY	nasal	878-883
26525473_en	FINDING	tolerance to fibroendoscopy	1044-1071
26525473_en	FINDING	tolerance of fibroendoscopy	1194-1221
26525473_en	FINDING	tolerance to fibroendoscopy	1490-1517
26525473_en	ANATOMY	nasal	1573-1578
26525473_en	CHEM	lidocaine	1613-1622
26525473_en	CHEM	xylometazoline solution	1706-1729
26525473_en	ANATOMY	nasal	78-83
26525473_en	FINDING	effectiveness of various anesthetic techniques	241-287
26525473_en	CHEM	anesthetics	129-140
26525473_en	CHEM	solution	643-651
26525473_en	CHEM	solution	686-694
26525473_en	CHEM	solution	722-730
26525473_en	CHEM	solutions	798-807
26525473_en	FINDING	tolerance to the pretreatment of the nasal cavity	841-890
26525473_en	FINDING	significantly (p<0.05) worse	976-1004
26525473_en	FINDING	on the average similar	1104-1126
26525473_en	FINDING	worst	1232-1237
26525473_en	FINDING	best	1311-1315
26525473_en	CHEM	solution	1284-1292
26525473_en	FINDING	not significantly different	1446-1473
26525473_en	CHEM	solution	1623-1631
26525473_en	CHEM	solution	1721-1729
26525473_en	CHEM	anesthetic	1780-1790
26525473_en	FINDING	nduces more pronounced negative emotions	1792-1832
26525473_en	FINDING	before fibroendoscopy has no advantage	1632-1670
26525480_en	DISO	influenza	85-94
26525480_en	DISO	acute respiratory viral infection	99-132
26525480_en	DISO	Acute cough	291-302
26525480_en	DISO	ARVI	310-314
26525480_en	DISO	cough	466-471
26525480_en	DISO	ARVI	479-483
26525480_en	ANATOMY	sputum	551-557
26525480_en	INJURY_POISONING	chest injuries	651-665
26525480_en	DISO	dry pleuritis	667-680
26525480_en	DISO	subacute cough	785-799
26525480_en	CHEM	ambroxol	857-865
26525480_en	PHYS	mucociliary clearance	884-905
26525480_en	ANATOMY	sputum	953-959
26525480_en	CHEM	ambroxol	1025-1033
26525480_en	ANATOMY	bronchial mucus	1146-1161
26525480_en	CHEM	ambroxol	1258-1266
26525480_en	CHEM	neo-bronchol	1268-1280
26525480_en	ANATOMY	oral cavity	1428-1439
26525480_en	ANATOMY	blood plasma	1536-1548
26525480_en	CHEM	ambroxol	1578-1586
26525480_en	CHEM	ambroxol	1643-1651
26525480_en	CHEM	menthol	1660-1667
26525480_en	CHEM	cineol	1673-1679
26525480_en	FINDING	antibacterial actions	1718-1739
26525480_en	ANATOMY	trachea	1762-1769
26525480_en	ANATOMY	bronchi	1774-1781
26525480_en	ANATOMY	mucous membrane	1835-1850
26525480_en	ANATOMY	larynx	1858-1864
26525480_en	ANATOMY	pharynx	1866-1873
26525480_en	ANATOMY	nasal cavity	1879-1891
26525480_en	CHEM	neo-bronchol	2014-2026
26525480_en	PHYS	excretion	2200-2209
26525480_en	ANATOMY	bronchial mucus	2248-2263
26525480_en	DISO	pneumonia	2303-2312
26525480_en	DISO	obstructive pulmonary disease	2322-2351
26525480_en	DISO	bronchial asthma	2353-2369
26525480_en	PHYS	sputum discharge	2389-2405
26525480_en	DISO	bronchoectatic disease	2411-2433
26525480_en	DISO	acute cough	42-53
26525480_en	DISO	cough	48-53
26525480_en	DISO	Acute cough	57-68
26525480_en	DISO	cough	63-68
26525480_en	DISO	respiratory viral infection	105-132
26525480_en	DISO	ARVI	134-138
26525480_en	DISO	cough	297-302
26525480_en	PHYS	young	603-608
26525480_en	ANATOMY	chest	651-656
26525480_en	DISO	pleuritis	671-680
26525480_en	DISO	cough	794-799
26525480_en	CHEM	mucokinetic	845-856
26525480_en	CHEM	mucokinetic ambroxol	845-865
26525480_en	PHYS	MCC	907-910
26525480_en	PHYS	sputum expectoration	953-973
26525480_en	ANATOMY	bronchial	1146-1155
26525480_en	ANATOMY	mucus	1156-1161
26525480_en	ANATOMY	oral	1428-1432
26525480_en	ANATOMY	circulatory system	1472-1490
26525480_en	ANATOMY	blood	1536-1541
26525480_en	ANATOMY	plasma	1542-1548
26525480_en	ANATOMY	mucous	1835-1841
26525480_en	ANATOMY	membrane	1842-1850
26525480_en	ANATOMY	nasal	1879-1884
26525480_en	FINDING	cough-suppressive effect	1946-1970
26525480_en	DISO	inflamed	1826-1834
26525480_en	ANATOMY	bronchial	2248-2257
26525480_en	ANATOMY	mucus	2258-2263
26525480_en	DISO	bronchitis	2291-2301
26525480_en	DISO	pulmonary disease	2334-2351
26525480_en	ANATOMY	pulmonary	2334-2343
26525480_en	DISO	asthma	2363-2369
26525480_en	ANATOMY	bronchial	2353-2362
26525480_en	DISO	difficulty in sputum discharge	2375-2405
26525480_en	ANATOMY	sputum	2389-2395
26525480_en	DISO	viscous and difficult-of-discharge bronchial mucus	2213-2263
26525480_en	PHYS	discharge bronchial mucus	2238-2263
26525480_en	DISO	abnormal expectoration of sputum	525-557
26525480_en	PHYS	expectoration of sputum	534-557
26525480_en	PHYS	rheological properties	1120-1142
26525480_en	FINDING	mucolytic	1691-1700
26525480_en	FINDING	antiseptic	1702-1712
26525480_en	DISO	cough	1946-1951
26525480_en	CHEM	receptors	1801-1810
26525480_en	DISO	infection	123-132
26525480_en	DISO	chronic obstructive pulmonary disease	2314-2351
26525480_en	PHYS	elderly	585-592
26525480_en	PHYS	aged	576-580
26525480_en	FINDING	prevent the development of subacute cough	758-799
26525480_en	FINDING	improves the mucociliary clearance	871-905
26525480_en	FINDING	improvement of rheological properties	1105-1142
26525480_en	FINDING	antiviral effects	1184-1201
26525480_en	FINDING	ant-inflammatory	1163-1179
26525480_en	DISO	chronic bronchitis	2283-2301
26525480_en	DISO	acute bronchitis	2273-2301
26525480_en	PHYS	respiratory	105-116
26525480_en	PHYS	healthy	334-341
26525480_en	INJURY_POISONING	injuries	657-665
26525480_en	CHEM	mucoactive preparations	730-753
26525480_en	PHYS	clearance	896-905
26525480_en	FINDING	antioxidation effect	1079-1099
26525480_en	CHEM	surfactant	1056-1066
26525480_en	PHYS	surfactant production	1056-1077
26525480_en	FINDING	stimulation of surfactant production	1041-1077
26525480_en	FINDING	rapid penetration into the circulatory system	1445-1490
26525480_en	FINDING	high concentration in blood plasma	1514-1548
26525480_en	PHYS	concentration in blood plasma	1519-1548
26525480_en	FINDING	absorption of this medication	1391-1420
26525480_en	CHEM	volatile metabolites	1554-1574
26525480_en	CHEM	metabolites	1563-1574
26525480_en	FINDING	Irrigation of the receptors	1783-1810
26525480_en	DISO	acute diseases	2154-2180
26525480_en	DISO	chronic diseases	2164-2180
26525480_en	FINDING	recommended for the inclusion in the combined treatment	2066-2121
26525616_en	DISO	Myofascial pain syndrome	1-25
26525616_en	DISO	pain syndrome	77-90
26525616_en	DISO	dorsalgia	108-117
26525616_en	DISO	back pain	248-257
26525616_en	LABPROC	MRI	305-308
26525616_en	LABPROC	CT	316-318
26525616_en	ANATOMY	spine	326-331
26525616_en	DISO	anxiety	348-355
26525616_en	DISO	depression	360-370
26525616_en	DISO	myofascial pain syndrome	519-543
26525616_en	DISO	anxiety-depressive disorders	582-610
26525616_en	ANATOMY	cervical	634-642
26525616_en	DISO	pain	665-669
26525616_en	DISO	fibromyalgia	671-683
26525616_en	ANATOMY	neural structure	735-751
26525616_en	LABPROC	MRI	777-780
26525616_en	LABPROC	CT	785-787
26525616_en	DISO	MFPS	825-829
26525616_en	DISO	MFPS	900-904
26525616_en	CHEM	amelotex	927-935
26525616_en	CHEM	compligam B	960-971
26525616_en	DISO	dorsopathy	989-999
26525616_en	DISO	MFPS	1004-1008
26525616_en	DISO	emotional disorders	1050-1069
26525616_en	DISO	pain syndrome	12-25
26525616_en	ANATOMY	back	248-252
26525616_en	DISO	pain syndrome	530-543
26525616_en	DISO	MFPS	545-549
26525616_en	DISO	anxiety	582-589
26525616_en	DISO	depressive	590-600
26525616_en	ANATOMY	cervical/pectoral	647-664
26525616_en	ANATOMY	pectoral	656-664
26525616_en	ANATOMY	cervical	647-655
26525616_en	DISO	neurological symptoms	697-718
26525616_en	DISO	pain	12-16
26525616_en	DISO	pain	77-81
26525616_en	LABPROC	neurological examination	279-303
26525616_en	DISO	pain	253-257
26525616_en	DISO	pain	530-534
26525616_en	DISO	Anxiety	389-396
26525616_en	DISO	Depression	401-411
26525616_en	DISO	Chronic myofascial pain syndrome	511-543
26525616_en	DISO	chronic MFPS	817-829
26525616_en	DISO	Pain	436-440
26525616_en	DISO	Pain	472-476
26525616_en	ANATOMY	Myofascial	1-11
26525616_en	DISO	chronic back pain	240-257
26525616_en	DISO	subacute chronic back pain	231-257
26525616_en	DISO	acute chronic back pain	221-257
26525616_en	ANATOMY	myofascial	519-529
26525616_en	FINDING	no signs	723-731
26525616_en	DISO	neural structure compression	735-763
26525616_en	CHEM	chondroprotectors	1089-1106
26525616_en	FINDING	frequently associated	555-576
26525616_en	FINDING	effective together with correction	1012-1046
26525622_en	DISO	cognitive impairment	29-49
26525622_en	DISO	cognitive impairment	111-131
26525622_en	CHEM	hopantenic acid	152-167
26525622_en	CHEM	pantogam	169-177
26525622_en	DISO	epilepsy	221-229
26525622_en	DISO	cognitive impairment	234-254
26525622_en	DISO	epilepsy	314-322
26525622_en	CHEM	pantogam	336-344
26525622_en	DISO	epilepsy	383-391
26525622_en	CHEM	pantogam	412-420
26525622_en	DISO	cryptogenic epilepsy	478-498
26525622_en	DISO	epilepsy	515-523
26525622_en	LABPROC	EEG	602-605
26525622_en	LABPROC	brain MRI	632-641
26525622_en	DISO	cognitive impairment	658-678
26525622_en	CHEM	pantogam	769-777
26525622_en	DISO	cognitive impairment	984-1004
26525622_en	LABPROC	EEG	1116-1119
26525622_en	DISO	seizures	1242-1250
26525622_en	DISO	epilepsy	81-89
26525622_en	DISO	symptomatic epilepsy	503-523
26525622_en	DISO	epilepsy	490-498
26525622_en	LABPROC	video-EEG monitoring	607-627
26525622_en	LABPROC	EEG	613-616
26525622_en	LABPROC	MRI	638-641
26525622_en	ANATOMY	brain	632-637
26525622_en	FINDING	improvement of EEG	1101-1119
26525622_en	FINDING	no increase in the frequency of seizures	1210-1250
26525622_en	FINDING	decrease in cognitive impairment	972-1004
26525622_en	CHEM	acid	163-167
26525622_en	FINDING	good tolerability	1176-1193
26525622_en	PHYS	age	63-66
26525622_en	PHYS	age	1079-1082
26525622_en	FINDING	efficacy of hopantenic acid	140-167
26525622_en	PHYS	preschool age	53-66
26525622_en	FINDING	did not receive pantogam	396-420
26525622_en	FINDING	age normalization	1079-1096
26525625_en	CHEM	cytoflavin	17-27
26525625_en	DISO	burnout syndrome	48-64
26525625_en	CHEM	cytoflavin	105-115
26525625_en	DISO	burnout syndrome	150-166
26525625_en	LABPROC	neurophysiological examinations	236-267
26525625_en	CHEM	cytoflavin	343-353
26525625_en	CHEM	ethylmethylhydroxypyridine succinate	371-407
26525625_en	CHEM	cytoflavin	617-627
26525625_en	CHEM	ethylmethylhydroxypyridine succinate	673-709
26525625_en	CHEM	cytoflavin	762-772
26525625_en	CHEM	ethylmethylhydroxypyridine	371-397
26525625_en	CHEM	ethylmethylhydroxypyridine	673-699
26525625_en	FINDING	efficacy of cytoflavin	5-27
26525625_en	FINDING	efficacy of cytoflavin	93-115
26525625_en	FINDING	efficacy of cytoflavin	605-627
26525625_en	FINDING	higher efficacy of cytoflavin	598-627
26525625_en	FINDING	stability of the resulting effect	536-569
26525625_en	FINDING	improvement	629-640
26525625_en	CHEM	succinate	700-709
26525625_en	CHEM	succinate	398-407
26525625_en	FINDING	improvement	711-722
26525625_en	FINDING	improvement was more persisten	788-818
26525625_en	FINDING	clinical results	827-843
26525628_en	DISO	syringomyelia	29-42
26525628_en	DISO	syringomyelia	125-138
26525628_en	PHYS	sensory	488-495
26525628_en	DISO	motor disorders	500-515
26525628_en	ANATOMY	skin	540-544
26525628_en	ANATOMY	joint	546-551
26525628_en	DISO	bone deformations	556-573
26525628_en	DISO	lesion	593-599
26525628_en	PHYS	motor	500-505
26525628_en	DISO	trophic changes	517-532
26525628_en	ANATOMY	bone	556-560
26525628_en	ANATOMY	spine	652-657
26525628_en	ANATOMY	cervical	620-628
26525628_en	ANATOMY	thoracic	629-637
26525628_en	ANATOMY	cervical-thoracic region	620-644
26525628_en	DISO	Clinical characteristics	1-25
26525628_en	DISO	sensory disorders	488-515
26525628_en	DISO	clinical characteristics	97-121
26525628_en	FINDING	Disease duration	308-324
26525628_en	FINDING	slowly progressive course was most frequent	662-705
26525809_en	CHEM	ipidacrine	60-70
26525809_en	DISO	mononeuropathies	88-104
26525809_en	CHEM	ipidacrine	170-180
26525809_en	DISO	focal neuropathies	322-340
26525809_en	DISO	radiculopathies	360-375
26525809_en	CHEM	axamon	404-410
26525809_en	CHEM	group B vitamins	484-500
26525809_en	CHEM	lipoic acid	502-513
26525809_en	LABPROC	electroneuromyographic	718-740
26525809_en	PHYS	M-response	818-828
26525809_en	ANATOMY	hand	851-855
26525809_en	ANATOMY	feet	860-864
26525809_en	PHYS	nerve conduction velocity	876-901
26525809_en	ANATOMY	peripheral nerves	909-926
26525809_en	PHYS	remyelination activity	949-971
26525809_en	CHEM	axamon	1048-1054
26525809_en	CHEM	ipidacrine	1056-1066
26525809_en	CHEM	cholinesterase inhibitor with conduction action	1080-1127
26525809_en	ANATOMY	peripheral nerves	1182-1199
26525809_en	CHEM	axamon	162-168
26525809_en	DISO	focal neuropathies	207-225
26525809_en	DISO	neuropathies	213-225
26525809_en	DISO	mononeuropathies	227-243
26525809_en	DISO	neuropathies	328-340
26525809_en	DISO	tunnel syndromes	342-358
26525809_en	CHEM	ipidacrine	412-422
26525809_en	FINDING	positive clinical changes	642-667
26525809_en	LABPROC	ENMG	742-746
26525809_en	FINDING	more significant positive electroneuromyographic	692-740
26525809_en	ANATOMY	muscles	836-843
26525809_en	ANATOMY	nerves	920-926
26525809_en	LABPROC	ENMG	1024-1028
26525809_en	ANATOMY	nerves	1193-1199
26525809_en	ANATOMY	efferent (motor) fibers	1151-1174
26525809_en	LABPROC	clinical-electroneuromyographic study	3-40
26525809_en	ANATOMY	nerve	876-881
26525809_en	CHEM	vitamins	492-500
26525809_en	PHYS	conduction	882-892
26525809_en	FINDING	efficacy of ipidacrine	48-70
26525809_en	FINDING	efficacy and tolerability of axamon	133-168
26525809_en	FINDING	increased amplitude of M-response	795-828
26525809_en	FINDING	increased nerve conduction velocity	866-901
26525809_en	PHYS	amplitude of M-response	805-828
26525809_en	ANATOMY	fibers	1168-1174
26525809_en	PHYS	efferent	1151-1159
26525809_en	PHYS	motor	1161-1166
26525809_en	CHEM	inhibitor	1095-1104
26525809_en	CHEM	cholinesterase	1080-1094
26525809_en	CHEM	cholinesterase inhibito	1080-1103
26528618_en	ANATOMY	odontoid process	49-65
26528618_en	ANATOMY	C2 vertebra	73-84
26528618_en	ANATOMY	craniovertebral region	129-151
26528618_en	ANATOMY	clivus	153-159
26528618_en	ANATOMY	C2 vertebra	212-223
26528618_en	ANATOMY	C2	236-238
26528618_en	ANATOMY	craniovertebral junction	296-320
26528618_en	DISO	lesion	374-380
26528618_en	ANATOMY	C2	387-389
26528618_en	ANATOMY	clivus structures	442-459
26528618_en	ANATOMY	C1-C2 vertebrae	464-479
26528618_en	DISO	chordoma	552-560
26528618_en	DISO	giant cell tumor	562-578
26528618_en	DISO	osteoblastoma	580-593
26528618_en	DISO	rheumatoid lesion	595-612
26528618_en	DISO	metastases	614-624
26528618_en	DISO	platybasia	626-636
26528618_en	DISO	basilar impression	642-660
26528618_en	ANATOMY	craniovertebral junction	718-742
26528618_en	ANATOMY	C2 vertebra	978-989
26528618_en	DISO	neurological symptoms	1201-1222
26528618_en	PHYS	strength and range of motions	1269-1298
26528618_en	ANATOMY	arms	1306-1310
26528618_en	ANATOMY	legs	1322-1326
26528618_en	DISO	spasticity	1338-1348
26528618_en	ANATOMY	arms	1356-1360
26528618_en	DISO	spasticity	1387-1397
26528618_en	ANATOMY	legs	1405-1409
26528618_en	PHYS	sensitivity	1457-1468
26528618_en	ANATOMY	arms	1476-1480
26528618_en	ANATOMY	legs	1482-1486
26528618_en	ANATOMY	torso	1492-1497
26528618_en	DISO	liquorrhea	1514-1524
26528618_en	DISO	fistula	1589-1596
26528618_en	DISO	liquorrhea	1631-1641
26528618_en	LABPROC	MRI	1677-1680
26528618_en	LABPROC	spiral CT	1685-1694
26528618_en	DISO	bone defect	1720-1731
26528618_en	ANATOMY	medulla oblongata	1801-1818
26528618_en	ANATOMY	upper cervical spine segments	1823-1852
26528618_en	DISO	spinal canal stenosis	1873-1894
26528618_en	ANATOMY	soft palate	2085-2096
26528618_en	ANATOMY	oropharynx	2117-2127
26528618_en	ANATOMY	oral cavity	2303-2314
26528618_en	ANATOMY	oropharynx area	2348-2363
26528618_en	DEVICE	stomach tube	2450-2462
26528618_en	DISO	inflammatory complications	2486-2512
26528618_en	ANATOMY	oral cavity	2520-2531
26528618_en	ANATOMY	C1-C2 segment	2610-2623
26528618_en	ANATOMY	vertebra	76-84
26528618_en	DISO	invaginated	37-48
26528618_en	ANATOMY	C1 anterior arch	161-177
26528618_en	ANATOMY	odontoid process	179-195
26528618_en	ANATOMY	vertebra	215-223
26528618_en	ANATOMY	body of the C2 vertebra	200-223
26528618_en	ANATOMY	C1	233-235
26528618_en	ANATOMY	C0	230-232
26528618_en	ANATOMY	C0-C1-C2 segments	230-247
26528618_en	ANATOMY	craniovertebral	296-311
26528618_en	DISO	craniovertebral junction instability	296-332
26528618_en	DISO	lesion of C1-C2 segments	374-398
26528618_en	ANATOMY	C1-C2 segments	384-398
26528618_en	ANATOMY	C2	467-469
26528618_en	DISO	destruction of the clivus structures	423-459
26528618_en	ANATOMY	spinal cord	503-514
26528618_en	DISO	compression of the spinal cord	484-514
26528618_en	ANATOMY	cell	568-572
26528618_en	DISO	tumor	573-578
26528618_en	ANATOMY	giant cell	562-572
26528618_en	DISO	lesion	606-612
26528618_en	ANATOMY	craniovertebral	718-733
26528618_en	DISO	instability of the craniovertebral junction	699-742
26528618_en	DISO	neurological disorders	771-793
26528618_en	ANATOMY	odontoid process	954-970
26528618_en	DISO	invagination	934-946
26528618_en	ANATOMY	odontoid process	1120-1136
26528618_en	ANATOMY	C2	1117-1119
26528618_en	ANATOMY	distal legs	1315-1326
26528618_en	FINDING	regressed spasticity	1328-1348
26528618_en	FINDING	reduced spasticity	1379-1397
26528618_en	DISO	Postoperative liquorrhea	1500-1524
26528618_en	FINDING	no signs of liquorrhea	1619-1641
26528618_en	LABPROC	CT	1692-1694
26528618_en	ANATOMY	bone	1720-1724
26528618_en	ANATOMY	odontoid process	1742-1758
26528618_en	ANATOMY	C2	1739-1741
26528618_en	DISO	postoperative bone defect	1706-1731
26528618_en	ANATOMY	clivus	1763-1769
26528618_en	ANATOMY	cervical	1829-1837
26528618_en	ANATOMY	spine	1838-1843
26528618_en	ANATOMY	spinal canal	1873-1885
26528618_en	ANATOMY	palate	2090-2096
26528618_en	FINDING	soft palate remains intact	2085-2111
26528618_en	ANATOMY	oropharynx area	2117-2132
26528618_en	FINDING	oropharynx area is less damaged	2117-2148
26528618_en	DISO	failure of sutures in the oral cavity	2277-2314
26528618_en	ANATOMY	oropharynx	2348-2358
26528618_en	INJURY_POISONING	wound surface	2327-2340
26528618_en	ANATOMY	stomach	2450-2457
26528618_en	ANATOMY	oral	2520-2524
26528618_en	ANATOMY	C2	2613-2615
26528618_en	ANATOMY	vertebra	981-989
26528618_en	FINDING	increase in the strength and range of motions	1253-1298
26528618_en	DISO	CSF fistula	1585-1596
26528618_en	FINDING	partial regression of the neurological symptoms	1175-1222
26528618_en	ANATOMY	oral	2303-2307
26528618_en	ANATOMY	C1	161-163
26528618_en	ANATOMY	C1	384-386
26528618_en	ANATOMY	C1	464-466
26528618_en	ANATOMY	C1	2610-2612
26528618_en	ANATOMY	C2	73-75
26528618_en	ANATOMY	C2	212-214
26528618_en	ANATOMY	C2	978-980
26528618_en	ANATOMY	spinal	503-509
26528618_en	ANATOMY	spinal	1873-1879
26528618_en	DISO	inflammatory	2486-2498
26528618_en	FINDING	improvement in all kinds of sensitivity	1429-1468
26528618_en	DISO	destruction	423-434
26528618_en	FINDING	complete decompression	1771-1793
26528618_en	FINDING	no evidence of spinal canal stenosis	1858-1894
26528618_en	FINDING	hospitalization and rehabilitation duration is reduced	2158-2212
26528618_en	ANATOMY	junction	734-742
26528618_en	ANATOMY	junction	312-320
26528618_en	ANATOMY	vertebrae	470-479
26528618_en	FINDING	complicates the diagnosis and surgical treatment	801-849
26528618_en	PHYS	motions	1291-1298
26528618_en	DISO	stenosis	1886-1894
26528618_en	FINDING	significant advantages	2050-2072
26528618_en	DISO	complications	2499-2512
26528618_en	FINDING	no problems and complications	2230-2259
26528618_en	DISO	complications	2246-2259
26528618_en	ANATOMY	sutures	2288-2295
26529536_en	DISO	Growing teratoma syndrome	1-26
26529536_en	DISO	intracranial germ cell tumor	45-73
26529536_en	ANATOMY	chiasmatic-sellar area	146-168
26529536_en	DISO	polyuria	179-187
26529536_en	DISO	polydipsia	192-202
26529536_en	PHYS	puberty	277-284
26529536_en	DISO	vision impairment	289-306
26529536_en	LABPROC	MRI	309-312
26529536_en	DISO	shiasmatic sellar tumor	336-359
26529536_en	DISO	occlusive hydrocephalus	364-387
26529536_en	ANATOMY	blood serum	412-423
26529536_en	CHEM	alpha-fetoprotein	444-461
26529536_en	CHEM	human chorionic gonadotropin	490-518
26529536_en	CHEM	Ifosfamide	625-635
26529536_en	CHEM	Cisplatin	648-657
26529536_en	CHEM	Etoposide	670-679
26529536_en	CHEM	Cisplatin	759-768
26529536_en	CHEM	Endoxan	795-802
26529536_en	DISO	tumor	853-858
26529536_en	PHYS	vision	905-911
26529536_en	PHYS	vision	1039-1045
26529536_en	DISO	intracranial hypertension	1076-1101
26529536_en	ANATOMY	tumor tissue	1128-1140
26529536_en	DISO	teratoma	1164-1172
26529536_en	DISO	growing teratoma syndrome	1200-1225
26529536_en	ANATOMY	intracranial	1260-1272
26529536_en	DISO	teratoma	9-17
26529536_en	DISO	tumor	68-73
26529536_en	ANATOMY	cell	63-67
26529536_en	ANATOMY	germ cell	58-67
26529536_en	ANATOMY	intracranial	45-57
26529536_en	DISO	germ cell tumor	58-73
26529536_en	DISO	tumor	133-138
26529536_en	ANATOMY	cell	128-132
26529536_en	ANATOMY	germ cell	123-132
26529536_en	DISO	non-germinomatous germ cell tumor	105-138
26529536_en	DISO	precocious puberty	266-284
26529536_en	DISO	hydrocephalus	374-387
26529536_en	DISO	tumor	354-359
26529536_en	ANATOMY	shiasmatic sellar	336-353
26529536_en	ANATOMY	blood	412-417
26529536_en	ANATOMY	serum	418-423
26529536_en	PHYS	alpha-fetoprotein level	444-467
26529536_en	CHEM	gonadotropin	506-518
26529536_en	PHYS	tumor marker levels	853-872
26529536_en	FINDING	vision still deteriorated	905-930
26529536_en	LABPROC	MRI	932-935
26529536_en	DISO	tumor	962-967
26529536_en	DISO	tumor	1016-1021
26529536_en	FINDING	vision improvement	1039-1057
26529536_en	ANATOMY	intracranial	1076-1088
26529536_en	DISO	hypertension	1089-1101
26529536_en	DISO	tumor	1128-1133
26529536_en	ANATOMY	tissue	1134-1140
26529536_en	DISO	mature teratoma	1157-1172
26529536_en	DISO	teratoma	1208-1216
26529536_en	DISO	tumors	1301-1307
26529536_en	ANATOMY	cell	1296-1300
26529536_en	ANATOMY	germ cell	1291-1300
26529536_en	DISO	intracranial non-germinomatous germ cell tumors	1260-1307
26529536_en	PHYS	vision	289-295
26529536_en	FINDING	decrease in tumor marker levels to normal values	841-889
26529536_en	LABPROC	Histological analysis	1103-1124
26529536_en	CHEM	Tumor marker	389-401
26529536_en	CHEM	tumor marker	853-865
26529536_en	DISO	Tumor	389-394
26529536_en	FINDING	elevated	429-437
26529536_en	FINDING	increased	472-481
26529536_en	DISO	germ cell tumor	123-138
26529536_en	DISO	non-germinomatous germ cell tumors	1273-1307
26529536_en	FINDING	tumor size increased and its structure changed	962-1008
26529536_en	CHEM	chorionic gonadotropin	496-518
26529536_en	PHYS	Tumor marker levels	389-408
26529536_en	FINDING	levels increased over time	534-560
26529621_en	ANATOMY	medial temporal region	84-106
26529621_en	ANATOMY	medial temporal region	228-250
26529621_en	ANATOMY	brain tissue	475-487
26529621_en	ANATOMY	MTR	651-654
26529621_en	DISO	Benign tumors	743-756
26529621_en	ANATOMY	MTRs	842-846
26529621_en	ANATOMY	MTR	888-891
26529621_en	DISO	Cerebellar edema	1002-1018
26529621_en	DISO	hemiparesis	1048-1059
26529621_en	DISO	drug resistant epilepsy	1136-1159
26529621_en	ANATOMY	MTR	1325-1328
26529621_en	ANATOMY	MTR	1361-1364
26529621_en	ANATOMY	anterior MTR portions	1482-1503
26529621_en	ANATOMY	MTR	1514-1517
26529621_en	ANATOMY	infraoccipital	1591-1605
26529621_en	ANATOMY	temporal region	91-106
26529621_en	ANATOMY	posterior portions of the medial temporal region	58-106
26529621_en	DISO	tumors	44-50
26529621_en	ANATOMY	temporal region	235-250
26529621_en	ANATOMY	MTR	252-255
26529621_en	ANATOMY	posterior part of the medial temporal region	206-250
26529621_en	ANATOMY	brain	475-480
26529621_en	ANATOMY	tissue	481-487
26529621_en	ANATOMY	glial	614-619
26529621_en	DISO	tumors	620-626
26529621_en	ANATOMY	posterior MTR	641-654
26529621_en	DISO	glial tumors	614-626
26529621_en	DISO	tumors	750-756
26529621_en	ANATOMY	posterior	821-830
26529621_en	ANATOMY	middle MTRs	835-846
26529621_en	ANATOMY	anterior MTR	879-891
26529621_en	ANATOMY	Cerebellar	1002-1012
26529621_en	DISO	edema	1013-1018
26529621_en	DISO	epilepsy	1151-1159
26529621_en	ANATOMY	posterior MTR portions	1304-1337
26529621_en	ANATOMY	middle MTR portions	1318-1337
26529621_en	ANATOMY	MTR	1491-1494
26529621_en	ANATOMY	anterior MTR portions	1352-1373
26529621_en	ANATOMY	Anterior MTR structures	1505-1528
26529621_en	FINDING	operative risks of STA increase	1404-1435
26549907_en	DISO	Tuberculosis	0-12
26549907_en	DISO	tuberculosis	172-184
26549907_en	DISO	tuberculosis	335-347
26549907_en	DISO	tuberculosis	424-436
26549907_en	DISO	tuberculosis	530-542
26549907_en	DISO	tuberculosis	618-630
26549907_en	DISO	tuberculosis	848-860
26549907_en	DISO	drug-susceptible tuberculosis	936-965
26549907_en	DISO	multidrug-resistant tuberculosis	995-1027
26549907_en	DISO	tuberculosis	1061-1073
26549907_en	DISO	multidrug-resistant tuberculosis	1143-1175
26549907_en	DISO	tuberculosis	1238-1250
26549907_en	DISO	tuberculosis	1460-1472
26549907_en	FINDING	mortality	237-246
26549907_en	DISO	drug-resistant tuberculosis	409-436
26549907_en	DISO	tuberculosis	953-965
26549907_en	DISO	tuberculosis	1015-1027
26549907_en	DISO	tuberculosis	1163-1175
26549907_en	DISO	tuberculosis	1319-1331
26549907_en	FINDING	reduction in mortality	224-246
26549907_en	FINDING	reduction in incidence	191-213
26549907_en	FINDING	reductions in the incidence of multidrug-resistant tuberculosis	1112-1175
26549907_en	DISO	epidemic	397-405
26569010_en	CHEM	chondroprotectors	30-47
26569010_en	CHEM	chondroprotectors	123-140
26569010_en	DISO	chronic pain syndromes	161-183
26569010_en	CHEM	placebo	203-210
26569010_en	DISO	osteoarthritis	434-448
26569010_en	DISO	pain syndrome	470-483
26569010_en	DISO	osteoarthritis	487-501
26569010_en	DISO	low back pain	506-519
26569010_en	CHEM	NSAIDs	562-568
26569010_en	CHEM	celecoxib	570-579
26569010_en	CHEM	placebo	584-591
26569010_en	CHEM	SYSADOA	853-860
26569010_en	CHEM	NSAIDs	877-883
26569010_en	DISO	osteoarthritis	913-927
26569010_en	DISO	chronic back pain	941-958
26569010_en	CHEM	SYSADOA	1125-1132
26569010_en	CHEM	cytokines	1178-1187
26569010_en	ANATOMY	blood	1195-1200
26569010_en	CHEM	IL-6	1202-1206
26569010_en	CHEM	anti-inflammatory cytokine	1262-1288
26569010_en	CHEM	IL-10	1289-1294
26569010_en	ANATOMY	synovial membrane	1302-1319
26569010_en	CHEM	interleukin 1-beta	1366-1384
26569010_en	CHEM	enzymes	1424-1431
26569010_en	CHEM	nitric oxide synthase	1437-1458
26569010_en	CHEM	cyclooxygenase-2	1463-1479
26569010_en	CHEM	glucosamine	1504-1515
26569010_en	ANATOMY	chondrocytes	1516-1528
26569010_en	CHEM	SYSADOA	1608-1615
26569010_en	CHEM	proinflammatory cytokines	1627-1652
26569010_en	DISO	joint pain	1722-1732
26569010_en	DISO	chronic pain syndromes	1748-1770
26569010_en	FINDING	antinociceptive effect	4-26
26569010_en	FINDING	antinociceptive effect	252-274
26569010_en	CHEM	symptomatic slow-acting drugs	400-429
26569010_en	CHEM	symptomatic slow-acting drugs for osteoarthritis	400-448
26569010_en	CHEM	SYSADOA	450-457
26569010_en	ANATOMY	low back	506-514
26569010_en	FINDING	definite antinociceptive and anti-inflammatory effect	796-849
26569010_en	ANATOMY	back	949-953
26569010_en	CHEM	inflammatory cytokines	1165-1187
26569010_en	CHEM	C-reactive protein	1208-1226
26569010_en	CHEM	cytokine	1280-1288
26569010_en	ANATOMY	membrane	1311-1319
26569010_en	ANATOMY	synovial	1302-1310
26569010_en	CHEM	interleukin	1366-1377
26569010_en	CHEM	interleukin 1	1366-1379
26569010_en	CHEM	inflammatory enzymes	1411-1431
26569010_en	CHEM	nitric oxide	1437-1449
26569010_en	CHEM	cytokines	1643-1652
26569010_en	ANATOMY	joint	1722-1727
26569010_en	DISO	pain	169-173
26569010_en	DISO	pain	470-474
26569010_en	DISO	back pain	510-519
26569010_en	DISO	pain	515-519
26569010_en	DISO	pain	607-611
26569010_en	DISO	pain	954-958
26569010_en	DISO	pain	1728-1732
26569010_en	DISO	pain	1756-1760
26569010_en	DISO	inflammatory	830-842
26569010_en	PHYS	life	721-725
26569010_en	ANATOMY	back	510-514
26569010_en	CHEM	cyclooxygenase	1463-1477
26569010_en	CHEM	analgesics	221-231
26569010_en	CHEM	IL	1289-1291
26569010_en	DISO	chronic pain syndrome	462-483
26569010_en	DISO	inflammatory	1165-1177
26569010_en	DISO	inflammatory	1411-1423
26569010_en	PHYS	functional status	616-633
26569010_en	PHYS	level of inflammatory cytokines	1156-1187
26569010_en	FINDING	reduce the level of inflammatory cytokines	1145-1187
26569010_en	FINDING	efficacy of chondroprotectors	111-140
26569010_en	DISO	pain syndromes	169-183
26569010_en	DISO	back pain	949-958
26569010_en	DISO	pain syndromes	1756-1770
26569010_en	FINDING	effect of symptomatic slow-acting drugs for osteoarthriti	390-447
26569010_en	CHEM	synthase	1450-1458
26569010_en	FINDING	long-term retention of the result	1029-1062
26569010_en	CHEM	IL	1202-1204
26569010_en	CHEM	protein	1219-1226
26569010_en	FINDING	activate the production of anti-inflammatory cytokine	1235-1288
26569010_en	PHYS	inhibition	1397-1407
26569010_en	CHEM	oxide	1444-1449
26569010_en	CHEM	nitric	1437-1443
26569010_en	PHYS	inhibit	1619-1626
26569010_en	FINDING	blocking of the effects of interleukin 1-beta	1339-1384
26591552_en	CHEM	pioglitazone	27-39
26591552_en	DISO	asthma	86-92
26591552_en	DISO	coronary heart disease	109-131
26591552_en	CHEM	pioglitazone	184-196
26591552_en	DISO	asthma	243-249
26591552_en	DISO	coronary heart disease	266-288
26591552_en	DISO	asthma	355-361
26591552_en	DISO	CHD	378-381
26591552_en	PHYS	External respiratory function	398-427
26591552_en	LABPROC	electrocardiograms	435-453
26591552_en	PHYS	blood pressure	455-469
26591552_en	PHYS	BP	471-473
26591552_en	ANATOMY	Blood	543-548
26591552_en	ANATOMY	urine	553-558
26591552_en	CHEM	high-sensitivity C-reactive protein	581-616
26591552_en	ANATOMY	endothelial	657-668
26591552_en	ANATOMY	endothelium	703-714
26591552_en	PHYS	endothelium-independent vasodilation	729-765
26591552_en	PHYS	EIVD	776-780
26591552_en	CHEM	pioglitazone	893-905
26591552_en	CHEM	pioglitazone	995-1007
26591552_en	PHYS	ERF	1189-1192
26591552_en	ANATOMY	endothelial	1197-1208
26591552_en	PHYS	endothelial function	1197-1217
26591552_en	DISO	asthma	1282-1288
26591552_en	DISO	angina attacks	1318-1332
26591552_en	PHYS	hs-CRP levels	1366-1379
26591552_en	CHEM	pioglitazone	1408-1420
26591552_en	DISO	asthma	1474-1480
26591552_en	DISO	CHD	1497-1500
26591552_en	DISO	bronchial obstruction	1560-1581
26591552_en	DISO	angina pain	1603-1614
26591552_en	DISO	asthma attacks	1619-1633
26591552_en	CHEM	nitroglycerin	1640-1653
26591552_en	CHEM	salbutamol	1658-1668
26591552_en	FINDING	lowered systolic and diastolic blood pressure	1670-1715
26591552_en	PHYS	diastolic blood pressure	1691-1715
26591552_en	PHYS	EDVD	1726-1730
26591552_en	PHYS	blood flow	1776-1786
26591552_en	PHYS	reactive hyperemia	1804-1822
26591552_en	ANATOMY	brachial artery	1862-1877
26591552_en	ANATOMY	BA	1879-1881
26591552_en	CHEM	pioglitazone	2100-2112
26591552_en	DISO	asthma	2157-2163
26591552_en	DISO	CHD	2180-2183
26591552_en	ANATOMY	endothelial	2302-2313
26591552_en	DISO	heart disease	118-131
26591552_en	ANATOMY	heart	118-123
26591552_en	ANATOMY	coronary	109-117
26591552_en	DISO	heart disease	275-288
26591552_en	ANATOMY	heart	275-280
26591552_en	ANATOMY	coronary	266-274
26591552_en	DISO	CHD	290-293
26591552_en	PHYS	ERF	429-432
26591552_en	PHYS	External respiratory	398-418
26591552_en	ANATOMY	blood	455-460
26591552_en	CHEM	hs-CRP	618-624
26591552_en	CHEM	C-reactive protein	598-616
26591552_en	CHEM	CRP	621-624
26591552_en	PHYS	endothelial function	657-677
26591552_en	PHYS	vasodilation	753-765
26591552_en	ANATOMY	endothelium	729-740
26591552_en	PHYS	endothelium-dependent vasodilation	703-765
26591552_en	PHYS	EDVD	767-771
26591552_en	FINDING	stabilization of ERF and endothelial function	1172-1217
26591552_en	DISO	asthma symptoms	1282-1297
26591552_en	DISO	angina	1318-1324
26591552_en	CHEM	hs-CRP	1366-1372
26591552_en	CHEM	CRP	1369-1372
26591552_en	ANATOMY	bronchial	1560-1569
26591552_en	DISO	angina	1603-1609
26591552_en	DISO	asthma	1619-1625
26591552_en	PHYS	blood pressure	1701-1715
26591552_en	ANATOMY	blood	1701-1706
26591552_en	PHYS	systolic blood pressure	1678-1715
26591552_en	ANATOMY	blood	1776-1781
26591552_en	PHYS	hyperemia	1813-1822
26591552_en	PHYS	RH	1824-1826
26591552_en	PHYS	index of reactivity	1829-1848
26591552_en	PHYS	IR	1850-1852
26591552_en	ANATOMY	artery	1871-1877
26591552_en	PHYS	EIVD	1897-1901
26591552_en	PHYS	IR	1916-1918
26591552_en	ANATOMY	BA	1926-1928
26591552_en	PHYS	BA diameter	1926-1937
26591552_en	CHEM	hs-CRP	1979-1985
26591552_en	CHEM	CRP	1982-1985
26591552_en	PHYS	hs-CRP values	1979-1992
26591552_en	DISO	hypercholesterolemia	2007-2027
26591552_en	CHEM	cholesterol	2039-2050
26591552_en	PHYS	total cholesterol levels	2033-2057
26591552_en	DISO	systemic inflammation	1952-1973
26591552_en	FINDING	reduced systemic inflammation	1944-1973
26591552_en	DISO	systemic inflammation	2266-2287
26591552_en	PHYS	endothelial functional activity	2302-2333
26591552_en	FINDING	reduces systemic inflammation	2258-2287
26591552_en	FINDING	improves endothelial functional activity	2293-2333
26591552_en	FINDING	improved EDVD	1717-1730
26591552_en	LABPROC	test for reactive hyperemia	1795-1822
26591552_en	DISO	inflammation	1961-1973
26591552_en	FINDING	decline in hs-CRP levels	1355-1379
26591552_en	FINDING	increases in IR and A% BA diameter	1903-1937
26591552_en	FINDING	duration of angina attacks	1306-1332
26591552_en	PHYS	linear velocity of blood flow	1757-1786
26591552_en	CHEM	protein	609-616
26591552_en	CHEM	total cholesterol	2033-2050
26591552_en	DISO	attacks	1626-1633
26591552_en	DISO	attacks	1325-1332
26591552_en	DISO	pain	1610-1614
26591552_en	FINDING	Clinical effectiveness of pioglitazone	1-39
26591552_en	FINDING	clinical effectiveness of pioglitazone	158-196
26591552_en	PHYS	anthropometric measurements	480-507
26591552_en	FINDING	increases	1252-1261
26591552_en	FINDING	improved clinical disease control	1501-1534
26591552_en	FINDING	decreased	1536-1545
26591552_en	FINDING	frequency	1590-1599
26591552_en	FINDING	increases in the maximum linear velocity of blood flow	1732-1786
26591552_en	FINDING	improves the clinical course of the diseases	2184-2228
26591552_en	FINDING	increases their control	2233-2256
26591552_en	PHYS	respiratory	407-418
26591552_en	FINDING	not statistically significantly differ in basic clinical and anamnestic data	1052-1128
26591552_en	LABPROC	measuring endothelium-dependent and endothelium-independent vasodilation	693-765
26591552_en	LABPROC	Blood and urine laboratory values	543-576
26591552_en	FINDING	frequency of asthma symptoms	1269-1297
26591552_en	ANATOMY	brachial	1862-1870
26591552_en	DISO	inflammation	2275-2287
26600613_en	DISO	podoconiosis	31-43
26600613_en	DISO	Podoconiosis	46-58
26600613_en	DISO	inflammatory disease	65-85
26600613_en	DISO	swelling of the lower limb	169-195
26600613_en	DISO	lymphoedema	197-208
26600613_en	DISO	acute pain	214-224
26600613_en	DISO	podoconiosis	378-390
26600613_en	DISO	podoconiosis	543-555
26600613_en	DEVICE	compression	811-822
26600613_en	DISO	podoconiosis	956-968
26600613_en	CHEM	irritant minerals in soil	119-144
26600613_en	ANATOMY	lower limb	185-195
26600613_en	ANATOMY	limb	191-195
26600613_en	DEVICE	footwear	611-619
26600613_en	ANATOMY	foot	629-633
26600613_en	DISO	lymphoedema	732-743
26600613_en	ANATOMY	legs	852-856
26600613_en	DEVICE	shoes	1127-1132
26600613_en	DISO	pain	220-224
26600613_en	FINDING	reduce podoconiosis incidence	536-565
26600613_en	ANATOMY	foot	774-778
26600613_en	ANATOMY	foot	788-792
26600613_en	INJURY_POISONING	wound	799-804
26600613_en	CHEM	minerals	128-136
26600613_en	DISO	acute infections	874-890
26600613_en	DISO	infections	880-890
26600613_en	DISO	tropical diseases	1022-1039
26600613_en	DISO	swelling	169-177
26753198_en	PHYS	gas exchange	128-140
26753198_en	ANATOMY	lungs	351-356
26753198_en	ANATOMY	trachea	358-365
26753198_en	ANATOMY	bronchi	367-374
26753198_en	ANATOMY	mediastinal structures	379-401
26753198_en	PHYS	gas exchange	645-657
26753198_en	DISO	cardiorespiratory pathology	1234-1261
26753198_en	PHYS	gas exchange	1314-1326
26753198_en	ANATOMY	trachea	1368-1375
26753198_en	ANATOMY	main bronchi	1380-1392
26753198_en	DEVICE	"shunt-breath" system	1443-1464
26753198_en	PHYS	respiratory	8-19
26753198_en	ANATOMY	thoracic	36-44
26753198_en	ANATOMY	thoracic	198-206
26753198_en	ANATOMY	mediastinal	379-390
26753198_en	ANATOMY	thoracic	499-507
26753198_en	FINDING	safety and efficacy of anesthetic management	451-495
26753198_en	PHYS	respiratory	557-568
26753198_en	FINDING	maximize the efficiency of gas exchange	618-657
26753198_en	PHYS	respiratory	867-878
26753198_en	ANATOMY	thoracic	896-904
26753198_en	ANATOMY	lung	933-937
26753198_en	ANATOMY	airways	983-990
26753198_en	PHYS	respiratory	1082-1093
26753198_en	ANATOMY	lung	1166-1170
26753198_en	PHYS	cardiorespiratory	1234-1251
26753198_en	ANATOMY	bronchi	1385-1392
26753198_en	PHYS	respiratory	1523-1534
26753198_en	CHEM	gas	128-131
26753198_en	CHEM	gas	645-648
26753198_en	FINDING	Effectiveness of special respiratory technologies for thoracic surgery	842-912
26753198_en	CHEM	gas	1314-1317
26753198_en	PHYS	breath	1450-1456
26753198_en	DEVICE	shunt	1444-1449
26821417_en	DISO	acute respiratory viral infections	37-71
26821417_en	DISO	acute respiratory viral infections	248-282
26821417_en	DISO	uncomplicated mild and moderate ARVI	364-400
26821417_en	CHEM	Influnet	482-490
26821417_en	CHEM	Rinza	516-521
26821417_en	CHEM	Influnet	683-691
26821417_en	DISO	fever	738-743
26821417_en	DISO	ARVI	754-758
26821417_en	CHEM	Rinza	838-843
26821417_en	DISO	ARVI	1022-1026
26821417_en	DISO	ARVI	1188-1192
26821417_en	DISO	ARVI	1330-1334
26821417_en	DISO	respiratory viral infections	43-71
26821417_en	DISO	ARVI	284-288
26821417_en	DISO	respiratory viral infections	254-282
26821417_en	FINDING	rapider alleviation of fever and other ARVI symptoms	715-767
26821417_en	DISO	ARVI symptoms	754-767
26821417_en	FINDING	shorter temporary disability	976-1004
26821417_en	CHEM	Influnet	1028-1036
26821417_en	CHEM	Influnet	1167-1175
26821417_en	CHEM	monocomponent drugs	865-884
26821417_en	CHEM	Influnet	219-227
26821417_en	CHEM	Combination drugs	1-18
26821417_en	CHEM	Combination drugs	1226-1243
26821417_en	CHEM	monocomponent drugs	1296-1315
26821417_en	DISO	infections	272-282
26821417_en	DISO	viral infections	266-282
26821417_en	CHEM	combination drug	202-218
26821417_en	FINDING	fewer adverse reactions	1250-1273
26821417_en	PHYS	respiratory	43-54
26821417_en	DISO	infections	61-71
26821417_en	PHYS	respiratory	254-265
26821417_en	FINDING	clinical effectiveness of the drugs	622-657
26821417_en	DISO	temporary disability	984-1004
26821417_en	DISO	disability	994-1004
26821417_en	FINDING	more economically sound	1049-1072
26821417_en	FINDING	more cost- effective	1343-1363
26821417_en	DISO	mild and moderate ARVI	378-400
26821417_en	DISO	ARVI	396-400
26821417_en	FINDING	higher clinical and economic feasibility of Influnet therapy	1123-1183
26821419_en	DISO	pulmonary arterial hypertension	13-44
26821419_en	DISO	connective tissue diseases	62-88
26821419_en	CHEM	sildenafil	101-111
26821419_en	DISO	PAH	436-439
26821419_en	DISO	CTD	456-459
26821419_en	DISO	PAH	569-572
26821419_en	ANATOMY	right heart	702-713
26821419_en	ANATOMY	pulmonary artery	718-734
26821419_en	CHEM	sildenafil	771-781
26821419_en	CHEM	phosphodiesterase type 5 inhibitor	785-819
26821419_en	PHYS	vasodilator	830-841
26821419_en	DISO	PAH	895-898
26821419_en	PHYS	hemodynamic parameters	1237-1259
26821419_en	PHYS	atrial pressure	1267-1282
26821419_en	PHYS	vascular resistance	1298-1317
26821419_en	CHEM	sildenafil	1394-1404
26821419_en	DISO	PAH	1454-1457
26821419_en	DISO	CTD	1474-1477
26821419_en	DISO	CTD	1685-1688
26821419_en	PHYS	Survival	1-9
26821419_en	DISO	hypertension	32-44
26821419_en	ANATOMY	pulmonary	13-22
26821419_en	ANATOMY	arterial	23-31
26821419_en	ANATOMY	pulmonary arterial	13-31
26821419_en	ANATOMY	tissue	73-79
26821419_en	ANATOMY	connective tissue	62-79
26821419_en	CHEM	sildenafil	182-192
26821419_en	PHYS	survival	200-208
26821419_en	DISO	pulmonary arterial hypertension	226-257
26821419_en	DISO	hypertension	245-257
26821419_en	DISO	PAH	259-262
26821419_en	DISO	connective tissue diseases	280-306
26821419_en	DISO	CTD	308-311
26821419_en	ANATOMY	pulmonary	226-235
26821419_en	ANATOMY	arterial	236-244
26821419_en	ANATOMY	pulmonary arterial	226-244
26821419_en	ANATOMY	tissue	291-297
26821419_en	ANATOMY	connective tissue	280-297
26821419_en	CHEM	phosphodiesterase	785-802
26821419_en	CHEM	potent vasodilator	823-841
26821419_en	FINDING	Survival rates	933-947
26821419_en	PHYS	survival	1050-1058
26821419_en	FINDING	Three-year survival rates	1039-1064
26821419_en	PHYS	right atrial pressure	1261-1282
26821419_en	PHYS	survival	1428-1436
26821419_en	ANATOMY	pulmonary	718-727
26821419_en	ANATOMY	artery	728-734
26821419_en	ANATOMY	heart	708-713
26821419_en	ANATOMY	atrial	1267-1273
26821419_en	PHYS	Survival	933-941
26821419_en	FINDING	survival rates	1050-1064
26821419_en	ANATOMY	vascular	1298-1306
26821419_en	DISO	arterial hypertension	236-257
26821419_en	DISO	arterial hypertension	23-44
26821419_en	FINDING	time to clinical deterioration	1152-1182
26821419_en	FINDING	improves survival	1419-1436
26821419_en	FINDING	duration of the follow-up	1207-1232
26821419_en	FINDING	clinical deterioration	1160-1182
26824818_en	CHEM	remaxol	44-51
26824818_en	CHEM	remaxol	204-211
26824818_en	PHYS	liver function	215-229
26824818_en	DISO	cirrhosis	233-242
26824818_en	DISO	chronic viral hepatitides	261-286
26824818_en	DISO	HCV	294-297
26824818_en	DISO	HBV	299-302
26824818_en	DISO	HCV+HBV,	304-312
26824818_en	DISO	HBV+HDV	317-324
26824818_en	DISO	liver cirrhosis	421-436
26824818_en	DISO	LC	438-440
26824818_en	DISO	CVH	460-463
26824818_en	DISO	HCV	465-468
26824818_en	DISO	HBV	470-473
26824818_en	DISO	HCV+HBV	475-482
26824818_en	DISO	cirrhotic	549-558
26824818_en	DISO	CVH B	586-591
26824818_en	DISO	CVH C	586-596
26824818_en	CHEM	remaxol	618-625
26824818_en	CHEM	ademetionine	765-777
26824818_en	CHEM	crystalloids	835-847
26824818_en	CHEM	isotonic sodium chloride solution	859-892
26824818_en	CHEM	Ringer's solution	894-911
26824818_en	DISO	cytolytic	1041-1050
26824818_en	DISO	cholestatic	1055-1066
26824818_en	FINDING	hepatotropic effect	1094-1113
26824818_en	CHEM	alanine aminotransferase	1198-1222
26824818_en	CHEM	aspartate aminotransferase	1224-1250
26824818_en	CHEM	total bilirubin	1256-1271
26824818_en	CHEM	remaxol	1483-1490
26824818_en	DISO	viral LC	1541-1549
26824818_en	PHYS	liver function	1568-1582
26824818_en	DISO	cytolysis	1606-1615
26824818_en	DISO	cholestasis	1617-1628
26824818_en	ANATOMY	peripheral blood cells	1674-1696
26824818_en	ANATOMY	lymphocytes	1710-1721
26824818_en	ANATOMY	platelets	1723-1732
26824818_en	DISO	hepatitides	114-125
26824818_en	DISO	viral hepatitides	108-125
26824818_en	DISO	chronic viral hepatitides	100-125
26824818_en	CHEM	hepatotropic drug	26-43
26824818_en	CHEM	hepatoprotector	188-203
26824818_en	ANATOMY	liver	215-220
26824818_en	DISO	viral hepatitides	269-286
26824818_en	DISO	hepatitides	275-286
26824818_en	DISO	CVH	288-291
26824818_en	ANATOMY	liver	421-426
26824818_en	DISO	cirrhosis	427-436
26824818_en	CHEM	alanine	1198-1205
26824818_en	CHEM	aspartate	1224-1233
26824818_en	DISO	LC	1547-1549
26824818_en	ANATOMY	liver	1568-1573
26824818_en	ANATOMY	blood cells	1685-1696
26824818_en	ANATOMY	blood	1685-1690
26824818_en	ANATOMY	cells	1691-1696
26824818_en	ANATOMY	leukocytes	1698-1708
26824818_en	FINDING	improves liver function	1559-1582
26824818_en	DISO	HBV+HDV	488-495
26824818_en	FINDING	cytoprotective effect	1649-1670
26824818_en	CHEM	sodium chloride	868-883
26824818_en	CHEM	chloride	875-883
26824818_en	CHEM	sodium	868-874
26824818_en	DISO	CVH	586-589
26824818_en	DISO	cirrhotic	84-93
26824818_en	CHEM	infusion hepatoprotector	179-203
26824818_en	DISO	cirrhotic stage chronic viral hepatitides	84-125
26824818_en	FINDING	Efficacy of the infusion hepatotropic drug remaxol	1-51
26824818_en	FINDING	relative values of a decrease in the levels of these biochemical parameters	1306-1381
26824818_en	FINDING	reduces the degree of cytolysis, cholestasis	1584-1628
26824818_en	CHEM	solution	903-911
26824818_en	CHEM	solution	884-892
26824818_en	PHYS	average concentrations of alanine aminotransferase	1172-1222
26824818_en	PHYS	average concentrations	1172-1194
26824818_en	CHEM	bilirubin	1262-1271
26824818_en	FINDING	rate of a decline in the average concentrations of alanine aminotransferase, aspartate aminotransferase, and total bilirubin	1147-1271
26824818_en	CHEM	aminotransferase	1206-1222
26824818_en	CHEM	aminotransferase	1234-1250
26824818_en	PHYS	biochemical parameters	1359-1381
26824818_en	FINDING	more significantly reduced cytolytic and cholestatic parameters	1014-1077
26824818_en	ANATOMY	peripheral blood	1674-1690
26845866_en	ANATOMY	eyes	324-328
26845866_en	ANATOMY	eyes	357-361
26845866_en	DISO	AMD	372-375
26845866_en	ANATOMY	eyes	395-399
26845866_en	DISO	neovascularization	418-436
26845866_en	LABPROC	spectral-domain OCT	461-480
26845866_en	LABPROC	OCT angiography	482-497
26845866_en	LABPROC	fluorescein angiography	503-526
26845866_en	LABPROC	OCT	533-536
26845866_en	LABPROC	angiography	537-548
26845866_en	DISO	neovascular	570-581
26845866_en	ANATOMY	eyes	749-753
26845866_en	ANATOMY	eyes	774-778
26845866_en	LABPROC	FA	801-803
26845866_en	LABPROC	OCT	878-881
26845866_en	LABPROC	angiography	882-893
26845866_en	CHEM	ranibizumab	935-946
26845866_en	ANATOMY	eyes	970-974
26845866_en	ANATOMY	eyes	1167-1171
26845866_en	DISO	CNV	1184-1187
26845866_en	ANATOMY	eyes	1204-1208
26845866_en	DISO	CNV	1222-1225
26845866_en	ANATOMY	Neovascular loops	1227-1244
26845866_en	ANATOMY	retinal pigment epithelium	1260-1286
26845866_en	DISO	CNV	1318-1321
26845866_en	DISO	CNV	1355-1358
26845866_en	ANATOMY	neovasculature	1364-1378
26845866_en	ANATOMY	eyes	1412-1416
26845866_en	LABPROC	OCT	1518-1521
26845866_en	LABPROC	angiography	1522-1533
26845866_en	CHEM	ranibizumab	1574-1585
26845866_en	ANATOMY	blood vessels	1729-1742
26845866_en	LABPROC	OCT	1775-1778
26845866_en	LABPROC	angiography	1779-1790
26845866_en	LABPROC	OCT	1853-1856
26845866_en	LABPROC	angiography	1857-1868
26845866_en	DISO	choroidal neovascularization	1914-1942
26845866_en	DISO	AMD	1960-1963
26845866_en	ANATOMY	neovascular complex	2013-2032
26845866_en	LABPROC	optical coherence tomography (OCT) angiography	18-64
26845866_en	LABPROC	tomography	36-46
26845866_en	LABPROC	OCT	48-51
26845866_en	LABPROC	angiography	53-64
26845866_en	DISO	choroidal neovascularization	93-121
26845866_en	ANATOMY	choroidal	93-102
26845866_en	DISO	CNV	123-126
26845866_en	DISO	neovascularization	103-121
26845866_en	DISO	occult choroidal neovascularization	86-121
26845866_en	DISO	age-related macular degeneration	145-177
26845866_en	DISO	macular degeneration	157-177
26845866_en	DISO	AMD	179-182
26845866_en	CHEM	VEGF	254-258
26845866_en	DISO	wet AMD	368-375
26845866_en	FINDING	no signs of neovascularization	406-436
26845866_en	LABPROC	OCT	477-480
26845866_en	LABPROC	OCT	482-485
26845866_en	LABPROC	angiography	515-526
26845866_en	LABPROC	FA	528-530
26845866_en	LABPROC	OCT angiography	533-548
26845866_en	ANATOMY	neovascular networks	570-590
26845866_en	DISO	CNV	745-748
26845866_en	LABPROC	OCT angiography	878-893
26845866_en	FINDING	information value of OCT angiography	857-893
26845866_en	DISO	occult CNV	1177-1187
26845866_en	DISO	classic CNV	1214-1225
26845866_en	DISO	Neovascular	1227-1238
26845866_en	ANATOMY	epithelium	1276-1286
26845866_en	ANATOMY	retinal	1260-1267
26845866_en	DISO	occult CNV	1311-1321
26845866_en	DISO	classic CNV	1347-1358
26845866_en	ANATOMY	tree-like networks	1432-1450
26845866_en	ANATOMY	loop-like	1418-1427
26845866_en	LABPROC	OCT angiography	1518-1533
26845866_en	DISO	neovascularization	1638-1656
26845866_en	PHYS	size of neovascularization	1630-1656
26845866_en	ANATOMY	blood	1729-1734
26845866_en	ANATOMY	vessels	1735-1742
26845866_en	ANATOMY	newly formed blood vessels	1716-1742
26845866_en	LABPROC	OCT angiography	1775-1790
26845866_en	LABPROC	OCT angiography	1853-1868
26845866_en	DISO	occult choroidal neovascularization	1907-1942
26845866_en	DISO	neovascularization	1924-1942
26845866_en	DISO	classic choroidal neovascularization	1895-1942
26845866_en	DISO	classic choroidal neovascularization	74-121
26845866_en	DISO	neovascular	2013-2024
26845866_en	CHEM	VEGF	2045-2049
26845866_en	LABPROC	angiography	486-497
26845866_en	ANATOMY	macular	157-164
26845866_en	ANATOMY	choroidal	1914-1923
26845866_en	PHYS	age	145-148
26845866_en	LABPROC	optical coherence tomography	18-46
26845866_en	FINDING	information value	203-220
26845866_en	PHYS	location	609-617
26845866_en	PHYS	shape	619-624
26845866_en	PHYS	size	626-630
26845866_en	PHYS	extent of visualization	636-659
26845866_en	FINDING	Sensitivity	661-672
26845866_en	FINDING	specificity of the method	677-702
26845866_en	FINDING	effect of intravitreal ranibizumab therapy	912-954
26845866_en	CHEM	pigment	1268-1275
26845866_en	ANATOMY	pigment epithelium	1268-1286
26845866_en	PHYS	density	1671-1678
26845866_en	PHYS	thickness	1680-1689
26845866_en	PHYS	branching pattern	1695-1712
26845866_en	FINDING	Sensitivity	1744-1755
26845866_en	FINDING	specificity	1760-1771
26845866_en	FINDING	diagnosis of both classic and occult choroidal neovascularization	1877-1942
26845866_en	FINDING	dynamic assessment of the size of the neovascular complex	1975-2032
26845866_en	PHYS	size of the neovascular complex	2001-2032
26845866_en	FINDING	high sensitivity	2076-2092
26845866_en	FINDING	specificity	2097-2108
26953424_en	ANATOMY	maxillary sinuses	115-132
26953424_en	DISO	Odontogenic maxillary sinusitis	175-206
26953424_en	ANATOMY	maxillofacial area	258-276
26953424_en	DISO	odontogenic lesions	394-413
26953424_en	DISO	odontogenic sinusitis	502-523
26953424_en	DISO	maxillary sinusitis	752-771
26953424_en	LABPROC	X-ray examinations	789-807
26953424_en	LABPROC	MSCT	868-872
26953424_en	ANATOMY	maxillary sinuses	1168-1185
26953424_en	ANATOMY	roots	1218-1223
26953424_en	ANATOMY	root fragments	1227-1241
26953424_en	DEVICE	implants	1243-1251
26953424_en	DEVICE	endodontic instruments	1281-1303
26953424_en	DISO	odontogenic cysts	1333-1350
26953424_en	DISO	mycotic infection	1406-1423
26953424_en	LABPROC	dental volumetric tomography	1586-1614
26953424_en	LABPROC	multislice CT	1618-1631
26953424_en	DISO	sinusitis	1747-1756
26953424_en	DISO	relapses	1782-1790
26953424_en	ANATOMY	maxillary sinuses	1833-1850
26953424_en	ANATOMY	odontogenic	61-72
26953424_en	DISO	sinusitis	73-82
26953424_en	DISO	odontogenic sinusitis	61-82
26953424_en	ANATOMY	sinuses	125-132
26953424_en	DISO	Inflammatory diseases	86-107
26953424_en	ANATOMY	Odontogenic	175-186
26953424_en	DISO	maxillary sinusitis	187-206
26953424_en	DISO	sinusitis	197-206
26953424_en	DISO	lesions	406-413
26953424_en	ANATOMY	odontogenic	394-405
26953424_en	DISO	sinusitis	514-523
26953424_en	ANATOMY	odontogenic	502-513
26953424_en	ANATOMY	oral	636-640
26953424_en	DISO	sinusitis	762-771
26953424_en	ANATOMY	sinuses	1178-1185
26953424_en	DISO	foreign bodies in the maxillary sinuses	1146-1185
26953424_en	DEVICE	rubber drains	1253-1266
26953424_en	DISO	cysts	1345-1350
26953424_en	ANATOMY	odontogenic	1333-1344
26953424_en	ANATOMY	sinuses	1843-1850
26953424_en	DISO	mycotic	1406-1413
26953424_en	LABPROC	CT	1629-1631
26953424_en	ANATOMY	Maxillofacial	575-588
26953424_en	FINDING	reduce the incidence	1758-1778
26953424_en	DISO	chronic inflammatory processes	1795-1825
26953424_en	ANATOMY	maxillofacial	1515-1528
26953424_en	ANATOMY	maxillary	115-124
26953424_en	ANATOMY	maxillary	187-196
26953424_en	ANATOMY	maxillary	752-761
26953424_en	ANATOMY	maxillary	1168-1177
26953424_en	ANATOMY	maxillary	1833-1842
26953424_en	LABPROC	tomography	1604-1614
26953424_en	DISO	inflammatory processes	232-254
26953424_en	LABPROC	volumetric tomography	1593-1614
26953424_en	LABPROC	radiological	21-33
26953424_en	PHYS	adult	157-162
26953424_en	FINDING	clinical and radiological characteristics of odontogenic sinusitis	457-523
26953424_en	LABPROC	radiological	470-482
26953424_en	CHEM	rubber	1253-1259
26953424_en	ANATOMY	endodontic	1281-1291
26953424_en	DEVICE	drains	1260-1266
26953424_en	DISO	infection	1414-1423
26953424_en	FINDING	ensure the correct clinical and radiological approaches	1636-1691
26953424_en	LABPROC	radiological	1668-1680
26953424_en	DISO	nflammatory processes	1804-1825
26977615_en	INJURY_POISONING	post-traumatic pancreatic necrosis	29-63
26977615_en	INJURY_POISONING	blunt abdominal trauma	81-103
26977615_en	DISO	necrotic complications	138-176
26977615_en	DISO	suppurative complications	151-176
26977615_en	INJURY_POISONING	acute post-traumatic pancreatitis	191-224
26977615_en	INJURY_POISONING	trauma of the pancreas	234-256
26977615_en	ANATOMY	pancreas	248-256
26977615_en	DISO	post-traumatic pancreatitis	261-288
26977615_en	DISO	depressurization of ductal system	297-330
26977615_en	ANATOMY	ductal system	317-330
26977615_en	ANATOMY	retroperitoneal fat	383-402
26977615_en	CHEM	roncoleukin	567-578
26977615_en	CHEM	octreotide	584-594
26977615_en	DISO	pancreatitis	633-645
26977615_en	DISO	severe destructive pancreatitis	921-952
26977615_en	INJURY_POISONING	pancreatic trauma	1073-1090
26977615_en	DISO	severe post-traumatic pancreatitis	1274-1308
26977615_en	DISO	suppurative complications	1310-1335
26977615_en	INJURY_POISONING	pancreatic trauma	1381-1398
26977615_en	ANATOMY	pancreatic	44-54
26977615_en	DISO	necrosis	55-63
26977615_en	DISO	pancreatic necrosis	44-63
26977615_en	INJURY_POISONING	abdominal trauma	87-103
26977615_en	ANATOMY	abdominal	87-96
26977615_en	DISO	pancreatitis	212-224
26977615_en	DISO	pancreatitis	276-288
26977615_en	INJURY_POISONING	pancreatic injury	795-812
26977615_en	ANATOMY	pancreatic	795-805
26977615_en	FINDING	overall mortality	813-830
26977615_en	DISO	pancreatitis	940-952
26977615_en	DISO	postnecrotic suppurative complications	954-992
26977615_en	ANATOMY	pancreatic	1073-1083
26977615_en	PHYS	hemostasis	1173-1183
26977615_en	DISO	pancreatitis	1296-1308
26977615_en	INJURY_POISONING	blunt pancreatic trauma	1067-1090
26977615_en	INJURY_POISONING	blunt pancreatic trauma	1375-1398
26977615_en	ANATOMY	pancreatic	1381-1391
26977615_en	FINDING	High incidence	120-134
26977615_en	FINDING	reduces the risk	1254-1270
26977615_en	FINDING	improves outcomes	1340-1357
26977615_en	DISO	necrotic	138-146
26977615_en	FINDING	adverse outcomes	900-916
26977615_en	INJURY_POISONING	post-traumatic pancreatitis	197-224
26977615_en	INJURY_POISONING	trauma	97-103
26977615_en	DISO	complications	163-176
26977615_en	DISO	suppurative	151-162
26977615_en	FINDING	efficacy of treatment	669-690
26977615_en	FINDING	mortality	821-830
26977615_en	INJURY_POISONING	injury	806-812
26977615_en	DISO	complications	979-992
26977615_en	DISO	suppurative	967-978
26977615_en	FINDING	outcomes	908-916
26977615_en	DISO	destructive pancreatitis	928-952
26977615_en	INJURY_POISONING	trauma	1084-1090
26977615_en	DISO	post-traumatic pancreatitis	1281-1308
26977615_en	DISO	suppurative	1310-1321
26977615_en	DISO	complications	1322-1335
26977615_en	INJURY_POISONING	trauma	1392-1398
26977625_en	CHEM	venlafaxine	376-387
26977625_en	CHEM	cerebrolysin	476-488
26977625_en	CHEM	NaCl	558-562
26977625_en	CHEM	venlafaxine	811-822
26977625_en	CHEM	cerebrolysin	827-839
26977625_en	ANATOMY	brain	907-912
26977625_en	LABPROC	EEG	1033-1036
26977625_en	PHYS	functional state	43-59
26977625_en	ANATOMY	brain	37-42
26977625_en	CHEM	venlafaxine	98-109
26977625_en	CHEM	cerebrolysin	115-127
26977625_en	LABPROC	EEG	224-227
26977625_en	LABPROC	quantitative EEG	211-227
26977625_en	CHEM	isotonic NaCl solution	549-571
26977625_en	PHYS	functional state	913-929
26977625_en	FINDING	improvement of their brain functional state	886-929
26977625_en	DISO	depressive	185-195
26977625_en	FINDING	increase of spectral power	942-968
26977625_en	FINDING	normalization of frequency alpha band	973-1010
26977625_en	PHYS	spectral power	954-968
26977625_en	PHYS	elderly	177-184
26977625_en	PHYS	frequency alpha band	990-1010
26977625_en	ANATOMY	parietal	1014-1022
26977625_en	ANATOMY	occipital	1023-1032
26977625_en	ANATOMY	parietal-occipital	1014-1032
26977625_en	PHYS	alpha band	1000-1010
26977625_en	CHEM	solution	563-571
26977625_en	FINDING	significant improvement of clinical conditions	601-647
26977723_en	ANATOMY	corneal	15-22
26977723_en	ANATOMY	cornea	174-180
26977723_en	DISO	bullous keratopathy	198-217
26977723_en	DEVICE	Ocular response analyzer	271-295
26977723_en	ANATOMY	eyes	352-356
26977723_en	DISO	bullous keratopathy	363-382
26977723_en	PHYS	Corneal hysteresis	752-770
26977723_en	DISO	bullous keratopathy	864-883
26977723_en	ANATOMY	eyes	884-888
26977723_en	ANATOMY	eyes	1194-1198
26977723_en	DISO	bullous keratopathy	1204-1223
26977723_en	PHYS	corneal-compensated intraocular pressure	1234-1274
26977723_en	PHYS	IOPcc	1276-1281
26977723_en	PHYS	IOP	1317-1320
26977723_en	PHYS	IOPcc	1394-1399
26977723_en	PHYS	IOPg	1404-1408
26977723_en	ANATOMY	eyes	1572-1576
26977723_en	PHYS	IOP	1585-1588
26977723_en	DISO	Chronic edema	1647-1660
26977723_en	ANATOMY	cornea	1668-1674
26977723_en	PHYS	CH	1752-1754
26977723_en	PHYS	CRF	1759-1762
26977723_en	ANATOMY	eye	1800-1803
26977723_en	ANATOMY	eye	1847-1850
26977723_en	ANATOMY	cornea	2057-2063
26977723_en	DISO	chronically swollen	2067-2086
26977723_en	ANATOMY	corneal	2105-2112
26977723_en	ANATOMY	corneal	2192-2199
26977723_en	ANATOMY	eyes	2212-2216
26977723_en	DISO	bullous keratopathy	2222-2241
26977723_en	PHYS	IOP	2308-2311
26977723_en	DISO	glaucoma	2362-2370
26977723_en	PHYS	biomechanics	23-35
26977723_en	DISO	bullous keratopathy	94-113
26977723_en	DISO	keratopathy	102-113
26977723_en	DISO	keratopathy	206-217
26977723_en	DEVICE	ORA	297-300
26977723_en	DISO	keratopathy	371-382
26977723_en	ANATOMY	endothelial	565-576
26977723_en	DEVICE	microkeratome	615-628
26977723_en	ANATOMY	Corneal	752-759
26977723_en	PHYS	CH	772-774
26977723_en	PHYS	corneal resistance factor	780-805
26977723_en	ANATOMY	corneal	780-787
26977723_en	PHYS	CRF	807-810
26977723_en	DISO	keratopathy	872-883
26977723_en	DISO	keratopathy	1212-1223
26977723_en	ANATOMY	corneal	1234-1241
26977723_en	PHYS	intraocular pressure	1254-1274
26977723_en	PHYS	Goldman-related IOP	1301-1320
26977723_en	PHYS	IOPg	1322-1326
26977723_en	ANATOMY	fellow healthy eyes	1557-1576
26977723_en	ANATOMY	fellow healthy eye	1832-1850
26977723_en	PHYS	corneal thickness	2105-2122
26977723_en	PHYS	corneal rigidity	2192-2208
26977723_en	DISO	keratopathy	2230-2241
26977723_en	FINDING	lower than normal	1056-1073
26977723_en	FINDING	lower than normal	1957-1974
26977723_en	PHYS	biomechanical properties	142-166
26977723_en	FINDING	difference between IOPcc and IOPg	1375-1408
26977723_en	DISO	edema	1655-1660
26977723_en	PHYS	viscoelastic properties	1704-1727
26977723_en	FINDING	CH and CRF values decrease significantly	1752-1792
26977723_en	DISO	swollen	2079-2086
26977723_en	PHYS	biomechanical indices	2142-2163
26977723_en	FINDING	correlate with its biomechanical indices	2123-2163
26977723_en	FINDING	Postoperative reduction in corneal rigidity	2165-2208
26977723_en	FINDING	significantly decreased in non-operated bullous keratopathy eyes	824-888
26977723_en	PHYS	healthy	904-911
26977723_en	FINDING	partially recovered and stabilized	991-1025
26977723_en	FINDING	exceeded the mean Goldman-related IOP	1283-1320
26977723_en	PHYS	healthy	1564-1571
26977723_en	FINDING	not statistically different.	1607-1635
26977723_en	FINDING	alteration of its viscoelastic properties	1686-1727
26977723_en	PHYS	healthy	1839-1846
26977723_en	FINDING	partially recover	1927-1944
26977723_en	FINDING	lead to underestimation of the true level of IOP	2263-2311
26977723_en	FINDING	delays in diagnosis of concomitant glaucoma	2327-2370
26977764_en	DISO	bronchial cancer	72-88
26977764_en	DISO	bronchial cancer	191-207
26977764_en	DISO	Squamous cell carcinoma	406-429
26977764_en	DISO	adenocarcinoma	431-445
26977764_en	DISO	dimorphic cancer	447-463
26977764_en	DISO	small cell cancer	496-513
26977764_en	DISO	clear cell renal cancer	518-541
26977764_en	ANATOMY	bronchopulmonary segment	965-989
26977764_en	ANATOMY	right upper lobe	993-1009
26977764_en	ANATOMY	m.latiss.dorsi	1075-1089
26977764_en	ANATOMY	m.intercostalis	1091-1106
26977764_en	ANATOMY	m.serr.anterior flaps	1111-1132
26977764_en	PHYS	head adduction	1304-1318
26977764_en	DISO	broncho-pleural fistula	1327-1350
26977764_en	DISO	tumors	1414-1420
26977764_en	DISO	tumors	1470-1476
26977764_en	ANATOMY	carina	1556-1562
26977764_en	DISO	N0-tumors	1695-1704
26977764_en	ANATOMY	tracheal	29-37
26977764_en	ANATOMY	tracheal bifurcation	29-49
26977764_en	DISO	cancer	82-88
26977764_en	ANATOMY	bronchial	72-81
26977764_en	ANATOMY	carina	152-158
26977764_en	DISO	cancer	201-207
26977764_en	ANATOMY	bronchial	191-200
26977764_en	DISO	bronchial malignant tumors	263-289
26977764_en	DISO	malignant tumors	273-289
26977764_en	DISO	tumors	283-289
26977764_en	ANATOMY	bronchial	263-272
26977764_en	DISO	carcinoma	420-429
26977764_en	ANATOMY	cell	415-419
26977764_en	ANATOMY	Squamous cell	406-419
26977764_en	DISO	cancer	457-463
26977764_en	DISO	carcinoid	465-474
26977764_en	DISO	adenocystic cancer	476-494
26977764_en	DISO	cancer	488-494
26977764_en	DISO	cancer	507-513
26977764_en	DISO	cancer	535-541
26977764_en	DISO	renal cancer	529-541
26977764_en	ANATOMY	renal	529-534
26977764_en	ANATOMY	clear cell	518-528
26977764_en	ANATOMY	Tracheal	722-730
26977764_en	ANATOMY	carina	731-737
26977764_en	ANATOMY	Tracheal carina	722-737
26977764_en	ANATOMY	carina	928-934
26977764_en	ANATOMY	bronchopulmonary	965-981
26977764_en	ANATOMY	upper lobe	999-1009
26977764_en	DISO	Postoperative complications	1171-1198
26977764_en	ANATOMY	head	1304-1308
26977764_en	DISO	fistula	1343-1350
26977764_en	ANATOMY	broncho	1327-1334
26977764_en	ANATOMY	pleural	1335-1342
26977764_en	ANATOMY	broncho-pleural	1327-1342
26977764_en	DISO	T3-T4N0 tumors	1406-1420
26977764_en	DISO	T3-4N1-2 tumors	1461-1476
26977764_en	FINDING	survival	1485-1493
26977764_en	DISO	tumors	1698-1704
26977764_en	FINDING	5-year survival	1478-1493
26977764_en	FINDING	In-hospital mortality	1236-1257
26977764_en	FINDING	mortality	1365-1374
26977764_en	ANATOMY	cell	524-528
26977764_en	FINDING	satisfactory long-term results	1647-1677
26977764_en	ANATOMY	small cell	496-506
26977764_en	ANATOMY	cell	502-506
26977764_en	FINDING	reduced broncho-pleural fistula incidence and mortality	1319-1374
26977764_en	DISO	complications	1185-1198
26977764_en	FINDING	mortality	1248-1257
26977764_en	FINDING	Long-term results in T3-T4N0 tumors were significantly better compared with T3-4N1-2 tumors	1385-1476
26977764_en	DISO	T3-T4N0	1406-1413
26977764_en	DISO	T3-4N1-2	1461-1469
26977764_en	FINDING	may be improved using primary bronhomyoplasty	1578-1623
26977789_en	LABPROC	diffusion kurtosis imaging	23-49
26977789_en	DISO	proliferative activity	58-80
26977789_en	LABPROC	diffusion kurtosis imaging	166-192
26977789_en	DISO	proliferative activity	226-248
26977789_en	ANATOMY	contralateral normal appearing white matter	360-403
26977789_en	DISO	brain gliomas	486-499
26977789_en	LABPROC	diffusion tensor	634-650
26977789_en	LABPROC	anisotropies	740-752
26977789_en	LABPROC	diffusion kurtosis	758-776
26977789_en	LABPROC	kurtosis	817-825
26977789_en	LABPROC	kurtosis anisotropy	827-846
26977789_en	ANATOMY	CNAWM	1016-1021
26977789_en	LABPROC	diffusion parameters	1140-1160
26977789_en	LABPROC	FA	1237-1239
26977789_en	LABPROC	RA	1244-1246
26977789_en	LABPROC	AK	1321-1323
26977789_en	LABPROC	RK	1329-1331
26977789_en	LABPROC	anisotropy	1337-1347
26977789_en	LABPROC	RD	1404-1406
26977789_en	ANATOMY	CNAWM	1956-1961
26977789_en	LABPROC	DKI	1984-1987
26977789_en	DISO	gliomas	2051-2058
26977789_en	LABPROC	DKI	2061-2064
26977789_en	ANATOMY	contralateral normal appearing white matter	2144-2187
26977789_en	ANATOMY	white matter	2175-2187
26977789_en	DISO	brain gliomas	2205-2218
26977789_en	ANATOMY	brain	2205-2210
26977789_en	DISO	glioma	90-96
26977789_en	ANATOMY	brain	84-89
26977789_en	LABPROC	DKI	194-197
26977789_en	DISO	gliomas	2211-2218
26977789_en	DISO	brain glioma	84-96
26977789_en	DISO	glioma	219-225
26977789_en	ANATOMY	CNAWM	405-410
26977789_en	DISO	glioma	292-298
26977789_en	DISO	proliferative activity	299-321
26977789_en	ANATOMY	contralateral	360-373
26977789_en	ANATOMY	white matter	391-403
26977789_en	ANATOMY	normal appearing white matter	374-403
26977789_en	LABPROC	glioma proliferative activity index	292-327
26977789_en	LABPROC	diffusion parameters	332-352
26977789_en	DISO	gliomas	492-499
26977789_en	ANATOMY	brain	486-491
26977789_en	DISO	gliomas	545-552
26977789_en	LABPROC	mean diffusivities	652-704
26977789_en	LABPROC	axial diffusivities	663-704
26977789_en	LABPROC	radial diffusivities	679-704
26977789_en	LABPROC	diffusivities	691-704
26977789_en	LABPROC	MD	658-660
26977789_en	LABPROC	AD	670-672
26977789_en	LABPROC	RD	687-689
26977789_en	LABPROC	fractional anisotropies	706-752
26977789_en	LABPROC	relative anisotropies	726-752
26977789_en	LABPROC	RA	736-738
26977789_en	LABPROC	FA	718-720
26977789_en	LABPROC	mean kurtosis	778-825
26977789_en	LABPROC	MK	784-786
26977789_en	LABPROC	axial kurtosis	789-825
26977789_en	LABPROC	AK	796-798
26977789_en	LABPROC	radial kurtosis	805-825
26977789_en	LABPROC	RK	813-815
26977789_en	LABPROC	KA	848-850
26977789_en	DISO	proliferative activity	861-883
26977789_en	DISO	glioma	912-918
26977789_en	DISO	malignant glioma parts	902-924
26977789_en	DISO	glioma	1030-1036
26977789_en	DISO	proliferative activity	1037-1059
26977789_en	DISO	glioma	1169-1175
26977789_en	DISO	proliferative activity	1176-1198
26977789_en	LABPROC	Kurtosis	1307-1315
26977789_en	LABPROC	MK	1317-1319
26977789_en	LABPROC	KA	1349-1351
26977789_en	LABPROC	FA	1353-1355
26977789_en	LABPROC	RA	1357-1359
26977789_en	LABPROC	AD	1400-1402
26977789_en	LABPROC	MD	1396-1398
26977789_en	LABPROC	diffusivity	1383-1394
26977789_en	DISO	glioma	1432-1438
26977789_en	DISO	proliferative activity	1439-1461
26977789_en	DISO	proliferative activity	1512-1534
26977789_en	LABPROC	RK	1554-1556
26977789_en	LABPROC	MK	1603-1605
26977789_en	LABPROC	AK	1627-1629
26977789_en	LABPROC	RK	1652-1654
26977789_en	LABPROC	RD	1681-1683
26977789_en	DISO	glioma	1779-1785
26977789_en	DISO	proliferative activity	1786-1808
26977789_en	LABPROC	RK	1836-1838
26977789_en	LABPROC	KA	1859-1861
26977789_en	LABPROC	RD	1882-1884
26977789_en	LABPROC	FA	1904-1906
26977789_en	LABPROC	RA	1931-1933
26977789_en	ANATOMY	contralateral	2144-2157
26977789_en	ANATOMY	normal appearing white matter	2158-2187
26977789_en	LABPROC	kurtosis	768-776
26977789_en	LABPROC	kurtosis	827-835
26977789_en	LABPROC	anisotropy	836-846
26977789_en	FINDING	correlation between all the absolute and normalized diffusion parameters and the glioma proliferative activity index	1088-1204
26977789_en	FINDING	correlation between diffusion kurtosis imaging and the proliferative activity	3-80
26977789_en	FINDING	statistically significant correlation between the glioma proliferative activity index and diffusion values	1729-1835
26977789_en	FINDING	strong correlation between the proliferative activity index	1481-1540
26977789_en	LABPROC	immunohistochemical	2020-2039
26977789_en	LABPROC	kurtosis	993-1001
26977789_en	LABPROC	tensor	982-988
26977789_en	FINDING	values increased	1361-1377
26977789_en	FINDING	values decreased	1408-1424
26977789_en	FINDING	glioma proliferative activity index increased	1432-1477
26977789_en	LABPROC	diffusion kurtosis	23-41
26977789_en	LABPROC	kurtosis	33-41
26977789_en	LABPROC	diffusion kurtosis	166-184
26977789_en	LABPROC	kurtosis	176-184
26977789_en	FINDING	relationship between the tensor and kurtosis parameters of CNAWM and the glioma proliferative activity index	957-1065
26977789_en	FINDING	immunohistochemical changes	2020-2047
26977789_en	FINDING	microstructural changes	2113-2136
26977789_en	FINDING	DKI demonstrated a high sensitivity	2061-2096
26977790_en	DISO	gliomas	184-191
26977790_en	ANATOMY	eloquent brain regions	205-227
26977790_en	DISO	severe neurological deficit	583-610
26977790_en	INJURY_POISONING	anatomic injury	663-690
26977790_en	DISO	ischemic injury	675-690
26977790_en	ANATOMY	subcortical pathways	694-714
26977790_en	ANATOMY	internal capsule	719-735
26977790_en	DISO	neurological deterioration	833-859
26977790_en	DISO	neurological complications	869-895
26977790_en	INJURY_POISONING	blood vessel injury	994-1013
26977790_en	ANATOMY	brain	214-219
26977790_en	ANATOMY	brain regions	214-227
26977790_en	DISO	neurological complications	139-165
26977790_en	ANATOMY	blood vessel	994-1006
26977790_en	ANATOMY	blood	994-999
26977790_en	FINDING	decrease the frequency of neurological complications	113-165
26977790_en	ANATOMY	subcortical	694-705
26977790_en	ANATOMY	brain	792-797
26977790_en	DISO	ischemic	675-683
26977790_en	FINDING	good neurological outcome canot be ensured	244-286
26977790_en	FINDING	neurological outcome	249-269
26977790_en	FINDING	good outcome	541-553
26977790_en	FINDING	prevention of neurological deterioration	819-859
26977790_en	FINDING	frequency of neurological complications	126-165
26977790_en	DISO	complications	389-402
26977790_en	PHYS	language	798-806
26977790_en	FINDING	neurosurgical risks	950-969
26977790_en	FINDING	underestimate neurosurgical risks	936-969
26977790_en	DISO	complications	1073-1086
26977790_en	DISO	complications	882-895
26977790_en	FINDING	prevention of such complications	1054-1086
26977790_en	DISO	complications	152-165
26977790_en	DISO	neurological deficit	590-610
26977908_en	DISO	Alexithymia	1-12
26977908_en	DISO	left-hemispheric cerebral infarction	30-66
26977908_en	PHYS	recovery	79-87
26977908_en	DISO	cerebral infarction	413-432
26977908_en	ANATOMY	middle cerebral artery	452-474
26977908_en	DISO	chronic brain ischemia	545-567
26977908_en	DISO	cerebral infarction	763-782
26977908_en	DISO	alexithymia	807-818
26977908_en	DISO	Alexithymia	821-832
26977908_en	DISO	cerebral infarction	850-869
26977908_en	ANATOMY	left-hemispheric	30-46
26977908_en	DISO	alexithymia	139-150
26977908_en	DISO	anxiety	152-159
26977908_en	DISO	depression	164-174
26977908_en	DISO	cerebral infarction	193-212
26977908_en	ANATOMY	middle cerebral artery	232-254
26977908_en	ANATOMY	cerebral artery	239-254
26977908_en	ANATOMY	artery	248-254
26977908_en	PHYS	recovery	286-294
26977908_en	ANATOMY	cerebral	413-421
26977908_en	ANATOMY	cerebral	193-201
26977908_en	ANATOMY	cerebral	47-55
26977908_en	ANATOMY	cerebral artery	459-474
26977908_en	ANATOMY	cerebral	239-247
26977908_en	ANATOMY	cerebral	459-467
26977908_en	ANATOMY	artery	468-474
26977908_en	DISO	ischemia	559-567
26977908_en	ANATOMY	brain	553-558
26977908_en	ANATOMY	cerebral	763-771
26977908_en	ANATOMY	cerebral	850-858
26977908_en	DISO	alexithymia	660-671
26977908_en	DISO	neurological deficit	692-712
26977908_en	DISO	anxiety	735-742
26977908_en	DISO	depression	747-757
26977908_en	DISO	infarction	56-66
26977908_en	DISO	infarction	202-212
26977908_en	DISO	infarction	422-432
26977908_en	DISO	infarction	772-782
26977908_en	DISO	infarction	859-869
26977908_en	PHYS	sex	714-717
26977908_en	FINDING	correlation between the level of alexithymia	627-671
26977908_en	DISO	brain ischemia	553-567
26977908_en	PHYS	physical	906-914
26977908_en	FINDING	complicate the rehabilitation	945-974
26977908_en	FINDING	affects the adequate self-esteem of physical and mental condition	870-935
26977916_en	CHEM	Melatonin	1-10
26977916_en	DISO	chronic pain syndromes	14-36
26977916_en	CHEM	Melatonin	39-48
26977916_en	CHEM	neurohormone	52-64
26977916_en	ANATOMY	epiphysis	84-93
26977916_en	ANATOMY	extrapineal structures	98-120
26977916_en	ANATOMY	cardiovascular system	263-284
26977916_en	ANATOMY	gastrointestinal tract	293-315
26977916_en	PHYS	reproductive functions	335-357
26977916_en	PHYS	metabolism	359-369
26977916_en	PHYS	metabolism and body mass regulation	359-394
26977916_en	CHEM	melatonin	455-464
26977916_en	DISO	pain syndromes	468-482
26977916_en	CHEM	melatonin	542-551
26977916_en	DISO	fibromyalgia	568-580
26977916_en	DISO	headache	582-590
26977916_en	DISO	irritated bowel syndrome	592-616
26977916_en	DISO	rheumatoid arthritis	640-660
26977916_en	CHEM	melatonin	710-719
26977916_en	PHYS	sleep	776-781
26977916_en	CHEM	melatonin	826-835
26977916_en	PHYS	circadian rhythms	851-868
26977916_en	FINDING	analgesic effect of melatonin	963-992
26977916_en	CHEM	melatonin	983-992
26977916_en	CHEM	melatonin receptors	1010-1029
26977916_en	CHEM	neurotransmitter systems	1042-1066
26977916_en	DISO	pain	22-26
26977916_en	DISO	pain	468-472
26977916_en	ANATOMY	bowel	602-607
26977916_en	DISO	chronic back pain	618-635
26977916_en	DISO	pain	631-635
26977916_en	ANATOMY	back	626-630
26977916_en	DISO	arthritis	651-660
26977916_en	FINDING	analgesic properties of melatonin	686-719
26977916_en	DISO	chronic pain syndromes	893-915
26977916_en	DISO	pain	901-905
26977916_en	ANATOMY	body	374-378
26977916_en	CHEM	receptors	1020-1029
26977916_en	CHEM	melatonin	1010-1019
26977916_en	FINDING	improvement of sleep	761-781
26977916_en	FINDING	efficacy of melatonin	443-464
26977916_en	DISO	pain syndromes	22-36
26977916_en	PHYS	chronobiotic	154-166
26977916_en	PHYS	antioxidant	168-179
26977916_en	PHYS	oncostatic	181-191
26977916_en	PHYS	immunomodulating	193-209
26977916_en	PHYS	normothymic	211-222
26977916_en	PHYS	anxiolytic	227-237
26977916_en	DISO	back pain	626-635
26977916_en	FINDING	normalizing circadian rhythms	839-868
26977916_en	DISO	pain syndromes	901-915
26977916_en	PHYS	synthesized	65-76
26977916_en	PHYS	body mass	374-383
26977916_en	CHEM	neurotransmitter	1042-1058
26977916_en	PHYS	adaptive potential	804-822
26977916_en	FINDING	activation of own adaptive potential	786-822
26977916_en	FINDING	analgesic effect	963-979
26977916_en	FINDING	analgesic properties	686-706
26978046_en	ANATOMY	internuclear interneurons	18-43
26978046_en	ANATOMY	brain stem	57-67
26978046_en	DISO	arterial hypertension	71-92
26978046_en	ANATOMY	internuclear interneurons	118-143
26978046_en	PHYS	metabolism	165-175
26978046_en	CHEM	nitric oxide	179-191
26978046_en	CHEM	hydrogen sulfide	193-209
26978046_en	CHEM	carbon monoxide	214-229
26978046_en	ANATOMY	caudal brainstem	237-253
26978046_en	DISO	hypertension	296-308
26978046_en	ANATOMY	postmortem material	359-378
26978046_en	DISO	arterial hypertension	440-461
26978046_en	LABPROC	Immunohistochemistry	464-484
26978046_en	CHEM	nNOS	497-501
26978046_en	CHEM	HO-2	503-507
26978046_en	CHEM	CBS	509-512
26978046_en	CHEM	NADPH-diaphorase	542-558
26978046_en	ANATOMY	IN	578-580
26978046_en	ANATOMY	giant cell reticular nuclei	608-645
26978046_en	ANATOMY	small cell reticular nuclei	618-645
26978046_en	ANATOMY	small cell reticular nucleus	653-681
26978046_en	ANATOMY	nucleus of the solitary tract	690-719
26978046_en	ANATOMY	lateral reticular nucleus	744-769
26978046_en	LABPROC	immunohistochemical reaction	906-934
26978046_en	DISO	high blood pressure	973-992
26978046_en	CHEM	nNOS-positive	1310-1323
26978046_en	ANATOMY	nNOS-positive neurons	1310-1331
26978046_en	ANATOMY	IN1	1419-1422
26978046_en	ANATOMY	IN	1451-1453
26978046_en	ANATOMY	IN3	1491-1494
26978046_en	ANATOMY	IN2	1499-1502
26978046_en	PHYS	hemodynamic	1579-1590
26978046_en	ANATOMY	interneurons	1632-1644
26978046_en	ANATOMY	IN	1716-1718
26978046_en	PHYS	blood pressure	1750-1764
26978046_en	PHYS	hemodynamics	1820-1832
26978046_en	ANATOMY	IN	1840-1842
26978046_en	PHYS	Topochemistry	1-14
26978046_en	ANATOMY	interneurons	31-43
26978046_en	ANATOMY	arterial	71-79
26978046_en	DISO	hypertension	80-92
26978046_en	ANATOMY	IN	145-147
26978046_en	ANATOMY	interneurons	131-143
26978046_en	ANATOMY	brainstem	244-253
26978046_en	DISO	hypertension	449-461
26978046_en	ANATOMY	arterial	440-448
26978046_en	LABPROC	histochemical	517-530
26978046_en	CHEM	NADPH	542-547
26978046_en	CHEM	diaphorase	548-558
26978046_en	ANATOMY	reticular nuclei	629-645
26978046_en	ANATOMY	reticular nucleus	664-681
26978046_en	ANATOMY	solitary tract	705-719
26978046_en	ANATOMY	reticular nucleus	752-769
26978046_en	ANATOMY	IN1	647-650
26978046_en	ANATOMY	IN2	721-724
26978046_en	ANATOMY	IN3	771-774
26978046_en	ANATOMY	IN	785-787
26978046_en	ANATOMY	intranuclear	1646-1658
26978046_en	ANATOMY	internuclear	1663-1675
26978046_en	PHYS	blood pressure	978-992
26978046_en	ANATOMY	blood	978-983
26978046_en	ANATOMY	blood	1750-1755
26978046_en	FINDING	increases in blood pressure	1737-1764
26978046_en	ANATOMY	brain	57-62
26978046_en	ANATOMY	cell	624-628
26978046_en	ANATOMY	cell	659-663
26978046_en	ANATOMY	cells	1192-1197
26978046_en	ANATOMY	small MN	1071-1079
26978046_en	ANATOMY	cell	1008-1012
26978046_en	ANATOMY	internuclear	18-30
26978046_en	ANATOMY	internuclear	118-130
26978046_en	CHEM	nNOS	1310-1314
26978046_en	FINDING	changes are more pronounced	1455-1482
26978046_en	ANATOMY	large IN	1710-1718
26978046_en	CHEM	oxide	186-191
26978046_en	CHEM	nitric	179-185
26978046_en	CHEM	hydrogen	193-201
26978046_en	CHEM	sulfide	202-209
26978046_en	CHEM	carbon	214-220
26978046_en	CHEM	monoxide	221-229
26978046_en	PHYS	healthy	257-264
26978046_en	PHYS	lifetime	287-295
26978046_en	PHYS	healthy	384-391
26978046_en	PHYS	lifetime	431-439
26978046_en	ANATOMY	nucleus	690-697
26978046_en	ANATOMY	nucleus	674-681
26978046_en	ANATOMY	small cell	653-663
26978046_en	ANATOMY	nucleus	762-769
26978046_en	ANATOMY	small cell	618-628
26978046_en	ANATOMY	nuclei	639-645
26978046_en	PHYS	size	798-802
26978046_en	PHYS	shape	804-809
26978046_en	ANATOMY	sprouts	835-842
26978046_en	PHYS	length and structure of sprouts	811-842
26978046_en	FINDING	intensity of immunohistochemical reaction	893-934
26978046_en	PHYS	cell size	1008-1017
26978046_en	ANATOMY	MN	1077-1079
26978046_en	ANATOMY	MN	954-956
26978046_en	FINDING	intensity of MN response	941-965
26978046_en	ANATOMY	MN	1117-1119
26978046_en	ANATOMY	major MN	1111-1119
26978046_en	PHYS	concentration	1199-1212
26978046_en	PHYS	reaction rate	1217-1230
26978046_en	ANATOMY	neurons	1324-1331
26978046_en	PHYS	quantitative indicators	1270-1293
26978046_en	FINDING	significant reduction in the proportion of these cells, concentration and reaction rate	1143-1230
26978046_en	FINDING	More significant changes in quantitative indicators	1242-1293
26978046_en	PHYS	quantitative indicators	1354-1377
26978046_en	FINDING	reduction in the quantitative indicators	1337-1377
26978046_en	ANATOMY	cells	1409-1414
26978046_en	PHYS	localization of cells	1393-1414
26978046_en	ANATOMY	arge IN	1446-1453
26978046_en	PHYS	hemodynamic control	1579-1598
26978046_en	ANATOMY	cells	1538-1543
26978046_en	PHYS	responsive	1723-1733
26978046_en	PHYS	regulation of hemodynamics	1806-1832
26978046_en	ANATOMY	Small IN	1834-1842
26978046_en	FINDING	stable, obviously, integrating function	1898-1937
26978051_en	CHEM	agomelatine	42-53
26978051_en	CHEM	valdoxan	55-63
26978051_en	DISO	anhedonia	85-94
26978051_en	DISO	depressions	123-134
26978051_en	CHEM	valdoxan	185-193
26978051_en	DISO	anhedonia	209-218
26978051_en	DISO	depressions	247-258
26978051_en	DISO	anhedonic depression	373-393
26978051_en	CHEM	Valdoxan	434-442
26978051_en	CHEM	valdoxan	810-818
26978051_en	FINDING	anxiolytic effects	863-881
26978051_en	DISO	depression	1032-1042
26978051_en	DISO	autonomic side-effects	1072-1094
26978051_en	DISO	anhedonic depressions	1162-1183
26978051_en	CHEM	valdoxan	1189-1197
26978051_en	FINDING	antianhedonic effect	1288-1308
26978051_en	CHEM	valdoxan	1522-1530
26978051_en	DISO	gedonic disorders	1583-1600
26978051_en	DISO	endogenous depressions	112-134
26978051_en	DISO	endogenous depressions	236-258
26978051_en	DISO	depression	383-393
26978051_en	FINDING	Antianhedonic effect	786-806
26978051_en	FINDING	thymoleptic	847-858
26978051_en	DISO	depression of moderate severity	1032-1063
26978051_en	DISO	depressions	1172-1183
26978051_en	FINDING	good tolerability	1473-1490
26978051_en	DISO	psychopathological characteristics	1545-1579
26978051_en	FINDING	therapeutic perspectives of agomelatine	14-53
26978051_en	FINDING	therapeutic effect of valdoxan	163-193
26978051_en	FINDING	tolerability	1478-1490
26978051_en	PHYS	Patient's status	519-535
26978051_en	FINDING	therapeutic effect	704-722
26978051_en	FINDING	superior to thymoleptic and anxiolytic effects	835-881
26978051_en	FINDING	marked effect	929-942
26978051_en	FINDING	best effect	1008-1019
26978051_en	PHYS	autonomic	1072-1081
26978051_en	DISO	side-effects	1082-1094
26978051_en	FINDING	Good and marked effects	1367-1390
26978051_en	FINDING	preferable and highly effective method	1222-1260
26978051_en	FINDING	antidepressive properties	1328-1353
26978172_en	CHEM	Leptin	1-7
26978172_en	PHYS	metabolic	36-45
26978172_en	DISO	type 2 diabetes	71-86
26978172_en	DISO	asthma	126-132
26978172_en	DISO	T2DM	393-397
26978172_en	DISO	T2DM	419-423
26978172_en	DISO	asthma	440-446
26978172_en	CHEM	carbohydrate	564-576
26978172_en	CHEM	lipid	581-586
26978172_en	CHEM	leptin	613-619
26978172_en	CHEM	adiponectin	631-642
26978172_en	CHEM	IL	657-659
26978172_en	CHEM	IL-10	667-672
26978172_en	DISO	Hyperleptinemia	702-717
26978172_en	DISO	hyperresistinemia	719-736
26978172_en	CHEM	adiponectin	748-759
26978172_en	DISO	T2DM	807-811
26978172_en	DISO	asthma	851-857
26978172_en	DISO	subclinical inflammation	935-959
26978172_en	DISO	insulin resistance	969-987
26978172_en	DISO	compensatory hyperinsulinemia	1008-1037
26978172_en	DISO	atherogenic dyslipidemia	1089-1113
26978172_en	CHEM	total cholesterol	1153-1170
26978172_en	CHEM	triglycerides	1176-1189
26978172_en	CHEM	resistin	1391-1399
26978172_en	CHEM	insulin	1405-1412
26978172_en	DISO	T2DM	1462-1466
26978172_en	DISO	asthma	1503-1509
26978172_en	DISO	IR	1528-1530
26978172_en	DISO	compensatory hyperinsulinemia	1546-1575
26978172_en	DISO	Hyperresistinemia	1577-1594
26978172_en	DISO	IR	1630-1632
26978172_en	DISO	T2DM	1689-1693
26978172_en	DISO	asthma	1730-1736
26978172_en	DISO	hyperleptinemia	1756-1771
26978172_en	DISO	hyperresistinemia	1773-1790
26978172_en	CHEM	adiponectin	1819-1830
26978172_en	DISO	subclinical inflammation	1857-1881
26978172_en	CHEM	resistin	9-17
26978172_en	DISO	diabetes	78-86
26978172_en	CHEM	resistin	180-188
26978172_en	CHEM	adiponectin	190-201
26978172_en	CHEM	leptin	203-209
26978172_en	DISO	type 2 diabetes mellitus	266-290
26978172_en	DISO	diabetes	273-281
26978172_en	DISO	diabetes mellitus	273-290
26978172_en	DISO	T2DM	292-296
26978172_en	DISO	asthma	337-343
26978172_en	PHYS	Anthropometric measurements	535-562
26978172_en	CHEM	resistin	621-629
26978172_en	CHEM	interleukin	644-655
26978172_en	CHEM	interleukin (IL)-6	644-662
26978172_en	DISO	lower adiponectin concentrations	742-774
26978172_en	DISO	IR	989-991
26978172_en	DISO	dyslipidemia	1101-1113
26978172_en	CHEM	cholesterol	1159-1170
26978172_en	CHEM	lipoprotein	1203-1214
26978172_en	CHEM	low-density lipoprotein C	1191-1216
26978172_en	DISO	atherogenic	1222-1233
26978172_en	CHEM	lipoprotein	1283-1294
26978172_en	CHEM	high-density lipoprotein C	1270-1296
26978172_en	FINDING	decreasing adiponectin values	1808-1837
26978172_en	DISO	inflammation	1869-1881
26978172_en	DISO	inflammation	947-959
26978172_en	PHYS	adiponectin values	1819-1837
26978172_en	CHEM	insulin	969-976
26978172_en	CHEM	IL	667-669
26978172_en	PHYS	metabolic	228-237
26978172_en	PHYS	metabolic parameters	587-607
26978172_en	FINDING	increases in the levels of total cholesterol (C), triglycerides, low-density lipoprotein C, and atherogenic index	1126-1239
26978172_en	FINDING	decrease in those of high-density lipoprotein C	1249-1296
26978172_en	PHYS	level of resistin	1382-1399
26978172_en	FINDING	positive correlation of the level of resistin with insulin	1354-1412
26978172_en	CHEM	hormonal	23-31
26978172_en	PHYS	hormonal and metabolic parameters	23-56
26978172_en	CHEM	hormonal	215-223
26978172_en	PHYS	hormonal and metabolic parameters	215-248
26978172_en	PHYS	apparently healthy	489-507
26978172_en	PHYS	metabolic	587-596
26978172_en	PHYS	levels	673-679
26978172_en	DISO	hyperinsulinemia	1021-1037
26978172_en	PHYS	levels of total cholesterol	1143-1170
26978172_en	PHYS	levels	1143-1149
26978172_en	CHEM	C	1172-1173
26978172_en	CHEM	C	1215-1216
26978172_en	CHEM	low-density lipoprotein	1191-1214
26978172_en	CHEM	high-density lipoprotein	1270-1294
26978172_en	CHEM	C	1295-1296
26978172_en	DISO	hyperinsulinemia	1559-1575
26978176_en	ANATOMY	podocyte	34-42
26978176_en	DISO	diabetes mellitus	67-84
26978176_en	DISO	diabetic	399-407
26978176_en	PHYS	normal albuminuria	582-600
26978176_en	DISO	microalbuminuria	639-655
26978176_en	DISO	proteinuria	697-708
26978176_en	ANATOMY	podocyte	802-810
26978176_en	CHEM	nephrin	831-838
26978176_en	CHEM	podocin	843-850
26978176_en	LABPROC	enzyme immunoassay	870-888
26978176_en	DISO	Nephrinuria	898-909
26978176_en	PHYS	NAU	968-971
26978176_en	DISO	MAU	973-976
26978176_en	DISO	PU	982-984
26978176_en	DISO	Podocinuria	1000-1011
26978176_en	DISO	NU	1093-1095
26978176_en	DISO	DN	1099-1101
26978176_en	DISO	PU	1107-1109
26978176_en	DISO	DM	1148-1150
26978176_en	PHYS	NAU	1156-1159
26978176_en	CHEM	podocin	1196-1203
26978176_en	PHYS	excretion	1204-1213
26978176_en	DISO	DM	1273-1275
26978176_en	DISO	albuminuria	1319-1330
26978176_en	DISO	MAU	1358-1361
26978176_en	DISO	DM	1393-1395
26978176_en	DISO	albuminuria	1420-1431
26978176_en	DISO	NU	1447-1449
26978176_en	PHYS	creatinine levels	1487-1504
26978176_en	PHYS	glomerular filtration rate	1524-1550
26978176_en	DISO	NU	1552-1554
26978176_en	PHYS	glycated hemoglobin levels	1580-1606
26978176_en	PHYS	systolic blood pressure	1716-1739
26978176_en	DISO	NU	1745-1747
26978176_en	CHEM	nephrin	1819-1826
26978176_en	CHEM	podocin	1831-1838
26978176_en	DISO	DN	1897-1899
26978176_en	ANATOMY	glomerular apparatus	1926-1946
26978176_en	DISO	DM	1950-1952
26978176_en	DISO	podocyte injury	34-49
26978176_en	DISO	diabetes	67-75
26978176_en	ANATOMY	urinary	108-115
26978176_en	PHYS	excretion	116-125
26978176_en	PHYS	urinary excretion	108-125
26978176_en	ANATOMY	podocyte	141-149
26978176_en	DISO	podocyte injury	141-156
26978176_en	DISO	diabetic nephropathy	208-228
26978176_en	DISO	DN	230-232
26978176_en	DISO	nephropathy	217-228
26978176_en	DISO	diabetes mellitus	294-311
26978176_en	DISO	diabetes	294-302
26978176_en	DISO	DM	313-315
26978176_en	DISO	albuminuria	341-352
26978176_en	DISO	proteinuria	353-364
26978176_en	DISO	DM	433-435
26978176_en	DISO	DM	455-457
26978176_en	LABPROC	urinary concentration in one urinary portion	516-560
26978176_en	PHYS	albuminuria	589-600
26978176_en	PHYS	NAU	602-605
26978176_en	DISO	MAU	657-660
26978176_en	DISO	PU	710-712
26978176_en	DISO	NU	911-913
26978176_en	DISO	PDU	1013-1016
26978176_en	PHYS	NAU	1061-1064
26978176_en	DISO	MAU	1066-1069
26978176_en	DISO	PU	1075-1077
26978176_en	PHYS	NAU	1168-1171
26978176_en	DISO	MAU	1173-1176
26978176_en	DISO	PU	1182-1184
26978176_en	PHYS	podocin excretion	1196-1213
26978176_en	DISO	NU	1311-1313
26978176_en	DISO	PDU	1454-1457
26978176_en	ANATOMY	serum	1481-1486
26978176_en	CHEM	hemoglobin	1589-1599
26978176_en	DISO	DM	1642-1644
26978176_en	ANATOMY	blood	1725-1730
26978176_en	PHYS	blood pressure	1725-1739
26978176_en	DISO	DM	1779-1781
26978176_en	ANATOMY	Urinary	1-8
26978176_en	PHYS	Urinary excretion	1-18
26978176_en	CHEM	creatinine	1487-1497
26978176_en	ANATOMY	glomerular	1524-1534
26978176_en	ANATOMY	urinary	516-523
26978176_en	ANATOMY	urinary	545-552
26978176_en	ANATOMY	urinary	780-787
26978176_en	ANATOMY	urinary	1811-1818
26978176_en	CHEM	podocyte structural proteins	802-830
26978176_en	DISO	diabetic	208-216
26978176_en	PHYS	glomerular filtration	1524-1545
26978176_en	PHYS	urinary levels of the podocyte structural proteins	780-830
26978176_en	FINDING	direct significant correlation of systolic blood pressure	1682-1739
26978176_en	FINDING	direct correlation of NU with albuminuria	1289-1330
26978176_en	DISO	type 1 DM	426-435
26978176_en	DISO	type 2 DM	448-457
26978176_en	FINDING	significantly higher	1114-1134
26978176_en	FINDING	equally higher and did not differ between the types of DM	1218-1275
26978176_en	FINDING	correlated directly	1458-1477
26978176_en	FINDING	correlated inversely	1458-1518
26978176_en	FINDING	directly correlated with glycated hemoglobin levels	1555-1606
26978176_en	DISO	types 1 DM	1628-1644
26978176_en	DISO	types 2 DM	1628-1644
26978176_en	DISO	type 2 DM	1772-1781
26978176_en	PHYS	excretion	9-18
26978176_en	PHYS	markers for podocyte injury	22-49
26978176_en	PHYS	markers for podocyte injury	129-156
26978176_en	PHYS	urinary concentration	516-537
26978176_en	PHYS	healthy	755-762
26978176_en	CHEM	enzyme	870-876
26978176_en	CHEM	structural proteins	811-830
26978176_en	CHEM	proteins	822-830
26978176_en	PHYS	glycated	1580-1588
26978176_en	PHYS	urinary nephrin and podocin levels	1811-1845
26978176_en	FINDING	may be used for the early preclinical diagnosis of DN	1846-1899
26978232_en	ANATOMY	Ileal	170-175
26978232_en	ANATOMY	Ileal biopsy specimens	170-192
26978232_en	DISO	Crohn's disease	258-273
26978232_en	DISO	colitis	302-309
26978232_en	DISO	IBD	313-316
26978232_en	ANATOMY	ileal mucosa	364-376
26978232_en	LABPROC	Immunohistochemical examination	399-430
26978232_en	CHEM	anti-somatostatin receptor type 2	451-484
26978232_en	ANATOMY	epitheliocytes	575-589
26978232_en	ANATOMY	cytoplasmic	669-680
26978232_en	DISO	Crohn's disease	819-834
26978232_en	DISO	IBDU	884-888
26978232_en	ANATOMY	cytoplasmic	1001-1012
26978232_en	DISO	Crohn's disease	1192-1207
26978232_en	ANATOMY	mucosa	1246-1252
26978232_en	DISO	indeterminate (unclassified) colitis	1271-1307
26978232_en	CHEM	SSTR2	1327-1332
26978232_en	ANATOMY	membranous	1363-1373
26978232_en	ANATOMY	cytoplasmic	1375-1386
26978232_en	ANATOMY	neuroendocrine	1474-1488
26978232_en	ANATOMY	cytoplasmic	1501-1512
26978232_en	ANATOMY	T lymphocytes	1545-1558
26978232_en	ANATOMY	neuroendocrine	1619-1633
26978232_en	ANATOMY	epithelial	1638-1648
26978232_en	CHEM	somatostatin	45-57
26978232_en	CHEM	somatostatin receptor	45-66
26978232_en	ANATOMY	mucosa	91-97
26978232_en	ANATOMY	ileal	85-90
26978232_en	ANATOMY	ileal mucosa	85-97
26978232_en	DISO	inflammatory bowel disease	115-141
26978232_en	DISO	bowel disease	128-141
26978232_en	DISO	IBD	143-146
26978232_en	ANATOMY	bowel	128-133
26978232_en	DISO	CD	275-277
26978232_en	DISO	indeterminate colitis	288-309
26978232_en	DISO	IBD unclassified	313-329
26978232_en	DISO	IBDU	331-335
26978232_en	DISO	indeterminate colitis of IBD unclassified	288-329
26978232_en	ANATOMY	ileal	364-369
26978232_en	ANATOMY	mucosa	370-376
26978232_en	CHEM	somatostatin receptor type 2	456-484
26978232_en	CHEM	SSTR-2	486-492
26978232_en	CHEM	somatostatin receptor	456-477
26978232_en	CHEM	SSTR	486-490
26978232_en	CHEM	SSTR2	523-528
26978232_en	ANATOMY	membranous	657-667
26978232_en	ANATOMY	membranous	1068-1078
26978232_en	ANATOMY	cytoplasmic	1079-1090
26978232_en	CHEM	SSTR-2	1121-1127
26978232_en	CHEM	SSTR	1121-1125
26978232_en	ANATOMY	membranous	1399-1409
26978232_en	ANATOMY	cytoplasmic	1410-1421
26978232_en	ANATOMY	membranous	693-703
26978232_en	ANATOMY	cytoplasmic	704-715
26978232_en	ANATOMY	intraepithelial	1529-1544
26978232_en	ANATOMY	lymphocytes	1547-1558
26978232_en	ANATOMY	intraepithelial T lymphocytes	1529-1558
26978232_en	ANATOMY	membranous	1575-1585
26978232_en	ANATOMY	cytoplasmic	1586-1597
26978232_en	LABPROC	biopsy	176-182
26978232_en	ANATOMY	membranous	1439-1449
26978232_en	ANATOMY	biopsy specimens	176-192
26978232_en	ANATOMY	cells	548-553
26978232_en	ANATOMY	cells	733-738
26978232_en	ANATOMY	cells	1139-1144
26978232_en	ANATOMY	cells	1428-1433
26978232_en	ANATOMY	membranous	744-754
26978232_en	CHEM	antibodies	494-504
26978232_en	DISO	inflammatory	115-127
26978232_en	PHYS	somatostatin receptor expression	45-77
26978232_en	PHYS	membranous expression	744-765
26978232_en	PHYS	receptor expression	616-635
26978232_en	PHYS	cytoplasmic expression	1001-1023
26978232_en	FINDING	number of SSTR-2-expressing cells was significantly smaller	1111-1170
26978232_en	PHYS	SSTR-2-expressing	1121-1138
26978232_en	PHYS	cytoplasmic expression	1501-1523
26978232_en	PHYS	membranous-cytoplasmic expression	1575-1608
26978232_en	CHEM	receptor	58-66
26978232_en	LABPROC	SSTR2-positively stained cells were counted	523-566
26978232_en	CHEM	receptor	469-477
26978232_en	CHEM	receptor	616-624
26978232_en	PHYS	expressing	1128-1138
26978232_en	DISO	colitis	1300-1307
26978232_en	PHYS	SSTR2 staining types	1327-1347
26978232_en	PHYS	membranous staining	1439-1458
26978232_en	PHYS	expression	1513-1523
26978232_en	PHYS	expression	1598-1608
26978233_en	PHYS	apoptosis	58-67
26978233_en	DISO	colorectal liver metastases	79-106
26978233_en	CHEM	p53 protein	143-154
26978233_en	CHEM	effector caspases-3	156-175
26978233_en	CHEM	effector caspases -7	156-182
26978233_en	CHEM	antiapoptotic protein	192-213
26978233_en	DISO	colorectal adenocarcinoma	226-251
26978233_en	ANATOMY	liver	270-275
26978233_en	CHEM	VEGF	368-372
26978233_en	DISO	colorectal carcinoma	452-472
26978233_en	ANATOMY	liver	491-496
26978233_en	LABPROC	immunohistologically examined	502-531
26978233_en	CHEM	Caspase 3	804-813
26978233_en	CHEM	survivin	833-841
26978233_en	CHEM	survivin	1160-1168
26978233_en	CHEM	caspase-7	1227-1236
26978233_en	CHEM	p53	1241-1244
26978233_en	CHEM	bevacizumab	1333-1344
26978233_en	DISO	colorectal adenocarcinoma	1391-1416
26978233_en	ANATOMY	liver	1435-1440
26978233_en	PHYS	apoptosis	1460-1469
26978233_en	ANATOMY	tumor cells	1473-1484
26978233_en	CHEM	effector caspase 3	1517-1535
26978233_en	PHYS	apoptosis	1627-1636
26978233_en	CHEM	antiapoptotic protein	1674-1695
26978233_en	CHEM	survivin	1696-1704
26978233_en	ANATOMY	liver	90-95
26978233_en	DISO	liver metastases	90-106
26978233_en	CHEM	survivin	214-222
26978233_en	ANATOMY	colorectal	79-89
26978233_en	ANATOMY	colorectal	226-236
26978233_en	DISO	adenocarcinoma	237-251
26978233_en	DISO	colorectal adenocarcinoma metastases to the liver	226-275
26978233_en	DISO	carcinoma	463-472
26978233_en	ANATOMY	colorectal	452-462
26978233_en	DISO	colorectal carcinoma metastases to the liver	452-496
26978233_en	CHEM	VEGF	669-673
26978233_en	CHEM	VEGF	947-951
26978233_en	ANATOMY	colorectal	1391-1401
26978233_en	DISO	adenocarcinoma	1402-1416
26978233_en	DISO	colorectal adenocarcinoma metastases to the liver	1391-1440
26978233_en	DISO	tumor	1473-1478
26978233_en	ANATOMY	cells	1479-1484
26978233_en	CHEM	effector caspases	156-173
26978233_en	CHEM	p53	143-146
26978233_en	CHEM	protein	206-213
26978233_en	CHEM	protein	1688-1695
26978233_en	CHEM	protein	147-154
26978233_en	DISO	metastases	252-262
26978233_en	DISO	metastases	473-483
26978233_en	DISO	metastases	1417-1427
26978233_en	PHYS	expression	129-139
26978233_en	PHYS	Expression	790-800
26978233_en	PHYS	expression	1213-1223
26978233_en	PHYS	expression	1503-1513
26978233_en	FINDING	enhancing the expression of effector caspase 3	1489-1535
26978233_en	PHYS	expression	1656-1666
26978233_en	FINDING	decreasing the expression of the antiapoptotic protein survivi	1641-1703
26978233_en	FINDING	activated apoptosis	1617-1636
26978233_en	PHYS	apoptosis markers	58-75
26978233_en	PHYS	expression	44-54
26978233_en	CHEM	cytotoxic agents	1004-1020
26978233_en	CHEM	cytotoxic drugs	615-630
26978233_en	FINDING	activated apoptosis	1450-1469
26978233_en	FINDING	significantly more frequently detected	847-885
26978233_en	PHYS	survivin expression	1160-1179
26978233_en	FINDING	no survivin expression	1157-1179
26978233_en	FINDING	no statistically significant differences	1254-1294
26978233_en	CHEM	anti-tumor drug	755-770
26978233_en	DISO	tumor	760-765
26978233_en	CHEM	effector caspase	1517-1533
26978233_en	CHEM	caspase	1526-1533
26978233_en	DISO	metastases	96-106
26978233_en	CHEM	caspases	165-173
26978233_en	ANATOMY	Intraoperative samples	406-428
26978233_en	CHEM	Caspase	804-811
26978233_en	CHEM	caspase	1227-1234
26978418_en	CHEM	ARTRA MSM FORTE	8-23
26978418_en	DISO	knee osteoarthritis	41-60
26978418_en	CHEM	ARTRA MSM FORTE	236-251
26978418_en	CHEM	chondroitin sulfate	260-279
26978418_en	CHEM	glucosamine hydrochloride	288-313
26978418_en	CHEM	methylsulfonylmethane	322-343
26978418_en	CHEM	sodium hyaluronate	361-379
26978418_en	CHEM	hyaluronic acid	409-424
26978418_en	DISO	knee osteoarthritis	443-462
26978418_en	DISO	knee OA	556-563
26978418_en	CHEM	ARTRA MSM	985-994
26978418_en	CHEM	MSM	991-994
26978418_en	CHEM	ARTRA	1065-1070
26978418_en	DISO	pain	1301-1305
26978418_en	FINDING	pain intensity	1337-1351
26978418_en	DISO	stiffness	1473-1482
26978418_en	PHYS	joint function	1530-1544
26978418_en	CHEM	ARTRA	1797-1802
26978418_en	CHEM	ARTRA MSM	1837-1846
26978418_en	CHEM	ARTRA MSM	2032-2041
26978418_en	CHEM	ARTRA	2326-2331
26978418_en	CHEM	MSM	2332-2335
26978418_en	CHEM	ARTRA MSM	2533-2542
26978418_en	FINDING	prompter pain relief	2589-2609
26978418_en	CHEM	ARTRA	2619-2624
26978418_en	CHEM	ARTRA MSM	2643-2652
26978418_en	DISO	OA	2693-2695
26978418_en	DISO	osteoarthritis	46-60
26978418_en	ANATOMY	knee	41-45
26978418_en	CHEM	MSM	14-17
26978418_en	CHEM	MSM	242-245
26978418_en	CHEM	MSM	345-348
26978418_en	DISO	osteoarthritis	448-462
26978418_en	ANATOMY	knee	443-447
26978418_en	DISO	OA	464-466
26978418_en	DISO	OA	561-563
26978418_en	ANATOMY	knee	556-560
26978418_en	DISO	pain syndrome	577-590
26978418_en	DISO	pain	577-581
26978418_en	DISO	pain	592-596
26978418_en	FINDING	pain intensity scores	592-613
26978418_en	FINDING	WOMAC index scores	737-755
26978418_en	FINDING	significant decrease in pain	1277-1305
26978418_en	DISO	pain	1337-1341
26978418_en	FINDING	Reduced pain intensity	1329-1351
26978418_en	CHEM	ARTRA	236-241
26978418_en	CHEM	ARTRA	985-990
26978418_en	FINDING	diminished stiffness	1462-1482
26978418_en	ANATOMY	joint	1530-1535
26978418_en	FINDING	alleviated joint function	1519-1544
26978418_en	FINDING	reduced total WOMAC scores	1549-1575
26978418_en	CHEM	ARTRA MSM	1754-1763
26978418_en	CHEM	ARTRA	1754-1759
26978418_en	CHEM	MSM	1760-1763
26978418_en	CHEM	ARTRA	1837-1842
26978418_en	CHEM	MSM	1843-1846
26978418_en	FINDING	positive effect occurred more rapidl	1987-2023
26978418_en	CHEM	ARTRA	2032-2037
26978418_en	CHEM	MSM	2038-2041
26978418_en	FINDING	positive results	2097-2113
26978418_en	CHEM	ARTRA MSM	2326-2335
26978418_en	FINDING	Get-Up and Go test results	2391-2417
26978418_en	FINDING	improvement in Get-Up and Go test results	2376-2417
26978418_en	CHEM	ARTRA	2533-2538
26978418_en	CHEM	MSM	2539-2542
26978418_en	DISO	pain	2598-2602
26978418_en	CHEM	ARTRA	2643-2648
26978418_en	CHEM	MSM	2649-2652
26978418_en	CHEM	ARTRA	8-13
26978418_en	CHEM	ARTRA MSM	8-17
26978418_en	CHEM	ARTRA MSM	236-245
26978418_en	FINDING	no adverse reactions	2263-2283
26978418_en	PHYS	quality of life	860-875
26978418_en	PHYS	life	871-875
26978418_en	CHEM	sulfate	272-279
26978418_en	CHEM	hydrochloride	300-313
26978418_en	CHEM	glucosamine	288-299
26978418_en	CHEM	sodium	361-367
26978418_en	FINDING	clinical efficacy and safety of the combined medication	180-235
26978418_en	FINDING	significant improvement	2127-2150
26978418_en	FINDING	efficacy and tolerability of the drug	122-159
26978418_en	CHEM	chondroitin	260-271
26978418_en	CHEM	hyaluronate	368-379
26978418_en	CHEM	acid	420-424
26978418_en	FINDING	efficiency of therapy in the opinion of a physician and a patient	789-854
26978418_en	FINDING	significantly less spent time	1637-1666
26978418_en	FINDING	differences reached the statistical significance	1698-1746
26978418_en	FINDING	effect ARTRA MSM occurred more rapidly	1830-1868
26978418_en	FINDING	evaluations of the efficiency of treatment	1918-1960
26978418_en	FINDING	may be recommended for the treatment of OA	2653-2695
26978418_en	FINDING	evaluations of the efficiency of treatment	2444-2486
26978418_en	FINDING	well tolerated	2237-2251
26978418_en	FINDING	decrease in pain	1289-1305
26978418_en	FINDING	rapider in its effect	2339-2360
26978491_en	DISO	chronic kidney disease	47-69
26978491_en	DISO	CI	477-479
26978491_en	PHYS	mental status	549-562
26978491_en	ANATOMY	frontal lobe	595-607
26978491_en	PHYS	arterial blood pressure	683-706
26978491_en	ANATOMY	carotid	751-758
26978491_en	FINDING	pulse-wave velocity	781-800
26978491_en	LABPROC	brain MRI	825-834
26978491_en	DISO	CKD, stages I-II	919-935
26978491_en	DISO	CI	983-985
26978491_en	DISO	CKD, stages III-IV	1014-1032
26978491_en	DISO	CKD	1080-1083
26978491_en	LABPROC	MRI	1154-1157
26978491_en	ANATOMY	white matter	1192-1204
26978491_en	DISO	leukoaraiosis	1225-1238
26978491_en	DISO	lateral ventricular dilatation	1249-1279
26978491_en	ANATOMY	sulci of brain hemispheres	1316-1342
26978491_en	PHYS	male sex	1391-1399
26978491_en	DISO	hyperhomocysteinemia	1401-1421
26978491_en	DISO	anemia	1423-1429
26978491_en	DISO	abdominal obesity	1431-1448
26978491_en	DISO	left ventricular myocardial hypertrophy	1450-1489
26978491_en	PHYS	age	1494-1497
26978491_en	DISO	CI	1529-1531
26978491_en	DISO	atherosclerotic	1565-1580
26978491_en	DISO	lesions	1581-1588
26978491_en	ANATOMY	common carotid arteries	1592-1615
26978491_en	PHYS	arterial rigidity	1631-1648
26978491_en	DISO	CKD	1684-1687
26978491_en	DISO	CI	1725-1727
26978491_en	ANATOMY	frontal lobes	1749-1762
26978491_en	DISO	CI	1802-1804
26978491_en	DISO	CKD, stages III-IV	1822-1840
26978491_en	DISO	CKD, stages III-IV	1842-1860
26978491_en	DISO	CI	1893-1895
26978491_en	DISO	kidney disease	55-69
26978491_en	ANATOMY	kidney	55-61
26978491_en	DISO	Cognitive impairment	1-21
26978491_en	DISO	cognitive impairment	128-148
26978491_en	DISO	CI	150-152
26978491_en	ANATOMY	vascular-wall	194-207
26978491_en	ANATOMY	vascular	194-202
26978491_en	DISO	vascular-wall remodeling	194-218
26978491_en	DISO	chronic kidney disease	236-258
26978491_en	DISO	kidney disease	244-258
26978491_en	ANATOMY	kidney	244-250
26978491_en	DISO	CKD	260-263
26978491_en	DISO	CKD, stages I-II	356-372
26978491_en	DISO	CKD, stage III	382-396
26978491_en	DISO	CKD, stage IV	410-423
26978491_en	PHYS	frontal lobe functions	595-617
26978491_en	LABPROC	echocardiographic study	654-677
26978491_en	LABPROC	24h arterial blood pressure monitoring	679-717
26978491_en	ANATOMY	arterial	683-691
26978491_en	PHYS	blood pressure	692-706
26978491_en	ANATOMY	blood	692-697
26978491_en	PHYS	thickness of carotid intima-media	738-771
26978491_en	ANATOMY	brain	825-830
26978491_en	LABPROC	MRI	831-834
26978491_en	DISO	CI	867-869
26978491_en	DISO	CKD, stage IV	952-965
26978491_en	DISO	CI	1113-1115
26978491_en	DISO	CI	1131-1133
26978491_en	DISO	focal lesions	1171-1184
26978491_en	ANATOMY	lateral ventricular	1249-1268
26978491_en	DISO	dilatation in the sulci of brain hemispheres	1298-1342
26978491_en	ANATOMY	brain hemispheres	1325-1342
26978491_en	ANATOMY	brain	1325-1330
26978491_en	DISO	CI	1384-1386
26978491_en	PHYS	sex	1396-1399
26978491_en	ANATOMY	abdominal	1431-1440
26978491_en	DISO	hypertrophy	1478-1489
26978491_en	ANATOMY	left ventricular	1450-1466
26978491_en	ANATOMY	ventricular	1455-1466
26978491_en	DISO	atherosclerotic lesions	1565-1588
26978491_en	ANATOMY	arteries	1607-1615
26978491_en	ANATOMY	carotid arteries	1599-1615
26978491_en	ANATOMY	arterial	1631-1639
26978491_en	DISO	dysfunction of frontal lobes	1734-1762
26978491_en	ANATOMY	myocardial	1467-1477
26978491_en	ANATOMY	ventricular	1257-1268
26978491_en	DISO	dysfunction	1734-1745
26978491_en	DISO	obesity	1441-1448
26978491_en	DISO	chronic kidney disease (CKD), stages I-IV	236-277
26978491_en	DISO	CKD	356-359
26978491_en	DISO	CKD	382-385
26978491_en	DISO	CKD	410-413
26978491_en	DISO	CKD	919-922
26978491_en	DISO	CKD	952-955
26978491_en	DISO	CKD stages I-II	1014-1068
26978491_en	DISO	CKD	1014-1017
26978491_en	DISO	CKD	1822-1825
26978491_en	DISO	CKD	1842-1845
26978491_en	DISO	predialysis stages of chronic kidney disease	25-69
26978491_en	FINDING	Frequency, severity and character of CI	440-479
26978491_en	PHYS	short-term memory	564-593
26978491_en	PHYS	delayed memory	579-593
26978491_en	LABPROC	Standard laboratory examinations	620-652
26978491_en	FINDING	severity of CI was higher	971-996
26978491_en	FINDING	predicted the development of CI	1084-1115
26978491_en	FINDING	frequency and severity of CI	1503-1531
26978491_en	FINDING	increased the CKD severity	1670-1696
26978491_en	FINDING	higher the severity of CI	1702-1727
26978491_en	FINDING	development of CI	1787-1804
26978491_en	DISO	predialysis stages	1909-1927
26978491_en	PHYS	memory	587-593
26978491_en	PHYS	pulse-wave	781-791
26978491_en	ANATOMY	sulci	1316-1321
26978491_en	FINDING	independent predictor of CI	1868-1895
26978491_en	ANATOMY	lobe	603-607
26978491_en	FINDING	development and progression of cognitive impairment	97-148
26978491_en	FINDING	risk factors	159-171
26978498_en	CHEM	agomelatine	35-46
26978498_en	DISO	depression	81-91
26978498_en	DISO	chronic brain ischemia	96-118
26978498_en	CHEM	agomelatine	174-185
26978498_en	CHEM	valdoxan	187-195
26978498_en	DISO	chronic brain ischemia	253-275
26978498_en	DISO	CBI	277-280
26978498_en	DISO	affective impairment	540-574
26978498_en	DISO	cognitive impairment	554-574
26978498_en	CHEM	Agomelatine	1121-1132
26978498_en	CHEM	valdoxan	1134-1142
26978498_en	CHEM	Agomelatine	1237-1248
26978498_en	PHYS	sleep	1258-1263
26978498_en	DISO	anxiety	1307-1314
26978498_en	DISO	depressive symptoms	1344-1363
26978498_en	DISO	chronic brain ischemia	1593-1615
26978498_en	DISO	anxiety	1653-1660
26978498_en	DISO	depression	1662-1672
26978498_en	DISO	insomnia	1674-1682
26978498_en	CHEM	agomelatine	1752-1763
26978498_en	DISO	CBI	1794-1797
26978498_en	ANATOMY	brain	104-109
26978498_en	DISO	brain ischemia	104-118
26978498_en	DISO	ischemia	110-118
26978498_en	DISO	brain ischemia	261-275
26978498_en	DISO	ischemia	267-275
26978498_en	ANATOMY	brain	261-266
26978498_en	DISO	depressive states	218-235
26978498_en	DISO	CBI stage I	414-426
26978498_en	DISO	CBI stage II	448-461
26978498_en	DISO	depressive episode	489-507
26978498_en	DISO	depressive episode of mild severity	489-524
26978498_en	DISO	Depression	651-661
26978498_en	DISO	Anxiety	699-706
26978498_en	DISO	Depression	711-721
26978498_en	PHYS	night sleep	740-751
26978498_en	DISO	anxiety symptoms	1307-1323
26978498_en	FINDING	reduced anxiety symptoms	1299-1323
26978498_en	FINDING	improved sleep	1249-1263
26978498_en	FINDING	improvement of cognitive functions	1387-1421
26978498_en	FINDING	No side-effects	1441-1456
26978498_en	FINDING	antidepressive activity	1501-1524
26978498_en	FINDING	high antidepressive activity	1496-1524
26978498_en	DISO	brain ischemia	1601-1615
26978498_en	DISO	ischemia	1607-1615
26978498_en	FINDING	positive effect on cognitive functions	1688-1726
26978498_en	ANATOMY	brain	1601-1606
26978498_en	DISO	mild depressive states	213-235
26978498_en	DISO	depressive	218-228
26978498_en	DISO	depressive	489-499
26978498_en	DISO	depressive	1344-1354
26978498_en	DISO	mild depressive states	1553-1575
26978498_en	DISO	CBI	414-417
26978498_en	DISO	CBI	448-451
26978498_en	FINDING	efficacy and tolerability of agomelatine	145-185
26978498_en	PHYS	sleep	746-751
26978498_en	DISO	depressive states	1558-1575
26978498_en	FINDING	balanced spectrum of effects on anxiety, depression, insomnia	1621-1682
26978498_en	FINDING	recommend agomelatine in treatment of patients	1742-1788
26978499_en	CHEM	teraligen	28-37
26978499_en	DISO	brain ischemia	55-69
26978499_en	DISO	psychoautonomic syndrome	92-116
26978499_en	CHEM	teraligen	166-175
26978499_en	DISO	psychoautonomic syndrome	193-217
26978499_en	DISO	brain ischemia	230-244
26978499_en	CHEM	teraligen	471-480
26978499_en	PHYS	Neurological status	626-645
26978499_en	PHYS	autonomic changes	647-664
26978499_en	LABPROC	Neurophysiological examination	740-770
26978499_en	LABPROC	EEG	772-775
26978499_en	FINDING	no side-effects	1078-1093
26978499_en	DISO	vascular disorders	1127-1145
26978499_en	LABPROC	neurophysiological examinations	1216-1247
26978499_en	DISO	psychoautonomic syndrome	1295-1319
26978499_en	PHYS	elderly	1323-1330
26978499_en	DISO	brain ischemia	1345-1359
26978499_en	DISO	ischemia	61-69
26978499_en	ANATOMY	brain	55-60
26978499_en	ANATOMY	brain	230-235
26978499_en	DISO	ischemia	236-244
26978499_en	DISO	brain ischemia	350-364
26978499_en	DISO	ischemia	356-364
26978499_en	ANATOMY	brain	350-355
26978499_en	DISO	psychoautonomic syndrome	401-425
26978499_en	LABPROC	P300 event-related potential	780-808
26978499_en	DISO	psychoautonomic symptoms	929-953
26978499_en	FINDING	positive dynamics of the decrease of psychoautonomic symptoms	892-953
26978499_en	DISO	cephalgic syndrome	955-973
26978499_en	PHYS	sleep	975-980
26978499_en	FINDING	sleep normalization	975-994
26978499_en	FINDING	improvement of cognitive function	1010-1043
26978499_en	FINDING	Good tolerability	1056-1073
26978499_en	ANATOMY	vascular	1127-1135
26978499_en	DISO	ischemia	1351-1359
26978499_en	ANATOMY	brain	1345-1350
26978499_en	DISO	disorders	1136-1145
26978499_en	FINDING	efficacy and safety of teraligen	5-37
26978499_en	FINDING	efficacy and safety of teraligen	143-175
26978499_en	DISO	brain ischemia, stages I and II	55-86
26978499_en	DISO	brain ischemia, stages I and II	350-381
26978499_en	LABPROC	event-related potential	785-808
26978499_en	FINDING	decrease of psychoautonomic symptoms, cephalgic syndrome	917-973
26978499_en	DISO	brain ischemia, stages I and II	1345-1376
26978499_en	FINDING	recommended for treatment of psychoautonomic syndrome	1266-1319
26978504_en	CHEM	xefocam	206-213
26978504_en	CHEM	mydocalm-richter	218-234
26978504_en	DISO	spinal osteochondrosis	396-418
26978504_en	DISO	root syndrome	424-437
26978504_en	DISO	radiculopathia	442-456
26978504_en	ANATOMY	lumbar/sacral spine	464-483
26978504_en	DISO	pain syndrome	489-502
26978504_en	DISO	pain syndrome	582-595
26978504_en	CHEM	xefocam	997-1004
26978504_en	CHEM	mydocalm-richter	1060-1076
26978504_en	ANATOMY	lumbar/sacral spine	1137-1156
26978504_en	CHEM	xefocam	1242-1249
26978504_en	CHEM	mydocalm-richter	1254-1270
26978504_en	DISO	pain syndrome	1341-1354
26978504_en	FINDING	pain reduction	1515-1529
26978504_en	DISO	low-back pain	86-99
26978504_en	DISO	pain	95-99
26978504_en	ANATOMY	low-back	86-94
26978504_en	ANATOMY	back	90-94
26978504_en	DISO	low-back pain	259-272
26978504_en	DISO	pain	268-272
26978504_en	ANATOMY	low-back	259-267
26978504_en	ANATOMY	back	263-267
26978504_en	DISO	osteochondrosis	403-418
26978504_en	ANATOMY	spinal	396-402
26978504_en	ANATOMY	lumbar	464-470
26978504_en	ANATOMY	sacral	471-477
26978504_en	ANATOMY	spine	478-483
26978504_en	DISO	pain	489-493
26978504_en	DISO	pain	582-586
26978504_en	DISO	Pain	687-691
26978504_en	PHYS	Quality-of-life	707-722
26978504_en	DEVICE	Farma T.E.B. Trans Epidermal Barrier Physio	902-945
26978504_en	ANATOMY	lumbar	1137-1143
26978504_en	ANATOMY	sacral	1144-1150
26978504_en	ANATOMY	spine	1151-1156
26978504_en	DISO	pain	1341-1345
26978504_en	FINDING	reduction of pain syndrome	1328-1354
26978504_en	DISO	pain	1515-1519
26978504_en	FINDING	Positive treatment effect	1645-1670
26978504_en	FINDING	good tolerability	1702-1719
26978504_en	PHYS	life	718-722
26978504_en	DISO	Pain	1372-1376
26978504_en	FINDING	Clinical outcome	807-823
26978504_en	FINDING	high clinical efficacy of electrode pharmaphoresis	1185-1235
26978504_en	FINDING	Treatment efficacy	531-549
26978504_en	FINDING	clinical efficacy of electrode pharmaphoresis	3-48
26978504_en	FINDING	clinical efficacy and tolerability of electrode pharmaphoresis	124-186
26978504_en	FINDING	reduced to mild grade	1390-1411
26978504_en	FINDING	increased significantly	1599-1622
26978504_en	FINDING	quality of self-service	1556-1579
26978504_en	ANATOMY	root	424-428
26978504_en	CHEM	solution	1006-1014
26978504_en	CHEM	solution for injections	1006-1029
26978504_en	CHEM	solution	1078-1086
26978504_en	CHEM	solution for injections	1078-1101
26978504_en	CHEM	mydocalm	1254-1262
26978504_en	CHEM	mydocalm	1060-1068
26978504_en	FINDING	clinical efficacy of electrode pharmaphoresis	1190-1235
26978635_en	DISO	carotid artery dissection	10-35
26978635_en	DISO	severe ischemic stroke	50-72
26978635_en	PHYS	male	142-146
26978635_en	DISO	ischemic stroke	166-181
26978635_en	ANATOMY	right internal carotid artery	202-231
26978635_en	DISO	dissection	238-248
26978635_en	LABPROC	magnetic resonance imaging	297-323
26978635_en	LABPROC	pathomorphological examination	328-358
26978635_en	CHEM	creatine phosphokinase	392-414
26978635_en	ANATOMY	blood	453-458
26978635_en	PHYS	coagulation	474-485
26978635_en	LABPROC	Autopsy	510-517
26978635_en	DISO	intramural hematoma	527-546
26978635_en	ANATOMY	adventitia of the arterial wall,	594-626
26978635_en	ANATOMY	arterial wall	612-625
26978635_en	ANATOMY	common carotid artery bifurcation	651-684
26978635_en	ANATOMY	skull	717-722
26978635_en	ANATOMY	lumen of the ICA	729-745
26978635_en	ANATOMY	ICA	742-745
26978635_en	ANATOMY	intracranial parts	774-792
26978635_en	ANATOMY	middle cerebral artery	811-833
26978635_en	DISO	thrombus	854-862
26978635_en	ANATOMY	right ICA wall	900-914
26978635_en	ANATOMY	internal elastic membrane	971-996
26978635_en	DISO	media fibrosis	1005-1019
26978635_en	DISO	myocyte necrosis	1021-1037
26978635_en	DISO	dissection	1057-1067
26978635_en	ANATOMY	leukocyte	1089-1098
26978635_en	DISO	lymphocytic infiltrates	1124-1147
26978635_en	ANATOMY	eosinophils	1161-1172
26978635_en	ANATOMY	adventitia	1176-1186
26978635_en	ANATOMY	myocyte	1212-1219
26978635_en	DISO	necrosis	1220-1228
26978635_en	ANATOMY	brain	1272-1277
26978635_en	ANATOMY	arteries	1288-1296
26978635_en	DISO	fibromuscular dysplasia	1340-1363
26978635_en	LABPROC	electron microscopic studies	1389-1417
26978635_en	ANATOMY	skeletal muscles	1421-1437
26978635_en	DISO	mitochondrial cytopathy	1454-1477
26978635_en	DISO	dissection	1528-1538
26978635_en	DISO	FMD	1540-1543
26978635_en	ANATOMY	mitochondrial	1548-1561
26978635_en	DISO	stroke	66-72
26978635_en	ANATOMY	carotid artery	10-24
26978635_en	ANATOMY	artery	18-24
26978635_en	DISO	Internal carotid artery dissection	1-35
26978635_en	DISO	stroke	175-181
26978635_en	ANATOMY	internal carotid artery	208-231
26978635_en	ANATOMY	Internal carotid artery	1-24
26978635_en	ANATOMY	ICA	233-236
26978635_en	ANATOMY	carotid artery	217-231
26978635_en	ANATOMY	carotid	217-224
26978635_en	ANATOMY	artery	225-231
26978635_en	ANATOMY	head	270-274
26978635_en	FINDING	high level of creatine phosphokinase	378-414
26978635_en	DISO	hematoma	538-546
26978635_en	DISO	IMH	548-551
26978635_en	ANATOMY	media of the arterial wall,	584-626
26978635_en	ANATOMY	carotid artery	658-672
26978635_en	ANATOMY	artery	666-672
26978635_en	ANATOMY	base of the skull	705-722
26978635_en	ANATOMY	intracranial	774-786
26978635_en	ANATOMY	cerebral artery	818-833
26978635_en	ANATOMY	artery	827-833
26978635_en	ANATOMY	ICA	906-909
26978635_en	DISO	splitting	921-930
26978635_en	DISO	thinning	932-940
26978635_en	DISO	fragmentation	942-955
26978635_en	DISO	disrupters of internal elastic membrane	957-996
26978635_en	ANATOMY	elastic membrane	980-996
26978635_en	ANATOMY	media	1005-1010
26978635_en	DISO	fibrosis	1011-1019
26978635_en	DISO	necrosis	1029-1037
26978635_en	ANATOMY	myocyte	1021-1028
26978635_en	DISO	leukocyte infiltration	1089-1111
26978635_en	ANATOMY	lymphocytic	1124-1135
26978635_en	FINDING	clusters of eosinophils in adventitia	1149-1186
26978635_en	DISO	myocyte necrosis	1212-1228
26978635_en	ANATOMY	brain supplying arteries	1272-1296
26978635_en	DISO	dysplasia	1354-1363
26978635_en	DISO	FMD	1365-1368
26978635_en	ANATOMY	muscles	1430-1437
26978635_en	DISO	cytopathy	1468-1477
26978635_en	ANATOMY	mitochondrial	1454-1467
26978635_en	DISO	mitochondrial pathology	1548-1571
26978635_en	LABPROC	histological examination	868-892
26978635_en	PHYS	fatal	160-165
26978635_en	PHYS	level of creatine phosphokinase	383-414
26978635_en	ANATOMY	membrane	988-996
26978635_en	ANATOMY	arterial	612-620
26978635_en	DISO	ischemic	57-65
26978635_en	DISO	ischemic	166-174
26978635_en	DISO	dissection	25-35
26978635_en	FINDING	lethal outcome	78-92
26978635_en	PHYS	lethal	78-84
26978635_en	LABPROC	Histochemical	1371-1384
26978635_en	DISO	severe media fibrosis	998-1019
26978635_en	DISO	ischemic stroke	57-72
26978635_en	FINDING	coagulation parameters were normal	474-508
26978635_en	ANATOMY	bifurcation	673-684
26978635_en	ANATOMY	skeletal	1421-1429
26978635_en	ANATOMY	common carotid artery	651-672
26978635_en	DISO	IMG	766-769
26978635_en	ANATOMY	right ICA	900-909
26978639_en	PHYS	lipid profile	5-18
26978639_en	DISO	psychosomatic illnesses	65-88
26978639_en	CHEM	triglyceride	191-203
26978639_en	DISO	psychosomatic illnesses	257-280
26978639_en	DISO	chronic cerebral ischemia	285-310
26978639_en	DISO	CCI	439-442
26978639_en	CHEM	cholesterol	478-489
26978639_en	LABPROC	cholesterol and triglyceride tests	478-512
26978639_en	PHYS	Cholesterol levels	607-625
26978639_en	DISO	post-infarct cardiosclerosis	655-683
26978639_en	DISO	peptic ulcer disease	771-791
26978639_en	CHEM	Triglyceride	800-812
26978639_en	DISO	PICS	900-904
26978639_en	DISO	PUD	935-938
26978639_en	ANATOMY	Plasma	940-946
26978639_en	CHEM	cholesterol	947-958
26978639_en	CHEM	triglyceride	963-975
26978639_en	DISO	Cognitive impairment	1085-1105
26978639_en	DISO	neurotization	1126-1139
26978639_en	DISO	psychosomatic illnesses	1177-1200
26978639_en	PHYS	plasma cholesterol and triglyceride levels	1245-1287
26978639_en	DISO	cognitive impairment	1319-1339
26978639_en	DISO	chronic cerebral ischemia	93-118
26978639_en	DISO	cerebral ischemia	101-118
26978639_en	DISO	ischemia	110-118
26978639_en	ANATOMY	cerebral	101-109
26978639_en	ANATOMY	plasma	168-174
26978639_en	CHEM	cholesterol	175-186
26978639_en	DISO	CCI	312-315
26978639_en	DISO	cerebral ischemia	293-310
26978639_en	DISO	ischemia	302-310
26978639_en	ANATOMY	cerebral	293-301
26978639_en	CHEM	triglyceride	494-506
26978639_en	DISO	neurotization	578-591
26978639_en	CHEM	Cholesterol	607-618
26978639_en	DISO	cardiosclerosis	668-683
26978639_en	DISO	PICS	685-689
26978639_en	DISO	infarct	660-667
26978639_en	DISO	PUD	793-796
26978639_en	PHYS	Triglyceride levels	800-819
26978639_en	PHYS	cholesterol and triglyceride levels	947-982
26978639_en	CHEM	cholesterol	1252-1263
26978639_en	ANATOMY	plasma	1245-1251
26978639_en	CHEM	triglyceride	1268-1280
26978639_en	PHYS	plasma cholesterol and triglyceride levels	168-210
26978639_en	CHEM	lipid	5-10
26978639_en	FINDING	correlations between plasma cholesterol and triglyceride levels	147-210
26978639_en	FINDING	Cholesterol levels were higher	607-637
26978639_en	FINDING	Triglyceride levels were high	800-829
26978639_en	FINDING	higher level of neurotization	1110-1139
26978639_en	DISO	psychosomatic	838-851
26978639_en	FINDING	not differ from those of patients with peptic ulcer disease	732-791
26978639_en	DISO	ulcer disease	778-791
26978639_en	FINDING	higher levels in the patients with PICS	865-904
26978639_en	FINDING	not correlated with assessments of cognitive functions	988-1042
26978639_en	FINDING	prognostic factor for cognitive impairment	1297-1339
27022660_en	DISO	polyangiitis	53-65
27022660_en	DISO	Granulomatosis with polyangiitis	96-128
27022660_en	DISO	Wegener's granulomatosis	162-186
27022660_en	DISO	necrotizing vasculitis	206-228
27022660_en	ANATOMY	vessels	255-262
27022660_en	DISO	granulomatous inflammation	315-341
27022660_en	DISO	GPA	371-374
27022660_en	ANATOMY	organ of vision	382-397
27022660_en	ANATOMY	ocular superficial structures	587-616
27022660_en	ANATOMY	orbital	646-653
27022660_en	ANATOMY	ocular	658-664
27022660_en	DISO	complete blindness	687-705
27022660_en	ANATOMY	organ of vision	767-782
27022660_en	DISO	lesions	955-962
27022660_en	ANATOMY	orbit	970-975
27022660_en	ANATOMY	appendages	980-990
27022660_en	ANATOMY	conjunctiva	1008-1019
27022660_en	ANATOMY	eyeball:	1045-1053
27022660_en	ANATOMY	retina	1070-1076
27022660_en	ANATOMY	optic nerve	1094-1105
27022660_en	ANATOMY	Orbital	1107-1114
27022660_en	ANATOMY	surrounding tissues	1236-1255
27022660_en	ANATOMY	tissues	1248-1255
27022660_en	ANATOMY	oculomotor muscles	1267-1285
27022660_en	DISO	destruction of orbital bony walls	1291-1324
27022660_en	ANATOMY	orbital bony walls	1306-1324
27022660_en	DISO	conjunctivitis	1338-1352
27022660_en	DISO	episcleritis	1357-1369
27022660_en	ANATOMY	fibrous tunic	1413-1426
27022660_en	DISO	necrotizing scleritis	1481-1502
27022660_en	DISO	peripheral ulcerative keratitis	1504-1546
27022660_en	DISO	stromal keratitis	1529-1546
27022660_en	ANATOMY	retina	1552-1558
27022660_en	ANATOMY	optic nerve	1640-1651
27022660_en	ANATOMY	orbit	1707-1712
27022660_en	ANATOMY	tissue	1725-1731
27022660_en	DISO	ischemic	1765-1773
27022660_en	DISO	Wegener's granulomatosis	67-91
27022660_en	DISO	granulomatosis with polyangiitis	33-65
27022660_en	DISO	GPA	130-133
27022660_en	ANATOMY	small and medium-sized vessels	232-262
27022660_en	DISO	inflammation	329-341
27022660_en	FINDING	fatal outcome	507-520
27022660_en	DISO	inflammation	567-579
27022660_en	ANATOMY	ocular	587-593
27022660_en	DISO	blindness bilateral	696-726
27022660_en	DISO	GPA	733-736
27022660_en	ANATOMY	fibrous tunic	1024-1037
27022660_en	ANATOMY	nerve	1100-1105
27022660_en	DISO	granulomas	1164-1174
27022660_en	DISO	dacryoadenitis	1176-1190
27022660_en	DISO	inflammatory infiltration	1203-1228
27022660_en	ANATOMY	muscles	1278-1285
27022660_en	PHYS	oculomotor	1267-1277
27022660_en	ANATOMY	orbital	1306-1313
27022660_en	ANATOMY	bony walls	1314-1324
27022660_en	ANATOMY	eyeball	1434-1441
27022660_en	DISO	scleritis	1493-1502
27022660_en	DISO	keratitis	1537-1546
27022660_en	ANATOMY	stromal	1529-1536
27022660_en	ANATOMY	nerve	1646-1651
27022660_en	DISO	compression of the orbit	1688-1712
27022660_en	FINDING	reduce quality of life	427-449
27022660_en	PHYS	quality of life	434-449
27022660_en	PHYS	fatal	507-512
27022660_en	PHYS	life	445-449
27022660_en	DISO	inflamed	1716-1724
27022660_en	DISO	polyangiitis	116-128
27022660_en	DISO	inflammatory	1203-1215
27022660_en	DISO	Orbital affection	1107-1124
27022660_en	DISO	Affection of the fibrous tunic	1396-1426
27022660_en	DISO	granulomatosis	33-47
27022660_en	DISO	granulomatosis	77-91
27022660_en	PHYS	vision	391-397
27022660_en	DISO	Granulomatosis	96-110
27022660_en	DISO	granulomatosis	172-186
27022660_en	DISO	vasculitis	218-228
27022660_en	DISO	blindness	696-705
27022660_en	PHYS	vision	776-782
27022660_en	DISO	lesions of the orbit and appendages	955-990
27022660_en	ANATOMY	tunic	1421-1426
27022660_en	DISO	necrotizing	1481-1492
27022660_en	DISO	complications	485-498
27022660_en	FINDING	lead to the severest complications	464-498
27029443_en	ANATOMY	arteries brachiocephalic	102-88
27029443_en	ANATOMY	coronary arteries	93-110
27029443_en	DISO	coronary heart disease	186-208
27029443_en	ANATOMY	cerebral vessels	240-256
27029443_en	ANATOMY	heart	297-302
27029443_en	ANATOMY	Cerebral	350-358
27029443_en	ANATOMY	coronary	363-371
27029443_en	PHYS	blood flow	372-382
27029443_en	ANATOMY	brain	411-416
27029443_en	ANATOMY	heart	421-426
27029443_en	ANATOMY	coronary	571-579
27029443_en	ANATOMY	brachiocephalic arteries	584-608
27029443_en	ANATOMY	brachiocephalic arteries	662-686
27029443_en	ANATOMY	coronary	788-796
27029443_en	ANATOMY	brachiocephalic arteries	801-825
27029443_en	ANATOMY	myocardium	851-861
27029443_en	ANATOMY	brain	866-871
27029443_en	ANATOMY	coronary arteries	1013-1050
27029443_en	ANATOMY	brachiocephalic arteries	1026-1050
27029443_en	DISO	atherosclerotic lesions	46-69
27029443_en	ANATOMY	arteries	102-110
27029443_en	ANATOMY	coronary	93-101
27029443_en	DISO	heart disease	195-208
27029443_en	ANATOMY	heart	195-200
27029443_en	ANATOMY	coronary	186-194
27029443_en	DISO	atherosclerotic lesions	213-236
27029443_en	ANATOMY	cerebral	240-248
27029443_en	ANATOMY	brain	307-312
27029443_en	ANATOMY	blood	372-377
27029443_en	PHYS	functional state	387-403
27029443_en	ANATOMY	brachiocephalic	584-599
27029443_en	ANATOMY	arteries	600-608
27029443_en	ANATOMY	brachiocephalic	662-677
27029443_en	ANATOMY	arteries	678-686
27029443_en	ANATOMY	graft	715-720
27029443_en	ANATOMY	brachiocephalic	801-816
27029443_en	ANATOMY	arteries	817-825
27029443_en	PHYS	functional state	827-843
27029443_en	ANATOMY	brachiocephalic	1026-1041
27029443_en	ANATOMY	arteries	1042-1050
27029443_en	ANATOMY	vessels	249-256
27029443_en	FINDING	postoperative risk	879-897
27029443_en	ANATOMY	brachiocephalic	73-88
27029443_en	ANATOMY	coronary arteries	571-608
27029443_en	ANATOMY	coronary arteries	788-825
27029443_en	ANATOMY	coronary	1013-1021
27029443_en	DISO	complications	313-326
27029443_en	FINDING	algorithm for choosing the order of priority of surgical interventions	939-1009
27029445_en	CHEM	actovegin	150-159
27029445_en	ANATOMY	carotid	163-170
27029445_en	ANATOMY	carotid arteries	343-359
27029445_en	CHEM	actovegin	462-471
27029445_en	DISO	post-surgery ischemic strokes	865-894
27029445_en	ANATOMY	brain areas	908-919
27029445_en	CHEM	actovegin	988-997
27029445_en	DISO	carotid artery stenosis	1023-1046
27029445_en	ANATOMY	carotid	52-59
27029445_en	DISO	lesions of carotid arteries	332-359
27029445_en	ANATOMY	carotid	343-350
27029445_en	CHEM	actovegin	562-571
27029445_en	PHYS	cerebral perfusion	586-604
27029445_en	FINDING	increased the cerebral perfusion	572-604
27029445_en	LABPROC	computed tomography	641-660
27029445_en	LABPROC	one-photon emission computed tomography	621-660
27029445_en	DISO	asymptotic post-surgery ischemic strokes	854-894
27029445_en	DISO	ischemic strokes	878-894
27029445_en	DISO	strokes	887-894
27029445_en	ANATOMY	brain	908-913
27029445_en	ANATOMY	carotid artery	1023-1037
27029445_en	ANATOMY	carotid	1023-1030
27029445_en	ANATOMY	artery	1031-1037
27029445_en	DISO	stenosis	1038-1046
27029445_en	ANATOMY	cerebral	586-594
27029445_en	DISO	ischemic	878-886
27029445_en	LABPROC	tomography	650-660
27029445_en	PHYS	perfusion	595-604
27029445_en	FINDING	efficacy of pharmacological preconditioning	5-48
27029445_en	FINDING	efficacy of pharmacological preconditioning	101-144
27029445_en	FINDING	positive role of pharmacological preconditioning	934-982
27029445_en	PHYS	hemodynamically	285-300
27029445_en	FINDING	improved significantly results of the surgery	666-711
27029445_en	FINDING	significant changes in patient's state	724-762
27029445_en	PHYS	patient's state	747-762
27029445_en	FINDING	improvement was correlated with the less number of asymptotic post-surgery ischemic strokes	803-894
27030091_en	INJURY_POISONING	fractures	23-32
27030091_en	ANATOMY	cervical vertebrae	40-79
27030091_en	ANATOMY	thoracic vertebrae	50-79
27030091_en	ANATOMY	lumbar vertebrae	63-79
27030091_en	ANATOMY	spinal regions	270-284
27030091_en	INJURY_POISONING	fractures	511-520
27030091_en	ANATOMY	cervical vertebrae	528-568
27030091_en	ANATOMY	lumbar vertebrae	552-568
27030091_en	INJURY_POISONING	fractures	718-727
27030091_en	INJURY_POISONING	fractures	893-902
27030091_en	ANATOMY	lower cervical vertebrae	910-934
27030091_en	INJURY_POISONING	fractures	1088-1097
27030091_en	ANATOMY	upper cervical vertebrae	1105-1129
27030091_en	ANATOMY	thoracic spine	1212-1226
27030091_en	INJURY_POISONING	fractures	1241-1250
27030091_en	ANATOMY	cervical vertebrae	1258-1287
27030091_en	ANATOMY	lumbar vertebrae	1271-1287
27030091_en	INJURY_POISONING	fractures	1357-1366
27030091_en	ANATOMY	thoracic part	1374-1387
27030091_en	ANATOMY	vertebral column	1395-1411
27030091_en	INJURY_POISONING	fractures	1461-1470
27030091_en	ANATOMY	lumbar vertebrae	1478-1494
27030091_en	ANATOMY	thoracic vertebrae	538-568
27030091_en	INJURY_POISONING	injuries	1196-1204
27030091_en	ANATOMY	vertebral	1395-1404
27030091_en	ANATOMY	thoracic	1212-1220
27030091_en	ANATOMY	spine	822-827
27030091_en	ANATOMY	spine	1221-1226
27030091_en	ANATOMY	cervical	916-924
27030091_en	ANATOMY	cervical	1111-1119
27030091_en	ANATOMY	spinal	270-276
27030091_en	ANATOMY	spinal	754-760
27030091_en	ANATOMY	lumbar	63-69
27030091_en	ANATOMY	lumbar	552-558
27030091_en	ANATOMY	lumbar	1271-1277
27030091_en	ANATOMY	lumbar	1478-1484
27030091_en	PHYS	fatal	470-475
27030091_en	ANATOMY	spinal column	754-767
27030091_en	PHYS	spine flexion	822-835
27030091_en	ANATOMY	cervical vertebrae	916-934
27030091_en	ANATOMY	cervical vertebrae	1111-1129
27030091_en	INJURY_POISONING	injuries	476-484
27030091_en	INJURY_POISONING	injuries	252-260
27030091_en	ANATOMY	vertebrae	70-79
27030091_en	ANATOMY	vertebrae	559-568
27030091_en	ANATOMY	cervical	40-48
27030091_en	ANATOMY	thoracic	50-58
27030091_en	INJURY_POISONING	fatal injuries	470-484
27030091_en	ANATOMY	vertebrae	925-934
27030091_en	ANATOMY	vertebrae	1120-1129
27030091_en	ANATOMY	vertebrae	1278-1287
27030091_en	ANATOMY	cervical	1258-1266
27030091_en	ANATOMY	vertebrae	1485-1494
27030091_en	ANATOMY	cervical	528-536
27030091_en	ANATOMY	thoracic	538-546
27030091_en	INJURY_POISONING	injuries	576-584
27030091_en	INJURY_POISONING	injuries	866-874
27030091_en	INJURY_POISONING	injuries	991-999
27030091_en	FINDING	injuries are much less frequent	576-607
27030091_en	FINDING	less frequently suffer from injuries	1168-1204
27030091_en	FINDING	most frequently experience fractures	1330-1366
27030091_en	FINDING	occur more frequently than injuries	964-999
27030091_en	FINDING	most frequently experience fractures	1061-1097
27030091_en	FINDING	most frequent fatal injuries	456-484
27030096_en	LABPROC	chemical toxicological analysis	5-36
27030096_en	CHEM	sertindole	40-50
27030096_en	CHEM	Sertindole	54-64
27030096_en	DISO	schizophrenic	135-148
27030096_en	DISO	intoxication	176-188
27030096_en	CHEM	sertindole	447-457
27030096_en	LABPROC	sertindole extraction from solutions	447-483
27030096_en	CHEM	sertindole	710-720
27030096_en	CHEM	organic solvent	790-805
27030096_en	CHEM	electrolyte	814-825
27030096_en	LABPROC	UV spectrophotometry	896-916
27030096_en	CHEM	sertindole	931-941
27030096_en	ANATOMY	liver	951-956
27030096_en	ANATOMY	kidneys	958-965
27030096_en	ANATOMY	brain	967-972
27030096_en	ANATOMY	heart	974-979
27030096_en	ANATOMY	intestinal	993-1003
27030096_en	CHEM	sertindole	1129-1139
27030096_en	LABPROC	TLC	1162-1165
27030096_en	LABPROC	UV spectrophotometry	1167-1187
27030096_en	LABPROC	HPLC	1193-1197
27030096_en	CHEM	sertindole	1232-1242
27030096_en	ANATOMY	internal organs	1268-1283
27030096_en	ANATOMY	blood plasma	1285-1297
27030096_en	ANATOMY	urine	1303-1308
27030096_en	LABPROC	HPLC	1326-1330
27030096_en	CHEM	sertindole	1359-1369
27030096_en	LABPROC	TLC-screening	1419-1432
27030096_en	LABPROC	TLC	1458-1461
27030096_en	LABPROC	UV spectrophotometric	1463-1484
27030096_en	LABPROC	HPLC techniques	1490-1505
27030096_en	CHEM	sertindole	1550-1560
27030096_en	CHEM	sertindole	1629-1639
27030096_en	ANATOMY	liver	1660-1665
27030096_en	ANATOMY	brain	1670-1675
27030096_en	INJURY_POISONING	acute poisoning	1698-1713
27030096_en	ANATOMY	kidneys	1723-1730
27030096_en	ANATOMY	stomach	1732-1739
27030096_en	ANATOMY	intestines	1745-1755
27030096_en	ANATOMY	heart	1812-1817
27030096_en	CHEM	sertindole	1834-1844
27030096_en	CHEM	sertindole	1872-1882
27030096_en	ANATOMY	blood plasma	1927-1939
27030096_en	LABPROC	measurements of pH, time and frequency of extraction	827-879
27030096_en	ANATOMY	organs	1277-1283
27030096_en	ANATOMY	plasma	1291-1297
27030096_en	ANATOMY	blood	1285-1290
27030096_en	ANATOMY	blood	1927-1932
27030096_en	PHYS	pH	843-845
27030096_en	ANATOMY	contents gastric	1004-988
27030096_en	ANATOMY	intestinal contents	993-1012
27030096_en	FINDING	efficiency of sertindole extraction from solutions	433-483
27030096_en	LABPROC	isolation from biological objects	524-557
27030096_en	LABPROC	detection	559-568
27030096_en	LABPROC	quantitative determination in the extracts	574-616
27030096_en	LABPROC	isolation of sertindole from solutions	697-735
27030096_en	LABPROC	Isolation of sertindole	918-941
27030096_en	LABPROC	determination of sertindole in the extracts	1533-1576
27030096_en	FINDING	maximum amounts of sertindole	1610-1639
27030096_en	FINDING	accumulated in smaller quantities	1760-1793
27030096_en	FINDING	Maximum efficiency of the sertindole extraction	1846-1893
27030096_en	LABPROC	sertindole extraction	1872-1893
27030096_en	CHEM	neuroleptic	85-96
27030096_en	ANATOMY	biological materials	297-317
27030096_en	CHEM	solutions	474-483
27030096_en	LABPROC	detection of intoxication with this medication	163-209
27030096_en	LABPROC	isolation from the biological materials	278-317
27030096_en	CHEM	extracts	608-616
27030096_en	CHEM	solutions	726-735
27030096_en	CHEM	solvent	798-805
27030096_en	FINDING	time and frequency of extraction	847-879
27030096_en	CHEM	extracts	1147-1155
27030096_en	LABPROC	detection of sertindole in the extracts	1116-1155
27030096_en	CHEM	extracts	1250-1258
27030096_en	CHEM	extracts	1390-1398
27030096_en	LABPROC	sertindole liberation from the extracts	1359-1398
27030096_en	CHEM	extracts	1568-1576
27030096_en	INJURY_POISONING	poisoning	1704-1713
27030096_en	FINDING	did not contain sertindole	1818-1844
27030096_en	ANATOMY	plasma	1933-1939
27030096_en	LABPROC	spectrophotometry	899-916
27030096_en	LABPROC	spectrophotometry	1170-1187
27030096_en	LABPROC	spectrophotometric	1466-1484
27030325_en	CHEM	budesonide	11-21
27030325_en	DISO	exacerbations	42-55
27030325_en	DISO	chronic obstructive pulmonary disease	59-96
27030325_en	CHEM	budesonide	243-253
27030325_en	CHEM	systemic glucocorticosteroids	258-287
27030325_en	CHEM	glucocorticosteroids	267-287
27030325_en	CHEM	GCS	289-292
27030325_en	CHEM	SGCS	295-299
27030325_en	DISO	exacerbation	324-336
27030325_en	DISO	chronic obstructive pulmonary disease	340-377
27030325_en	PHYS	leukocyte differentiation	441-466
27030325_en	CHEM	leukocyte differentiation antigens	441-475
27030325_en	DISO	acute exacerbation	544-562
27030325_en	DISO	COPD	566-570
27030325_en	CHEM	budesonide	634-644
27030325_en	CHEM	prednisolone	691-703
27030325_en	DISO	COPD	722-726
27030325_en	PHYS	forced expiratory volume in one second	728-766
27030325_en	PHYS	(FEV1	767-772
27030325_en	PHYS	peripheral blood oxygen saturation	808-842
27030325_en	PHYS	SpO2	844-848
27030325_en	PHYS	levels of the soluble adhesion molecules CD50 (sCD50) and CD54	894-956
27030325_en	CHEM	adhesion molecules	916-934
27030325_en	CHEM	CD50	935-939
27030325_en	CHEM	CD54	952-956
27030325_en	CHEM	lymphocyte activation molecules	973-1004
27030325_en	CHEM	CD38	1005-1009
27030325_en	CHEM	CD25	1022-1026
27030325_en	DISO	COPD	1141-1145
27030325_en	PHYS	FEV1	1147-1151
27030325_en	PHYS	SpO2	1157-1161
27030325_en	DISO	hyperglycemia	1211-1224
27030325_en	CHEM	budesonide	1251-1261
27030325_en	CHEM	sGCS	1280-1284
27030325_en	CHEM	GCSs	1292-1296
27030325_en	ANATOMY	serum	1322-1327
27030325_en	CHEM	soluble interleukin-2 receptor	1337-1367
27030325_en	CHEM	sCD25	1369-1374
27030325_en	CHEM	prednisolone	1394-1406
27030325_en	CHEM	budesonide	1423-1433
27030325_en	CHEM	sCD54	1481-1486
27030325_en	CHEM	sCD50	1488-1493
27030325_en	CHEM	sCD38	1499-1504
27030325_en	CHEM	budesonide	1527-1537
27030325_en	CHEM	SGCS	1578-1582
27030325_en	DISO	exacerbation	1598-1610
27030325_en	DISO	COPD	1614-1618
27030325_en	CHEM	GCSs	1628-1632
27030325_en	CHEM	SGCSs	1641-1646
27030325_en	DISO	pulmonary disease	79-96
27030325_en	DISO	obstructive pulmonary disease	67-96
27030325_en	PHYS	levels of soluble differentiation molecules	141-184
27030325_en	DISO	COPD	379-383
27030325_en	CHEM	soluble leukocyte differentiation antigens	433-475
27030325_en	DISO	exacerbation	550-562
27030325_en	FINDING	significant resolution of the symptoms of COPD, FEV1, and SpO2	1099-1161
27030325_en	FINDING	incidence of hyperglycemia episodes was lower	1198-1243
27030325_en	ANATOMY	serum	888-893
27030325_en	CHEM	soluble adhesion molecules	908-934
27030325_en	CHEM	sCD50	941-946
27030325_en	CHEM	sCD54	958-963
27030325_en	CHEM	soluble adhesion molecules CD50	908-939
27030325_en	CHEM	lymphocyte activation molecules CD38	973-1009
27030325_en	CHEM	sCD38	1011-1016
27030325_en	CHEM	CD25 lymphocyte activation molecules	1022-1004
27030325_en	CHEM	sCD25	1028-1033
27030325_en	FINDING	decrease in the serum level of soluble interleukin-2 receptor	1306-1367
27030325_en	FINDING	reduce the concentrations of sCD54, sCD50, and sCD38	1452-1504
27030325_en	FINDING	immunosuppressive activity	1697-1723
27030325_en	FINDING	exert no immunosuppressive activity	1688-1723
27030325_en	FINDING	exhibit anti-inflammatory activity	1648-1682
27030325_en	ANATOMY	pulmonary	79-88
27030325_en	ANATOMY	pulmonary	360-369
27030325_en	ANATOMY	leukocyte	441-450
27030325_en	ANATOMY	blood	819-824
27030325_en	ANATOMY	lymphocyte	973-983
27030325_en	ANATOMY	serum	410-415
27030325_en	CHEM	oxygen	825-831
27030325_en	CHEM	interleukin	1345-1356
27030325_en	DISO	pulmonary disease	360-377
27030325_en	DISO	obstructive pulmonary disease	348-377
27030325_en	CHEM	soluble differentiation molecules	151-184
27030325_en	PHYS	spirometric indicators	784-806
27030325_en	PHYS	level of soluble interleukin-2 receptor	1328-1367
27030325_en	ANATOMY	serum	135-140
27030325_en	PHYS	concentration of soluble leukocyte differentiation antigens	416-475
27030325_en	DISO	symptoms of COPD	710-726
27030325_en	DISO	symptoms of COPD	1129-1145
27030325_en	FINDING	Efficacy, safety, and effects on the serum levels of soluble differentiation molecules	98-184
27030325_en	CHEM	molecules	175-184
27030325_en	FINDING	efficacy and safety of nebulized budesonide and systemic glucocorticosteroids	210-287
27030325_en	CHEM	antigens	467-475
27030325_en	ANATOMY	peripheral blood	808-824
27030325_en	PHYS	oxygen saturation	825-842
27030325_en	DISO	adverse events	855-869
27030325_en	CHEM	molecules	925-934
27030325_en	CHEM	soluble adhesion molecules CD54	908-956
27030325_en	CHEM	enzyme	1059-1065
27030325_en	PHYS	levels	894-900
27030325_en	PHYS	lymphocyte activation	973-994
27030325_en	CHEM	interleukin-2 receptor	1345-1367
27030325_en	CHEM	receptor	1359-1367
27030325_en	CHEM	interleukin-2	1345-1358
27030325_en	PHYS	concentrations of sCD54, sCD50, and sCD38	1463-1504
27030325_en	FINDING	effective and safe alternative to SGCS	1544-1582
27030332_en	CHEM	protease inhibitors	15-34
27030332_en	DISO	chronic hepatitis C	88-107
27030332_en	DISO	liver cirrhosis	523-538
27030332_en	CHEM	peginterferon	578-591
27030332_en	CHEM	ribavirin	612-621
27030332_en	DISO	obesity	648-655
27030332_en	DISO	insulin resistance	663-681
27030332_en	CHEM	PIs	731-734
27030332_en	CHEM	boceprevir	736-746
27030332_en	CHEM	telaprevir	754-764
27030332_en	CHEM	simeprevir	776-786
27030332_en	PHYS	mutations	906-915
27030332_en	PHYS	mutations	988-997
27030332_en	FINDING	reducing drug susceptibility	1034-1062
27030332_en	DISO	CHC	1090-1093
27030332_en	CHEM	interferon-α	1135-1147
27030332_en	CHEM	PIs	1173-1176
27030332_en	PHYS	mutations	1301-1310
27030332_en	FINDING	Resistance to protease inhibitors	1-34
27030332_en	DISO	hepatitis C	96-107
27030332_en	DISO	hepatitis C virus (HCV) infection	428-461
27030332_en	FINDING	sustained virologic response	830-858
27030332_en	CHEM	protease inhibitors	199-218
27030332_en	CHEM	PIs	220-223
27030332_en	DISO	chronic hepatitis C	225-244
27030332_en	DISO	CHC	246-249
27030332_en	FINDING	sensitive to interferon-α	1122-1147
27030332_en	ANATOMY	liver	523-528
27030332_en	CHEM	insulin	663-670
27030332_en	CHEM	inhibitors	24-34
27030332_en	CHEM	inhibitors	208-218
27030332_en	DISO	infection	452-461
27030332_en	DISO	hepatitis C	233-244
27030332_en	DISO	hepatitis C	428-439
27030332_en	FINDING	efficiency of antiviral therapy	39-70
27030332_en	PHYS	virus resistance	138-154
27030332_en	CHEM	interferon-α	290-302
27030332_en	FINDING	failed to achieve a sustained virologic response	810-858
27030332_en	CHEM	protease	15-23
27030332_en	DISO	hepatitis	96-105
27030332_en	FINDING	efficiency of antiviral therapy	162-193
27030332_en	CHEM	protease	199-207
27030332_en	DISO	hepatitis	233-242
27030332_en	DISO	hepatitis	428-437
27030332_en	DISO	cirrhosis	529-538
27030332_en	FINDING	ineffectively treated	551-572
27030332_en	CHEM	interferon	1135-1145
27030431_en	CHEM	APPs	198-202
27030431_en	ANATOMY	tears	220-225
27030431_en	ANATOMY	oral fluid	227-237
27030431_en	ANATOMY	blood plasma	243-255
27030431_en	CHEM	C-reactive protein	435-453
27030431_en	CHEM	orosomucoid	458-469
27030431_en	CHEM	transferrin	520-531
27030431_en	ANATOMY	tears	535-540
27030431_en	DISO	herpes	560-566
27030431_en	ANATOMY	tear	597-601
27030431_en	ANATOMY	saliva	603-609
27030431_en	ANATOMY	plasma	615-621
27030431_en	DISO	corneal inflammation	697-717
27030431_en	CHEM	APPs	797-801
27030431_en	ANATOMY	tear	827-831
27030431_en	DISO	herpes keratitis	851-867
27030431_en	DISO	corneal lesions	897-912
27030431_en	FINDING	recurrence rate	914-929
27030431_en	CHEM	acute phase proteins	983-1003
27030431_en	ANATOMY	tear	1007-1011
27030431_en	ANATOMY	oral fluid	1016-1026
27030431_en	LABPROC	non-invasive monitoring	1096-1119
27030431_en	ANATOMY	Oral fluid	1157-1167
27030431_en	DISO	ophthalmic herpes	1233-1250
27030431_en	ANATOMY	plasma	34-40
27030431_en	ANATOMY	plasma	249-255
27030431_en	ANATOMY	saliva	22-28
27030431_en	ANATOMY	tear	16-20
27030431_en	ANATOMY	ophthalmic	292-302
27030431_en	ANATOMY	ophthalmic	1233-1243
27030431_en	ANATOMY	blood	243-248
27030431_en	ANATOMY	corneal	697-704
27030431_en	ANATOMY	corneal	897-904
27030431_en	CHEM	protein	446-453
27030431_en	CHEM	APPs	622-626
27030431_en	CHEM	proteins	63-71
27030431_en	CHEM	proteins	995-1003
27030431_en	CHEM	acute phase proteins	51-71
27030431_en	DISO	keratitis	119-128
27030431_en	DISO	keratitis	567-576
27030431_en	DISO	keratitis	858-867
27030431_en	DISO	ophthalmic herpes	292-309
27030431_en	DISO	herpes keratitis	112-128
27030431_en	DISO	herpes keratitis	560-576
27030431_en	DISO	herpes	112-118
27030431_en	DISO	herpes	303-309
27030431_en	DISO	herpes	851-857
27030431_en	DISO	inflammation	82-94
27030431_en	DISO	inflammation	705-717
27030431_en	DISO	inflammation	1053-1065
27030431_en	PHYS	APPs levels	622-633
27030431_en	FINDING	APPs concentration changes	797-823
27030431_en	FINDING	poor prognostic signs	651-672
27030431_en	PHYS	levels of acute phase proteins	41-71
27030431_en	CHEM	APPs	73-77
27030431_en	LABPROC	spectrophotometric methods of detection	371-410
27030431_en	LABPROC	immunoturbidimetric methods of detection	347-410
27030431_en	CHEM	ceruloplasmin	485-498
27030431_en	FINDING	low levels of ceruloplasmin, α1-antitrypsin, and transferrin	471-531
27030431_en	CHEM	α1-antitrypsin	500-514
27030431_en	FINDING	High levels of C-reactive protein and orosomucoid	420-469
27030431_en	FINDING	disease dynamics	935-951
27030431_en	LABPROC	Quantitative determination of acute phase proteins	953-1003
27030431_en	LABPROC	non-invasive diagnostics	1205-1229
27030431_en	FINDING	correlates with the depth of corneal lesions	868-912
27030431_en	PHYS	healthy	324-331
27030431_en	ANATOMY	oral	227-231
27030431_en	FINDING	abnormal tear, saliva, and plasma APPs levels	588-633
27030431_en	PHYS	APPs concentration	797-815
27030431_en	DISO	recurrence	914-924
27030431_en	ANATOMY	oral	1016-1020
27030431_en	ANATOMY	Oral	1157-1161
27030431_en	DISO	herpes	1244-1250
